B Cell Receptor Signaling Pathway%WikiPathways_20191210%WP23%Homo sapiens -6.92 -2.03 0.85 -3.45 -6.21 -2.17 8.21 5.36 -0.98 2.31 6.99 1.19 8.92 0.25 1.44 -2.56 -6.2 -4.81 1.52 4.46 -7.16 -4.83 -0.34 4.77 2.15 -1.19 -0.23 4.3 1.38 6.21 2.41 4.3 -6.61 -0.78 0.71 2.23 -3.2 -3.05 -7.24
Trans-sulfuration pathway%WikiPathways_20191210%WP2333%Homo sapiens -3.91 -1.5 0.08 1.33 -1.57 1.12 1.43 1.24 -0.93 1.32 2.34 -0.52 0.67 -0.19 0.06 -1.27 -2.46 -2.24 -1.07 1.98 -1.51 -2.08 -1.18 2.06 0.33 -0.96 0.96 1.59 -0.2 1.17 1.94 2.65 -0.8 0.95 1.11 1.1 -0.25 1.2 -3.99
Nanoparticle triggered autophagic cell death%WikiPathways_20191210%WP2509%Homo sapiens -2.19 -0.04 1.46 -3.62 -2.99 -1.35 4.97 1.79 -1.5 1.36 1.2 0.66 4.45 1.24 0.77 -1.48 -3.2 -1.95 1.1 1.22 -5.16 -2.96 0.56 3.19 -0.35 -1.21 0.43 1.18 0.67 3.97 1.25 1.98 -1.57 0.27 0.39 1.04 0.04 -1.79 -3.84
Mammary gland development pathway - Embryonic development (Stage 1 of 4)%WikiPathways_20191210%WP2813%Homo sapiens -2.12 -4.54 -0.28 4.57 0.51 2.3 -1.69 -0.1 -0.86 1.45 -1.35 -2.11 -3.25 0.44 0.08 -0.57 -0.31 -1.18 -1.55 0.69 5.68 0.96 -1.88 -1.64 -0.88 0.18 2 1.24 -0.71 -2.57 0.83 0.63 0.02 0.69 1.43 1.22 0.76 4.14 -2.23
Codeine and Morphine Metabolism%WikiPathways_20191210%WP1604%Homo sapiens -1.99 0.17 0.88 -3.17 -1.8 -2.18 5.24 2.06 -0.76 0.43 3.65 1.15 4.4 -0.66 0.53 -1.13 -2.34 -2.23 2.27 0.73 -4.02 -1.81 0.91 3.99 0.72 -1.15 -0.3 2.99 1.49 2.48 1.4 1.33 -3.24 -0.14 -0.25 -0.09 -2.58 -3.98 -2.98
Calcium Regulation in the Cardiac Cell%WikiPathways_20191210%WP536%Homo sapiens -9.24 -2.66 -0.07 -2.72 -7.41 -4.83 12.08 6.09 0.1 2.87 10.15 1.93 12.12 0.77 2.65 -3.9 -7.73 -7.03 1.37 4.08 -7.97 -6.12 -0.89 5.38 5.59 -0.62 -0.33 6.93 1.95 8.76 2.72 3.55 -9.73 -0.1 -0.62 1.1 -4.75 -3.83 -9.66
Alanine and aspartate metabolism%WikiPathways_20191210%WP106%Homo sapiens -3.34 -1.72 -0.59 0.35 -1.17 -0.61 4.4 2.4 -2.64 1.87 2.65 -0.36 4.01 -0.56 1.52 -0.7 -2.04 -2.63 -0.74 1.65 -1.51 -1.93 -0.34 1.07 0.64 -2.53 1.91 2.75 -0.2 2.27 -0.12 0.34 -3.03 0.23 0.96 2.05 -1.12 -0.18 -2.98
White fat cell differentiation%WikiPathways_20191210%WP4149%Homo sapiens 4.99 1.47 -0.8 0.28 2.72 -1.11 -6.1 -2.97 0.3 -1.91 -2.69 1.03 -4.88 0.4 -0.55 2.89 4.89 2.29 0.04 -1.24 3.13 2.69 0.76 -3.39 -3.18 0.15 0.07 -3.95 -0.29 -1.82 -2.81 -1.63 2.92 0.9 0.5 -1.53 1.6 1.39 5.49
EGF/EGFR Signaling Pathway%WikiPathways_20191210%WP437%Homo sapiens -11.79 -6.12 -0.84 0.85 -8.32 -0.53 8.57 5.91 -1.32 3.41 7.64 -1.08 9.39 1.91 3.04 -3.8 -9.01 -7.39 -1.37 4.3 -4.99 -6.31 -1.54 6.14 3.4 -1.29 2.65 6.15 0.25 6.89 3.96 4.44 -7.17 3.11 1.65 4.01 -2.06 -0.64 -12.09
DNA Replication%WikiPathways_20191210%WP466%Homo sapiens 3.64 -0.28 -2.27 5.13 3.79 3.83 -5.3 -2.73 0.86 -0.89 -5.05 -1.43 -5.32 0.36 -1.96 1 3.87 3.24 -2.77 -1.26 5.64 3.48 -0.35 -3.11 -2.33 -0.29 -0.21 -3.6 -1.93 -4.79 -2.16 -2.2 4.81 1.2 -1.21 -1.41 2.74 4.07 5.19
Pyrimidine metabolism%WikiPathways_20191210%WP4022%Homo sapiens 5.62 0.65 -2.46 3.15 5.13 1.46 -7.25 -4.28 1.78 -1.01 -4.75 -0.62 -5.76 0.28 -2.2 1.48 5.78 3.48 -2.13 -3.04 7.41 4.36 -0.88 -3.87 -2.85 1.31 -0.26 -3.28 -1.75 -5.95 -2.42 -4.15 5.49 -0.68 -1.25 -1.64 3.38 4.04 7.7
Vitamin B12 Metabolism%WikiPathways_20191210%WP1533%Homo sapiens 1.91 -0.58 -1.86 5.84 4.67 3.61 -7.59 -2.29 1.04 -0.43 -5.57 -1.9 -6.47 1.12 -0.56 -0.06 2.27 2.92 -3.07 -2.02 7.57 3.36 -0.38 -2.99 -1.88 -0.55 1.89 -4.31 -1.53 -5.46 -1.76 -3.68 4.73 0.9 -0.44 0.32 3.8 6.14 3.27
Angiopoietin Like Protein 8 Regulatory Pathway%WikiPathways_20191210%WP3915%Homo sapiens -8.57 -2.92 1.19 -4.01 -7.07 -3.93 12.11 5.6 -1.45 3.52 9.1 1.09 11.81 -0.1 2.69 -4.57 -7.45 -6.07 1.44 4.96 -9.72 -5.17 0.72 5.21 2.44 -1.19 -0.19 6.9 1.98 8.02 3.16 4.31 -8.45 -1.15 0.52 2.21 -3.44 -3.96 -9.57
DNA Damage Response%WikiPathways_20191210%WP707%Homo sapiens 4.64 0.72 -1.38 4.23 4.89 2.92 -8.1 -3.83 0.77 -2.01 -5.96 -0.95 -9.52 -0.97 0.09 2.48 6.18 3.45 -0.1 -1.75 7.01 4.46 0.66 -3.64 -3.6 1.51 -0.13 -4.89 -1.06 -5.6 -3.55 -2.55 5.24 -1.42 0 -1.12 2.52 3.54 6.8
Oxidative Damage%WikiPathways_20191210%WP3941%Homo sapiens 4.51 1.94 -0.4 -1.82 4.07 2.19 -5.08 -2.9 0.93 -1.81 -5.52 0.49 -3.33 0.31 -1.7 1.98 4.81 3.11 1.26 -1.39 2.46 2.38 1.06 -1.56 -3.02 1.38 -1.08 -7.11 0.37 -1.35 -2.2 -2.24 4.45 -0.21 -2.21 -1.96 2.64 0.72 5.84
Spinal Cord Injury%WikiPathways_20191210%WP2431%Homo sapiens -2.57 1.25 1.76 -9.55 -6.07 -5.36 12.37 6.31 1.7 1.59 9.23 3.64 10.15 -1.75 0.38 -1.8 -4.41 -3.53 4.24 2.6 -12.22 -5.57 1.55 5.51 3.08 0.86 -3.38 6.08 3.18 6.49 3.05 2.84 -7.32 -4.55 -2.98 -0.98 -4.43 -7.43 -3.96
Nicotine Activity on Dopaminergic Neurons%WikiPathways_20191210%WP1602%Homo sapiens -3.78 -2.23 -1.61 -1.16 -4.16 -2.36 5.02 3.65 2.34 1.27 3.56 2.39 5.78 1.17 0.46 -2.3 -2.75 -2.74 -0.82 0.23 -2.7 -3.2 -1.7 2.77 2 0.7 0.22 2.84 1 3.34 0.45 0.92 -3.62 0.34 -0.75 0.62 -1.47 0.45 -4.17
PI3K/AKT/mTOR - VitD3 Signalling%WikiPathways_20191210%WP4141%Homo sapiens 2.91 -0.02 -1.67 2.39 3.1 4.97 -5.37 -2.31 1.33 -1.62 -4.66 -1.57 -5.56 0.29 -0.23 0.75 2.99 2.59 -1.85 -1.99 4.36 2.64 -0.44 -2.77 -2.01 0.71 1.18 -2.3 -1.15 -4.04 -2.23 -1.75 3.31 2.27 -1.27 0.48 2.31 2.41 3.85
IL-1 signaling pathway%WikiPathways_20191210%WP195%Homo sapiens -7.83 -4 0.26 3.53 -5.37 -0.65 3.52 3.46 -1.65 0.96 3.24 -1.28 5.56 1.21 2.22 -2.61 -6.26 -5 -1.52 3.41 -0.71 -3.67 -1.62 2.46 2.42 -1.88 3.55 2.74 -0.95 3.57 2.4 3.31 -5.01 3.01 2.14 3.41 -0.57 2.77 -8.54
Gastric Cancer Network 1%WikiPathways_20191210%WP2361%Homo sapiens -2.39 -0.44 1.39 -2.28 -3.01 -2.12 5.96 1.82 -1.16 0.69 5.78 1.45 5 0.4 0.74 -1.17 -2.85 -2.97 1.36 1.22 -4.47 -1.78 1.12 2.55 1.09 -0.74 -1.86 3.45 2.59 3.52 1.39 0.76 -3.41 -1.72 0.71 -0.01 -3.1 -3.17 -4.34
Copper homeostasis%WikiPathways_20191210%WP3286%Homo sapiens 6.08 0.47 -0.33 2.51 4.93 0.81 -4.67 -3.01 -1.27 -2.74 -3.27 -2.38 -7.88 -3.04 -1.68 2.69 5.59 1.64 2.07 -0.19 5.13 4.48 0.3 -3.07 -1.76 -0.49 0.91 -1.15 -2.15 -5.47 -1.46 -1.63 2.06 -3.67 0.48 -1.68 1.07 2.79 9
Kit receptor signaling pathway%WikiPathways_20191210%WP304%Homo sapiens -4.96 -1.86 0.32 -3.02 -4.22 -2.72 6.95 4.86 0.33 0.75 6.44 1.75 7.77 -0.79 1.04 -1.86 -4.65 -4.37 1.58 2.54 -6.4 -3.56 0.29 3.95 0.87 0.25 -0.76 4.54 1.21 4.16 1.57 2.61 -4.75 -1.53 -0.85 1.22 -2.21 -2 -4.5
TGF-beta Receptor Signaling%WikiPathways_20191210%WP560%Homo sapiens 0.18 -1.66 -1.23 6.61 3.42 3.95 -9.13 -1.99 0.21 -1.48 -5.43 -1.39 -6.72 1.88 0.2 1.55 1.74 3.08 -3.38 -2.21 8.05 2.01 -2.15 -3.37 -0.33 0.67 2.25 -2.98 -1.32 -4.93 -1.73 -1.54 4.09 3.11 0.57 0.37 3.16 4.6 1.25
Vitamin D Metabolism%WikiPathways_20191210%WP1531%Homo sapiens -1.98 0.26 1.23 -2.99 -2.5 -2.62 5.1 2.09 -0.19 1.37 3.49 1.57 5.12 0.26 0.05 -1.42 -2.83 -2.32 1.06 0.73 -4.11 -2.09 0.2 3.12 1.96 -0.14 -0.58 2.65 1.39 2.76 2.33 0.59 -2.85 -1.34 -0.9 -0.12 -2.61 -3.07 -2.68
miRNAs involvement in the immune response in sepsis%WikiPathways_20191210%WP4329%Homo sapiens -2.23 0.27 2.46 -2.24 -4.03 -3.4 5.13 2.43 -0.68 0.13 5.98 1.31 5.33 -0.85 3.58 -1.31 -3.56 -2.28 1.82 2.63 -3.36 -2.38 0.94 3.13 2.21 -0.65 -1.08 2.44 0.4 3.59 1.01 2.26 -5.38 -1.85 -0.19 0.28 -4.14 -4.24 -3.48
Prostaglandin Synthesis and Regulation%WikiPathways_20191210%WP98%Homo sapiens 0.41 1.09 1.29 -8.98 -1.88 -3.36 6.76 1.9 0.44 1.36 3.88 2.99 7.19 -0.8 1.02 -2.15 -1.99 -1.99 2.52 1.03 -7.4 -1.64 1.37 3.12 0.55 0.27 -1.29 2.82 2.38 4.5 0.99 0.52 -3.06 -3.55 -1.78 -0.28 -2.93 -5.63 0.32
Amyotrophic lateral sclerosis (ALS)%WikiPathways_20191210%WP2447%Homo sapiens -5.69 -2.87 -0.42 0.6 -3.95 -0.19 2.09 3.22 -3.46 2.25 1.73 -2.45 7.26 1.33 1.87 -1.42 -4.06 -2.79 -1.9 1.39 -0.83 -3.03 -0.73 1.24 2.55 -3.7 3.37 1.35 -1.26 5.51 1.09 1.91 -3.27 3.96 2.04 2.49 0.18 1.36 -6.77
Serotonin Receptor 4/6/7 and NR3C Signaling%WikiPathways_20191210%WP734%Homo sapiens -4.39 -2 0.18 -0.57 -3.02 0.09 5 4.02 -0.51 0.49 4.05 -0.95 4.6 -1.17 0.45 -1.87 -2.79 -2.85 0.9 2.4 -3.54 -1.52 1.01 1.82 1.16 -0.76 0.75 1.95 0.32 3.22 1.92 0.62 -4.07 -1.24 -1.09 0.34 -0.84 1.31 -3.43
ID signaling pathway%WikiPathways_20191210%WP53%Homo sapiens 3.15 3.24 -0.06 -5.83 1.31 -3.28 2.52 -2.04 0.38 -2.6 1.04 1.33 0.89 0.76 -1.26 0.94 2.14 1.07 1.68 0.29 -5.43 1.17 1.64 0.49 -2.31 -0.81 -3.06 -1.13 -0.1 2.02 0.58 1.16 0.4 0.54 -0.87 0.53 0.29 -3.64 2.84
Integrated Breast Cancer Pathway%WikiPathways_20191210%WP1984%Homo sapiens -8.05 -2.04 1.22 -3.79 -6.77 -3.89 11.19 4.05 -0.56 2.37 8.82 1.28 9.28 2.27 1.73 -2.69 -7.02 -5.34 0.38 3.9 -9.2 -4.34 -1.05 3.62 5.43 -1.71 -0.52 6.24 1.26 8.06 2.59 4.2 -7.56 3.36 1.21 0.04 -3.8 -4.9 -9.26
Glycerolipids and Glycerophospholipids%WikiPathways_20191210%WP4722%Homo sapiens -3.88 -2.04 -1.13 -0.93 -3.78 -4.69 1.74 2.44 0.2 0.72 2 1.49 4.73 0.57 1.98 -1.12 -0.96 -3.46 0.13 0.86 -1.11 -2.88 -1.23 2.84 1.42 0.86 1.11 2.78 1.24 1.57 0.42 -0.43 -2.04 -1.02 0.41 1.07 0.1 2.48 -2.47
Type II interferon signaling (IFNG)%WikiPathways_20191210%WP619%Homo sapiens 2.47 -0.84 0.48 -8.46 -0.28 -0.75 5.23 -0.31 2.12 0.53 -1.04 3.48 6.15 -0.45 -3.06 1.85 0.65 -5 2.7 0.57 -7 -0.06 2.59 2.92 -1.19 1.81 -1.84 -4.04 3.52 4.7 1.35 0.51 -0.56 -1.11 -4.43 -1.26 -0.91 -3.56 2.49
Development and heterogeneity of the ILC family%WikiPathways_20191210%WP3893%Homo sapiens -2.08 1.01 2.13 -5.65 -4.13 -2.43 9.19 3.49 -0.93 0.9 6.12 1.94 7.67 -0.99 1.06 -2.06 -3.25 -2.79 3.33 0.85 -7.66 -4.03 1.29 4.53 3.25 0.02 -1.55 4.84 2.69 4.34 2.71 0.18 -5.33 -3.28 -1.86 0.64 -4.08 -5.99 -4.06
Mitochondrial LC-Fatty Acid Beta-Oxidation%WikiPathways_20191210%WP368%Homo sapiens 2.81 -0.3 0.18 1.28 1.1 0.85 -5.63 -0.45 -0.88 0.06 -2.21 -2.56 -1.34 -1.14 0.45 0.26 1.94 1.06 0.7 -1.58 2.8 -0.09 1.1 -0.76 -1.91 -0.37 0.54 1.82 -0.47 -3.43 0.32 -2.68 1.92 -1.63 1.04 0.74 1.29 2.39 2.78
Hematopoietic Stem Cell Differentiation%WikiPathways_20191210%WP2849%Homo sapiens 2.21 -0.79 -1.99 6.01 5.55 4.16 -8.78 -3.46 0.13 -1.96 -6.33 -1.99 -8.31 0.79 -1.3 2.2 4.4 4.01 -3.81 -2.2 7.91 3.61 -1.12 -4.7 -3.09 -0.21 1.64 -4.91 -2.44 -5.86 -2.97 -1.89 6.57 3.35 1.93 -0.64 3.9 5.73 4.66
Methionine De Novo and Salvage Pathway%WikiPathways_20191210%WP3580%Homo sapiens -3.38 -1.42 0.25 -2.84 -2.36 -1.22 5.36 2.05 -0.36 -0.32 4.56 0.87 3.39 -0.02 0.02 -1.44 -2.42 -2.05 0.87 2.33 -3.32 -2.69 0.92 3.27 -0.9 0.12 -0.26 3.15 1.51 1.26 1.54 2.85 -3.32 -0.43 -0.41 1.09 -1.81 -0.99 -3.44
TP53 Network%WikiPathways_20191210%WP1742%Homo sapiens -1.62 0.47 1.21 -3.6 -2.17 -2.31 5.23 2.34 -1.42 0.15 3.19 0.85 3.52 -0.5 0.55 0.85 -2.14 -2.57 1.54 0.99 -3.54 -2.31 0.31 2.01 0.78 -0.16 -1.02 3.08 0.44 3.49 0.91 2.98 -2.71 -1.74 -0.37 1.79 -1.43 -4.55 -2.54
GABA receptor Signaling%WikiPathways_20191210%WP4159%Homo sapiens -5.34 -2.58 0.15 1.3 -4.47 -1.49 6.34 3 -2.55 1.49 4.06 -0.2 5.48 0.09 1.87 -1.56 -2.83 -3.79 0.91 3.12 -3.78 -4.01 -0.05 3.27 2.14 -1.54 1.57 3.35 0.16 3.42 2.48 1.53 -5.97 0.48 1.01 1.14 -2.21 -1.38 -4.61
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition%WikiPathways_20191210%WP3859%Homo sapiens 0.6 -1.63 0.13 3.96 1.49 2.28 -5.45 -1.21 -0.28 0.04 -5.19 -1.36 -3.83 0.92 -0.79 0.92 0.95 1.52 -1.43 0.03 5.58 1.27 -1.12 -1.35 -2.02 -0.14 1.51 -2.19 -1.02 -2.17 -0.8 -0.05 1.94 2.74 0.37 0.36 2.08 2.92 0.42
Valproic acid pathway%WikiPathways_20191210%WP3871%Homo sapiens -1.32 -0.04 0.72 -2.59 -2.34 -0.44 4.08 1.99 1.53 0.76 1.89 0.53 4.82 -0.13 0.26 -1.39 -2.45 -1.21 0.15 0.56 -2.93 -2.43 -1.33 1.01 2.39 0.12 0.22 2.86 1.51 3.62 0.45 0.77 -1.86 -0.97 -0.71 -0.7 -1.63 -2.33 -3.43
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways%WikiPathways_20191210%WP706%Homo sapiens -8.95 -1.77 0.74 -2.51 -8.96 -6 12.57 7.52 0.4 4.04 9.48 2.88 15.25 1.01 1.48 -4.05 -9.45 -6.54 1.6 3.53 -10.57 -8.4 -1.13 7.91 6.07 -0.51 -0.37 6.05 2.19 8.6 4.44 3.83 -11.41 0.57 -1.2 2.06 -5.15 -4.08 -11.19
Histone Modifications%WikiPathways_20191210%WP2369%Homo sapiens 3.58 0.18 -1.5 2.77 3.48 1.22 -5.96 -1.97 -0.35 0.21 -3.2 -0.33 -6.4 0.35 -0.61 1.72 3.2 2.34 -0.5 -1.06 5.48 1.94 0.31 -3.54 -1.6 0.26 0.36 -2.26 -1.17 -4.08 -2.45 -2.33 2.29 0.25 -0.83 -0.06 1.45 4.05 4.77
Pathways in clear cell renal cell carcinoma%WikiPathways_20191210%WP4018%Homo sapiens -8.86 -6.01 0.36 2.24 -7.09 -0.73 8.04 7.42 -3.2 3.61 9.1 -2.09 6.61 -2.29 1.82 -4.11 -5.78 -5.66 0.65 3.23 -3.79 -6.15 -1.36 4.99 3.3 -1.13 2.43 9.75 -0.02 2.48 4.31 1.65 -6.2 -1.43 0.59 2.1 -1.79 1.44 -8.45
miRNAs involved in DNA damage response%WikiPathways_20191210%WP1545%Homo sapiens -0.52 1.29 1.22 -4.23 -1.05 -1.24 3 1.26 0.48 -0.37 2.39 1.22 5 0.08 0.09 -1.13 -1.5 -0.37 1.21 0.27 -3.81 -1.76 1.51 0.76 2.33 -0.58 -1.36 0.84 0.65 2.86 0.3 0.12 -1.48 -0.56 -1.19 -0.16 -1.39 -3.34 -0.83
Zinc homeostasis%WikiPathways_20191210%WP3529%Homo sapiens -5.78 0.42 1.02 -0.97 -4.77 -0.81 1.18 1.66 1.91 2.56 -0.15 2.08 5.95 4.25 2.8 -3.47 -5.18 -0.3 -2.95 0.28 -3.19 -5.2 1.74 2.24 0.38 1.27 0.01 -1.89 2.03 4.82 0.32 1.2 0.1 3.34 1.22 2.27 0.66 -2.3 -8.74
BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation%WikiPathways_20191210%WP3876%Homo sapiens 1.64 -0.86 -0.31 2.62 2.18 1.67 -6.39 -1.33 1.03 -1.76 -3.37 -0.5 -3.62 0.73 -0.26 1.16 2.06 2.45 -1.4 -1.02 3.86 1.32 -1.55 -2.71 -1.22 0.53 1.32 -2.33 -1.29 -3.03 -2 -0.35 3.14 2.63 0.3 0.27 2.23 2.29 1.89
Alzheimers Disease%WikiPathways_20191210%WP2059%Homo sapiens -9.23 -4.05 1.66 1.31 -6.7 -1.67 7.74 4.67 -1.77 3.02 6.26 -0.69 7.71 1.85 1.85 -2.82 -6.4 -5.07 0.18 4.01 -3.7 -5.71 -0.62 3.28 3.93 -1.6 1.83 5.04 0.1 5.05 3.75 3.91 -7.15 2.28 0.2 1.37 -2.93 -0.91 -9.96
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway%WikiPathways_20191210%WP2203%Homo sapiens 6.42 1.66 -0.25 -0.03 4.55 1.66 -5.83 -3.66 1.22 -0.74 -5.51 -0.25 -6.14 0.04 -2.08 1.9 4.92 3.92 -0.58 -3.49 2.92 2.96 -0.12 -2.93 -2.24 0.89 -0.65 -3.49 -0.43 -3.6 -1.52 -2.15 5.7 -0.31 -0.66 -2.03 2.84 0.63 6.49
Imatinib and Chronic Myeloid Leukemia%WikiPathways_20191210%WP3640%Homo sapiens -4.44 -4.03 1.73 6.02 -1.31 1.77 0.9 1.37 -0.76 1.43 1.41 -0.76 0.65 0.14 -0.31 -1.49 -3.54 -3.75 0.16 2.38 0.63 -1.61 -1.05 1.01 2.36 -0.04 2.31 1.74 -2.63 -1.49 1.45 2.17 -2.37 1.7 0.59 0.88 -0.75 1.78 -4.22
Eicosanoid Synthesis%WikiPathways_20191210%WP167%Homo sapiens 0.44 -0.44 -0.38 5.38 1.29 3.52 -4.77 -1.26 0.16 -0.48 -2.88 -1.74 -5.98 -0.21 -0.48 0.73 0.4 3.53 -3.32 -1 6.06 1.18 -1.31 -1.65 -0.17 0.27 2.49 -1.58 -1.06 -4.35 -0.97 -1.01 3.27 1.07 1.1 -1.05 0.2 4 1.01
Signaling of Hepatocyte Growth Factor Receptor%WikiPathways_20191210%WP313%Homo sapiens -6.31 -3.42 -0.78 1.67 -3.8 0.79 2.79 5.2 0.86 1.19 3.31 0.62 2.93 -0.49 1.23 -2.02 -3.72 -2.86 -0.95 1.9 -0.31 -3.27 -0.82 3.4 2.83 0.62 2.21 3.25 1.41 0.37 1.24 -0.64 -4.11 -0.56 -0.64 1.44 -0.94 2.74 -6.36
Signal Transduction of S1P Receptor%WikiPathways_20191210%WP26%Homo sapiens 3.8 1.21 0.12 0.7 3.6 2.08 -4.07 -2.12 0.06 -1.97 -3.53 0.58 -5.01 0.32 -1.6 2.32 2.25 2.41 -0.48 -1.04 3.33 2.53 0.69 -1.65 -1.87 0.31 -1.54 -3.03 -1.07 -2.56 -2.21 -0.9 4.53 0.03 -0.3 -0.93 0.26 0.82 3.94
Selenium Micronutrient Network%WikiPathways_20191210%WP15%Homo sapiens -2.97 -0.31 1.86 -6.73 -5.09 -5.4 9.41 2.53 -0.97 0.32 7.68 2.2 9.31 -1.74 0.95 -0.54 -3.65 -4.79 3.84 3.22 -9.67 -2.74 0.51 4.74 1.97 0.28 -2.52 4.57 1.5 6.49 2.3 4.76 -5.9 -1.96 0.99 0.72 -3.48 -7.25 -4.43
Eukaryotic Transcription Initiation%WikiPathways_20191210%WP405%Homo sapiens -5.04 -1.67 2.7 -3.12 -2.26 -1.89 4.45 1.56 -4.82 -0.33 1.9 -1.91 -0.26 1.33 0.81 -0.79 -1.89 -3.03 1.95 4.94 -2.3 -2.7 1.83 1.69 -1.84 -1.94 2.43 2.69 0.08 1.9 1.29 5.78 -2.16 0.97 2.8 3.53 -0.29 -1.03 -5.35
Wnt Signaling Pathway and Pluripotency%WikiPathways_20191210%WP399%Homo sapiens -6.6 -1.56 1.81 -3.97 -5.75 -1.24 10.18 4.43 -0.84 1.8 8.02 1.55 9.17 -0.19 1.22 -3.04 -6.59 -4.58 2.42 3.75 -9.46 -5.08 0.89 4.23 4.26 -0.47 -1.22 3.86 1.25 7.4 2.64 4.3 -6.48 0.62 -0.25 1.37 -3.79 -5.18 -8.92
Glutathione metabolism%WikiPathways_20191210%WP100%Homo sapiens 2.3 0.44 -1.63 3.05 2.4 0.58 -6.62 -1.77 0.09 1 -3.13 -1.68 -3.15 1.09 -1.45 1.38 2.52 2.69 -0.82 -3.48 3.9 1.3 -0.4 -1.76 -1.4 -0.44 2.12 -1.77 0.19 -1.26 -1.23 -1.81 2.48 -0.29 -0.63 -0.14 1.85 3.02 2.46
NOTCH1 regulation of human endothelial cell calcification%WikiPathways_20191210%WP3413%Homo sapiens 2.24 2.81 -2.6 -2.82 1.41 -3.17 1.14 -1.85 1.91 -1.07 1.08 1.27 1.2 0.09 -0.04 1.38 1.93 2.23 -0.8 -3.45 -3.14 0.07 0.25 -0.06 -2.68 1.13 -1.5 -0.8 1.14 1.76 -0.79 -0.62 1.83 -0.87 -0.49 -1.51 0.54 -1.4 4.25
Role of Osx and miRNAs in tooth development%WikiPathways_20191210%WP3971%Homo sapiens 1.31 -0.37 -0.49 2.54 1.84 -0.01 -2.7 -1.85 0.65 -1.24 -2.2 -1.35 -3.14 -0.94 -0.42 0.8 2.33 1.06 -1.99 0.05 4.73 2.24 -0.16 -1.44 -0.63 0.15 -0.37 -0.69 -1.39 -2.47 -1.08 -0.79 1.95 0.92 1.47 -0.06 0.89 1.51 1.35
Deregulation of Rab and Rab Effector Genes in Bladder Cancer%WikiPathways_20191210%WP2291%Homo sapiens -3.68 -1.88 -0.31 -0.66 -2.81 -2.19 3.88 2.19 -0.07 0.48 3.82 0.9 3.52 0.87 0.65 -0.51 -1.73 -3.26 -0.52 1.79 -1.52 -1.72 -1.75 1.47 0.29 0.63 0.62 1.87 -0.18 3.19 0.21 1.75 -2.72 0.45 0.37 0.97 -0.23 -1.27 -2.91
IL-5 Signaling Pathway%WikiPathways_20191210%WP127%Homo sapiens -5.09 -1.81 -0.33 -2.52 -3.84 -0.36 5.67 5.31 0.22 0.72 4.09 1.43 5.49 -1.25 0.42 -1.53 -4.58 -3.5 0.54 3.08 -4.57 -3.38 -0.43 3.86 2.28 0.28 -0.19 4.1 1.53 3.87 1.12 1.63 -3.48 -1.71 -0.81 0.57 -1.52 -1.22 -4.05
Sterol Regulatory Element-Binding Proteins (SREBP) signalling%WikiPathways_20191210%WP1982%Homo sapiens 8.24 3.58 -0.42 -0.29 6.51 2.81 -5.57 -4.53 3.24 -3.73 -5.42 1.34 -7.78 -2.43 -2.11 3.1 5.74 4.38 0.11 -2.72 5.08 4.37 0.47 -3.71 -3.68 1.93 -1.6 -4.25 0.59 -6.22 -3.74 -3.15 4.08 -3.1 -2.71 -0.87 2.89 0.58 8.96
GPCRs, Class A Rhodopsin-like%WikiPathways_20191210%WP455%Homo sapiens -5.17 2.91 3.81 -14.51 -11.04 -13.02 23.15 8.28 -1.52 4.5 18.57 6.55 21.69 -1.67 3.4 -6.35 -8.63 -9 10.06 4.21 -20.54 -8.23 4.56 11.36 6.86 -0.55 -5.27 9.92 5.88 13.81 5.07 4.19 -15.45 -8.06 -3.01 -0.76 -11.74 -14.6 -9.65
Allograft Rejection%WikiPathways_20191210%WP2328%Homo sapiens -2.19 0.07 3.23 -7.57 -4.54 -6.94 10.93 3.93 -0.05 1.81 6.79 3.63 13.8 -0.68 2.02 -1.85 -4.2 -6 4.6 2.47 -10.33 -4.22 1.74 5.72 1.82 -0.2 -3.34 4.32 4.02 9.75 2.47 1.02 -7.64 -4.18 -2.2 -1.07 -4.9 -7.28 -4.76
IL1 and megakaryocytes in obesity%WikiPathways_20191210%WP2865%Homo sapiens -3.01 -1.58 -0.72 9.46 -0.56 1.68 -3.23 0.11 -1.12 1.28 -0.51 -2.05 -2.58 0.29 2.09 -1.54 -2.6 0.6 -2.37 -1.26 5.91 0.23 -0.87 -3.21 2.32 -1.23 2.92 0.72 -2.59 -2.88 0.98 -1.23 -0.76 2.32 2.77 0.25 -0.69 5.62 -2.99
Chemokine signaling pathway%WikiPathways_20191210%WP3929%Homo sapiens -7.07 -1.08 1.58 -6.49 -7.16 -4.89 11.96 7.58 -1.13 3.05 10.4 1.82 10.86 0.22 2.89 -3.21 -7.33 -5.36 3.37 3.81 -10.62 -6.43 -0.34 6.63 5 -1.21 -0.93 7.7 1.86 8.73 3.97 4.09 -10.21 -1.54 -0.97 0.94 -4.98 -5.71 -9.79
MECP2 and Associated Rett Syndrome%WikiPathways_20191210%WP3584%Homo sapiens 7.29 2.35 -0.29 1.7 4.24 3.41 -5.86 -5.14 0.98 -3.19 -4.27 0.55 -7.41 0.1 -2.97 3.25 4.9 3.96 0.7 -1.53 4.16 5 0.44 -4.72 -3.98 0.03 -1.85 -6.44 -1.43 -5.49 -4.57 0.76 5.52 0.28 -0.53 -1.58 2.78 1.29 7.57
Focal Adhesion%WikiPathways_20191210%WP306%Homo sapiens -7.2 -0.85 1.92 -6.5 -7.89 -5.28 13.47 7 0.22 3.26 11.51 2.6 12.22 -1.41 1.67 -3.89 -7.76 -5.66 3.96 3.41 -11.88 -6.75 1.41 7.47 4.82 -0.03 -1.74 7.88 2.85 7.96 3.98 3.38 -8.82 -3.2 -1.43 0.98 -5.12 -6.54 -9.98
miRs in Muscle Cell Differentiation%WikiPathways_20191210%WP2012%Homo sapiens -3.27 -0.31 0.07 -1.98 -3.27 -2.97 5.27 1.74 0.76 0.89 3.74 1.88 6.56 1.01 0.91 -1.43 -3.9 -3.12 0.9 1.6 -4.6 -2.44 -0.48 2.96 2.14 -0.11 -0.45 1.42 0.7 5.66 1.69 2.29 -4.78 0.78 -1.05 0.24 -2.47 -2.32 -4.25
Primary Focal Segmental Glomerulosclerosis FSGS%WikiPathways_20191210%WP2572%Homo sapiens 2.85 -0.99 -1.08 5.87 3.71 3.65 -7.28 -4.6 0.91 -1.59 -6.47 -1.26 -9.05 0.42 -0.38 2.43 3.93 3.17 -2.79 -1.73 8.76 3.94 -1.55 -4.76 -3.58 0.53 0.98 -4.07 -1.56 -4 -3.37 -1.61 5.13 3.52 1.36 -0.06 4.03 3.95 2.63
Glucuronidation%WikiPathways_20191210%WP698%Homo sapiens -2.88 0.19 0.63 -2.58 -2.68 -1.27 4.73 2.74 -1.17 1.01 5.96 0.27 5.39 -0.27 0.29 -1.74 -2.29 -2.79 1.82 1.12 -3.81 -2.66 0.06 2.96 1.39 -0.07 -0.95 4.57 1.66 3.18 2.03 0.82 -4.04 -1.85 -0.73 0.35 -3.3 -2.38 -3.75
Genes targeted by miRNAs in adipocytes%WikiPathways_20191210%WP1992%Homo sapiens -1.46 -0.34 0.41 0.2 -2.81 -1.74 4.92 1.04 -0.06 0.06 4 0.06 2.64 0.18 1.23 -2.15 -2.96 -2.14 1.18 0.97 -3.22 -2.25 -0.24 1.86 2.1 0.54 -0.58 3.34 0.37 1.59 1.22 0.47 -3.19 -0.88 0.06 -0.4 -2.17 0.57 -2.4
mRNA Processing%WikiPathways_20191210%WP411%Homo sapiens -9.33 -7.13 -2.87 5.01 -6 4.21 2.86 5.01 1.34 4.02 -2.09 -3.5 6.84 4.02 1.46 -5.3 -7.65 -3.44 -5.62 -2.17 -0.24 -5.7 -4.11 6.13 3.77 0.16 6.4 2.84 -1.6 2.32 5.95 -1.15 -0.7 5.89 1.1 1.8 2.18 5 -9.69
Wnt/beta-catenin Signaling Pathway in Leukemia%WikiPathways_20191210%WP3658%Homo sapiens 2.51 -0.22 -0.54 4.38 2.66 0.76 -7.67 -0.9 1.06 -0.58 -4.61 -1.54 -2.78 0.34 -0.18 1.33 2.17 1.32 -1.34 -2.93 6.25 2.13 -0.72 -1.58 -0.76 0.8 1.25 -1.33 -0.57 -3.79 -0.68 -1.17 1.95 -0.65 0.13 -0.72 1.1 2.63 2.48
RalA downstream regulated genes%WikiPathways_20191210%WP2290%Homo sapiens -2.83 -1.54 0.16 3.95 -1.16 1.1 -0.23 0.53 -1.24 0.72 1.53 -2.6 -0.82 -0.52 2.33 -0.61 -1.06 -0.1 -0.46 0.01 2.57 -1.19 0.12 -0.84 -0.91 -1.42 1.77 2.57 -1.28 -1.9 1.24 -0.26 -1.1 -1.13 2.37 1.23 -0.03 3.06 -2.05
EBV LMP1 signaling%WikiPathways_20191210%WP262%Homo sapiens 2.36 0.33 -1.63 2.01 2.87 2.43 -5.49 -1.36 1.21 -0.38 -4.47 -1.69 -4.26 0.53 -2.33 0.99 2.88 2.35 -1.05 -3.02 4.37 1.93 -0.44 -1.54 -2.83 0.74 0.36 -2.28 -0.31 -3.13 -1.05 -1.66 4.76 -0.99 -0.24 -0.67 2.93 3.64 4.16
Farnesoid X Receptor  Pathway%WikiPathways_20191210%WP2879%Homo sapiens -2.24 0.96 1.26 -3.07 -3.44 -2.39 5.12 3.08 -0.48 1.99 4.22 1.6 5.25 -0.43 0.58 -1.85 -3.28 -2.94 2.41 1.33 -5.54 -2.74 1.04 3 1.36 0.02 -0.85 2.51 1.59 4.03 1.09 1.69 -3.2 -1.98 -0.19 0.28 -3.24 -3.21 -3.35
Hepatitis C and Hepatocellular Carcinoma%WikiPathways_20191210%WP3646%Homo sapiens 0.21 1.5 0.91 -8 -2.63 -2.68 6.11 3.45 1.11 -0.69 5.78 2.71 6.95 -1.4 -0.59 -0.25 -1.09 -1.57 2.58 1.18 -9.18 -2.77 1.16 3.19 1.76 0.45 -2.86 2.23 2.85 4.15 0.54 1.57 -2.68 -3.12 -2.44 -0.55 -2.82 -5.08 0.03
Transcription factor regulation in adipogenesis%WikiPathways_20191210%WP3599%Homo sapiens 2.42 0.5 -2.5 3.1 3.06 1.29 -5.12 -2.15 0.31 -1.03 -4.09 -1.02 -4.67 0.66 -0.49 1.56 3.04 2.18 -1.77 -1.38 4.88 2.82 -1.85 -2.3 -1.03 -0.61 0.21 -3.14 -1.57 -3.04 -1.19 -0.71 2.49 2.49 0.62 -0.43 1.97 3.4 3.09
Electron Transport Chain (OXPHOS system in mitochondria)%WikiPathways_20191210%WP111%Homo sapiens -7.59 -5.91 2.04 -0.99 -4.42 -3.26 4.32 -0.76 -9.97 -6.98 10.75 -6.75 -5.12 -0.19 2.48 -2.83 -0.91 -5.89 -0.02 8.82 2.91 0.78 -1.66 2.73 -2.9 -2.03 5.23 7.05 -2.38 -0.67 -1.87 10.72 0.47 2.88 8.13 11.72 0.57 -0.41 -8.12
Melatonin metabolism and effects%WikiPathways_20191210%WP3298%Homo sapiens 4.32 0.68 -0.22 2.22 2.91 1.68 -6.92 -2.65 0.16 -1.14 -5.87 -1.05 -4.65 0.37 -1.31 3.06 4.69 2.33 -0.81 -0.97 4.9 3.47 -1.09 -4.08 -1.74 0.52 0.05 -3.88 -1.25 -3.6 -3.29 -0.81 4 0.63 0.13 -0.98 2.15 2.66 5.41
AGE/RAGE pathway%WikiPathways_20191210%WP2324%Homo sapiens 6.84 2.69 -0.83 -0.54 6.04 1.29 -6.8 -2.47 1.4 -0.52 -6.55 0.98 -5.22 -1 -1.87 2.91 5.86 4.86 0.9 -3.28 3.55 4.06 0.76 -3.43 -3.27 1.43 -2.1 -4.9 0.53 -3.32 -2.82 -4.77 4.9 -2.98 -1.89 -1.56 2.52 0.71 7.89
miR-509-3p alteration of YAP1/ECM axis%WikiPathways_20191210%WP3967%Homo sapiens -2.18 -1.27 1.39 -1.09 -2.65 -0.42 4.12 1.14 -1.77 0.71 2.95 -0.43 3.85 -0.67 0.81 -1.48 -1.64 -1.58 1.51 1.96 -1.25 -1.77 0.85 0.5 0.79 -0.93 -0.02 1.64 -0.44 4.07 1.85 1.12 -3.45 0.08 -0.27 -0.52 -2.54 -1.36 -1.59
Nucleotide GPCRs%WikiPathways_20191210%WP80%Homo sapiens -1.57 0.72 1.52 -1.41 -2.3 -2.53 4.86 1.83 -0.4 0.92 3.49 1.53 4.06 -0.47 0.35 -1.83 -1.63 -1.9 2.09 0.8 -3.95 -1.52 0.76 1.28 2.03 0.27 -1.34 1.31 1.82 2.46 2.02 0.87 -2.78 -1.62 -0.88 -0.7 -3.15 -3.45 -1.57
Translation Factors%WikiPathways_20191210%WP107%Homo sapiens 6.18 3.34 0.91 -5.15 4.14 -2.18 -1.67 -4.36 -0.19 -3.41 -2.4 0.74 -3.78 0.1 -1.18 1.04 5.83 1.94 2.68 -0.97 1.32 3.69 3.22 -0.7 -6.97 1.13 -2.14 -3.07 1.63 -0.91 -3.21 -0.61 2.56 -2.84 0.91 -0.52 1 -2.75 6.67
Estrogen metabolism%WikiPathways_20191210%WP697%Homo sapiens -1.4 1.34 -0.04 -1.98 -0.8 -2.97 4.2 0.26 -0.25 0.13 5.15 0.46 2.35 -1.04 0.13 -0.83 -1.44 -1.19 2.19 0.91 -2.82 -1.07 1.91 1.81 -0.62 0.11 -1.7 1.65 0.4 1.27 3.81 1.95 -3.38 -1.45 0.41 -0.3 -2.12 -4.01 -1.03
miRNA regulation of p53 pathway in prostate cancer%WikiPathways_20191210%WP3982%Homo sapiens -2.51 -0.36 1.15 1.74 -3.4 -1.1 3.38 2.61 -1.47 2.08 3.63 -1.18 4.9 -0.57 0.27 -0.95 -4.97 -2.29 0.54 0.95 -2.77 -3.66 -0.23 1.31 1.5 -2.07 0.49 6.01 -0.8 1.96 4.19 0.74 -4.13 -0.27 0.4 0.98 -2.06 -0.33 -3.72
G Protein Signaling Pathways%WikiPathways_20191210%WP35%Homo sapiens -8.86 -4.71 -1.4 1 -6.61 -0.72 5.12 4.67 -0.38 3.26 6.39 -1.05 7.67 3.27 2.18 -3.06 -6.24 -5.07 -2.83 3.02 -2.28 -6.18 -3.35 3.07 5.98 -1.24 2.73 5.06 -0.76 6.47 1.7 4.26 -6.7 4.1 1.2 1.27 -1.44 1 -10.54
Differentiation Pathway%WikiPathways_20191210%WP2848%Homo sapiens 1.45 -1.48 -1.62 5.64 5.03 4.15 -8.99 -2.99 0.25 -1.51 -6.24 -2.2 -8.37 0.87 -0.51 1.83 3.44 3.33 -3.93 -1.19 7.42 3.1 -0.27 -5.01 -3.06 -0.25 1.98 -4.03 -1.61 -5.69 -1.86 -1.59 5.13 2.78 1.37 0.05 4.47 6.1 4.02
Nuclear Receptors Meta-Pathway%WikiPathways_20191210%WP2882%Homo sapiens -7.56 0.7 3.31 -9.58 -9.89 -7.4 18.64 8.17 -1.67 3.05 14.74 3.34 18.09 -1.87 1.98 -5.36 -8.76 -7.13 4.84 5.1 -16.31 -7.7 1.49 8.9 6 -0.63 -2.84 8.64 3.44 10.68 6.36 4.44 -11.17 -3.52 -1.72 -0.39 -7.27 -10.32 -10.83
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection%WikiPathways_20191210%WP3863%Homo sapiens 3.63 -0.41 -2.16 4.31 4.83 3.92 -8.02 -3.95 0.95 -0.29 -8.79 -1.7 -10.05 0.91 -0.91 2 4.93 3.33 -3.16 -4.05 8.35 4.24 -1.69 -4.38 -3.07 0.79 1.36 -4.4 -1.93 -5.9 -1.58 -1.73 7.07 1.78 1.5 -0.41 4.54 4.74 5.39
Overview of leukocyte-intrinsic Hippo pathway functions%WikiPathways_20191210%WP4542%Homo sapiens 4.63 1.13 -0.55 1.74 4.52 0.36 -4.59 -2.38 0.62 -1.74 -2.91 -0.48 -6.74 -0.36 -1.17 2.44 4.45 2.33 -0.36 -1.16 4.78 2.87 0.76 -2.6 -1.55 0.36 -0.42 -1.88 -0.81 -5.63 -1.4 -2.56 3.18 -1.61 -0.77 -0.92 0.77 2.01 5.64
TGF-beta Signaling Pathway%WikiPathways_20191210%WP366%Homo sapiens -10.62 -4.22 1.63 -0.92 -7.77 0.27 6.5 5.92 -2.39 2.53 6.52 -0.3 7.47 1.05 2.7 -4.67 -7.79 -6.64 -0.01 5.3 -4.61 -5.5 -0.68 4.07 4.73 -1.66 1.43 5.41 -0.27 6.77 2.72 5.35 -6.38 2.2 2.46 3.16 -1.72 -0.69 -11.32
ATM Signaling Pathway%WikiPathways_20191210%WP2516%Homo sapiens -4.53 -1.13 0.99 -2.61 -4 -2.23 7.51 3.1 -0.22 1.75 5.2 0.54 7.15 0.76 0.77 -2.57 -5.17 -3.31 -0.37 1.66 -5.01 -3.16 -1.16 4.37 2.73 -0.79 0.86 3.98 0.88 4.44 2.93 2 -5.11 1.23 0.38 0.5 -2.55 -3.35 -6.46
Toll-like Receptor Signaling Pathway%WikiPathways_20191210%WP75%Homo sapiens -5.49 0.17 2.72 -5.57 -7.09 -5.87 10.78 5.6 -2.19 1.69 9.69 2.41 9.5 -0.72 2.28 -3.08 -5.62 -4.17 3.58 4.13 -8.54 -5.84 1.33 5.19 4.9 -1.35 -1.12 7.16 2.53 7.83 2.57 3.45 -9.21 -2.86 0.02 0.35 -6.11 -6.01 -7.03
Interferon type I signaling pathways%WikiPathways_20191210%WP585%Homo sapiens 7.27 1.86 -0.37 -6.84 2.24 0.05 1.94 -1.19 2.72 -0.2 -0.41 3.35 1.89 -1.28 -2.48 2.27 3.86 0.46 3.14 0.55 -5.37 2.52 1.88 0.67 -3.11 0.48 -3.87 -3.45 1.72 0.24 -1.7 -0.69 0.41 -2.62 -2.87 -3.87 -0.5 -3.53 4.8
Oxidative phosphorylation%WikiPathways_20191210%WP623%Homo sapiens -5.69 -4.53 0.77 -1.03 -3.81 -3.61 2.92 0.12 -6.55 -4.28 7.83 -4.52 -1.84 -0.21 2.61 -2.28 -1 -4.5 0.16 5.66 1.32 -0.26 -1.7 2.94 -2.38 -1.69 3.72 5.13 -1.57 -0.37 -0.4 7.01 0.36 1.87 5.78 9.03 1.23 -0.03 -6.25
Photodynamic therapy-induced AP-1 survival signaling.%WikiPathways_20191210%WP3611%Homo sapiens 1.08 1.53 2.35 -6.6 -3.41 -4.44 7.17 1.88 2.25 -1.55 5.76 3.27 4.9 -1.12 0.02 0.78 -0.49 -1.34 2.05 1.8 -8.03 -3.17 1.24 2.35 0.76 0.85 -4.12 3.33 2.37 4.09 1.02 0.45 -2.68 -2.97 -1.79 -0.74 -1.86 -6.2 -0.81
NAD metabolism, sirtuins and aging%WikiPathways_20191210%WP3630%Homo sapiens 0.3 1.94 1 -3.94 -1.03 -1.94 4.32 -1.23 -0.83 0.24 2.63 1.6 1.81 0.69 -0.73 0.88 -1.02 -0.56 0.87 2.33 -3.6 -1.19 -0.31 1.36 -1.39 -0.52 -1.44 0.91 1.52 2.74 -0.22 3.09 -1.06 -0.52 -0.98 -0.78 -1.34 -3.63 0.03
Fatty Acid Biosynthesis%WikiPathways_20191210%WP357%Homo sapiens -4.79 -1.96 0.93 0.12 -3.69 1.67 -0.48 2.2 0.43 2.86 -0.22 0.68 4.3 2.11 1.07 -2.32 -3.94 -1.31 -2.46 1.11 -3.38 -3.18 -1.09 1.06 2.96 -0.49 2.35 -0.46 -0.27 5.39 1.6 1.43 -0.73 2.81 1.09 0.16 0.54 0.1 -6.2
Corticotropin-releasing hormone signaling pathway%WikiPathways_20191210%WP2355%Homo sapiens -5.27 -0.69 1.74 -5.19 -6.23 -3.75 9.29 3.94 -1.7 1.92 8.32 1.3 9.88 0.19 1.54 -2.12 -3.7 -4.71 3.24 4.03 -8.53 -4.33 1.35 4.01 3.57 -1.79 -0.63 3.39 0.79 6.41 2.68 3.23 -7.19 -1.09 0.52 0.11 -4.27 -3.99 -6.29
GPCRs, Class C Metabotropic glutamate, pheromone%WikiPathways_20191210%WP501%Homo sapiens -2.12 -0.36 -0.47 -2.38 -1.93 -2.4 4.32 0.92 0.51 0.51 4.91 1.38 2.32 -0.48 -0.27 0.45 -1.62 -1.08 0.32 0.86 -2.84 -1.36 -0.97 1.79 0.48 0.36 -0.67 1.93 0.98 1.54 1.84 1.21 -3.03 0.01 -0.89 -0.21 -1.86 -1.93 0.22
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits%WikiPathways_20191210%WP3678%Homo sapiens -2.78 -0.36 1.07 -2.32 -2.46 -0.44 4.87 4.54 -0.34 0.59 2.7 0.76 4.02 -0.53 -0.14 -1.85 -3.59 -1.44 0.95 0.33 -3.58 -2.56 -0.31 2.91 2.08 0.32 0.2 3.71 1.36 2.35 2.04 0.01 -3.16 -1.51 -1.36 0.42 -1.67 -1.21 -3.62
Exercise-induced Circadian Regulation%WikiPathways_20191210%WP410%Homo sapiens 7.76 5.39 -0.06 0.53 4.17 -0.19 -5.18 -2.35 0.97 -3.01 -3.74 0.44 -4.36 -2.73 -0.61 3.37 5.87 4.27 2.71 -2.01 2.75 3.06 1.66 -4.1 -2.63 0.42 -2.49 -2.59 -0.32 -3.57 -2.97 -2.48 2.71 -3.89 -0.89 -3.31 -0.35 -0.25 8.05
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities%WikiPathways_20191210%WP3844%Homo sapiens 6.98 3.44 0.61 -0.29 3.49 0.38 -4.12 -2.54 0.09 -1.43 -4.85 0.1 -3.05 -1.12 -1.23 2.11 4.19 3.27 1.42 -2.57 1.54 3 0.79 -2.22 -1.02 0.51 -0.92 -3.55 -0.6 -2.53 -2.73 -3.65 3.57 -2.42 -1.13 -1.68 1.22 0.79 6.16
Neural Crest Differentiation%WikiPathways_20191210%WP2064%Homo sapiens -3.57 0.26 1.92 -6.62 -6.22 -4.36 11.41 3.68 -0.18 3.08 8.37 2.34 9.9 -1.21 1.91 -2.76 -4.98 -5.04 4.65 1.63 -9.24 -3.99 1.3 5.8 4.6 -0.04 -1.83 5.82 1.63 7.05 2.58 1.88 -7.76 -2.57 -1.99 0.29 -5 -6.71 -6.02
Apoptosis Modulation by HSP70%WikiPathways_20191210%WP384%Homo sapiens -3.74 -1.58 0.79 3.06 -3.88 -1.66 3.25 2.87 -2.06 3.14 2.07 -2.03 3.66 0.94 1.28 -1.92 -3.72 -2.18 -0.32 0.14 0.08 -2.69 -1.55 0.89 2.97 -2.44 1.91 2.81 -1.26 1.83 2.62 0.18 -3.84 2.58 1.67 0.41 -1.06 1.06 -4.27
Serotonin Transporter Activity%WikiPathways_20191210%WP1455%Homo sapiens -1.37 1.74 -0.07 -2.64 -1.2 -0.91 2.55 1.01 0.49 -0.9 3.03 1.85 1.73 -0.61 0.65 -0.46 -1.12 -0.49 1.16 0.95 -3.1 -0.96 0.1 0.62 2.26 0.28 -1.98 2.2 0.49 1.87 0.26 1.47 -1.99 -0.31 -0.4 0.03 -1.42 -2.97 -1.82
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway%WikiPathways_20191210%WP2036%Homo sapiens 5.87 1.85 -0.85 -2.35 4.16 0.85 -2.88 -1.87 0.94 -1.8 -1.66 1.23 -6.22 -2.25 -1.89 2.58 5.09 2.94 0.98 -1.36 1.65 2.89 0.77 -2.28 -3.53 1.88 -1.11 -2.42 1.28 -4.5 -2.21 -1.1 4.14 -5.37 -1.12 -1.03 0.99 0.41 7.32
NRF2 pathway%WikiPathways_20191210%WP2884%Homo sapiens -5.74 -0.23 2.25 -4.84 -6.74 -4.77 12.65 4.57 -2.24 1.47 10.37 2.17 9.35 -0.64 1.25 -3.45 -5.53 -4.61 3.29 5.16 -9.33 -4.87 1.05 4.82 3.63 -0.96 -1.85 4.76 0.98 5.69 3.04 4.55 -8.18 -0.58 0.48 -0.26 -3.78 -5.79 -7.15
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)%WikiPathways_20191210%WP2817%Homo sapiens -3.3 0.75 0.8 -2.32 -3.13 -1.66 6.39 3.61 -0.75 1.41 5.21 1.28 6.26 -0.72 0.62 -2.01 -3.96 -2.71 1.68 0.85 -5.6 -3.29 0.36 3.69 3.14 -0.1 -0.42 4.36 1.8 3.2 1.96 1.02 -3.92 -1.88 -1.36 -0.13 -3.02 -3.48 -4.64
RAC1/PAK1/p38/MMP2 Pathway%WikiPathways_20191210%WP3303%Homo sapiens 7.09 2.52 -0.94 0.75 4.98 2.5 -6.37 -2.9 0.96 -2.09 -4.7 -0.51 -5.31 -2.54 -1.91 2.78 6.22 3.68 0.29 -3.58 3.87 3.66 1.21 -2.93 -2.53 2.33 -0.89 -2.41 0.59 -4.42 -4.01 -4.74 5.4 -4.6 -1.62 -1.78 1.81 1.8 8.36
Synaptic Vesicle Pathway%WikiPathways_20191210%WP2267%Homo sapiens -8.94 -4.37 -0.59 1.47 -5.49 -1.07 5.21 5.18 -1.55 3.18 4.47 -1.24 9.82 0.84 1.81 -2.31 -5.59 -5.48 -1.45 3.68 -3.07 -5.51 -1.17 4.15 3.12 -0.75 2.72 3.65 0.59 6.17 1.4 2.54 -5.71 1.92 -0.01 3.04 -1.45 0.46 -9.65
Ovarian Infertility Genes%WikiPathways_20191210%WP34%Homo sapiens -1.58 0.41 1.9 -4.07 -4.25 -4.51 8.54 3.24 -0.82 1.04 4.87 1.7 6.76 -0.98 0.97 -2.51 -2.93 -3.41 2.99 2.81 -7.25 -3.68 0.56 4.39 2.55 -0.13 -0.94 3.52 2.05 4.78 2.42 0.67 -4.52 -2.69 -1.2 0.7 -2.99 -4.87 -3.56
TCA Cycle (aka Krebs or citric acid cycle)%WikiPathways_20191210%WP78%Homo sapiens -5.08 -3.28 -0.09 0.55 -3.92 -2.75 2.59 3.06 -4.35 1.27 5.11 -3.13 2.83 0.12 1.09 -1.21 -2.54 -3.39 1.21 2.99 -1.8 -2.91 -1.14 1.52 1.41 -1.87 1.85 3.97 -0.61 1.81 1.02 2.8 -1.11 1.69 2.32 3.82 0.43 1.45 -5.76
Parkinsons Disease Pathway%WikiPathways_20191210%WP2371%Homo sapiens -6.32 -3.5 1.06 0.25 -5.15 -1.3 4.36 3.29 -0.6 1.48 3.25 -0.26 4.28 0.8 1.65 -2.76 -4.15 -3.62 -0.63 2.52 -3.44 -4.38 -0.8 2.11 1.91 -1.49 1.44 4.55 0.03 3.89 2.17 2.98 -4.06 1.94 1.23 2.1 -0.45 1.09 -5.46
Arrhythmogenic Right Ventricular Cardiomyopathy%WikiPathways_20191210%WP2118%Homo sapiens 4.09 0.99 -1.53 4.24 4.7 2.95 -9.63 -3.62 0.89 -2.07 -6.14 -1.62 -8.99 -0.67 -1.53 2.2 5.62 5.09 -3.15 -3.03 8.07 4.16 -0.33 -4.18 -2.25 0.78 1.49 -5.72 -2.27 -5.49 -3.39 -2.21 6.3 1.6 1.4 -0.63 4.09 3.89 5.93
MFAP5-mediated ovarian cancer cell motility and invasiveness%WikiPathways_20191210%WP3301%Homo sapiens -1.99 -0.16 0.89 -1.62 -2.33 -0.31 4.85 1.57 0.58 0.25 2.25 0.6 4.32 -0.44 1.15 -1.82 -2.11 -1.27 0.89 1.57 -4.71 -1.81 0.68 1.55 2.3 0.37 -0.37 2.75 0.75 1.91 1.21 0.23 -2.96 -1.38 -0.71 0.05 -1.97 -2.08 -2.69
Hair Follicle Development: Cytodifferentiation (Part 3 of 3)%WikiPathways_20191210%WP2840%Homo sapiens -2.48 1.2 1.82 -6.4 -3.9 -4.01 10.96 3.97 -0.85 1.43 8.11 2.18 8.99 -1.47 0.87 -2.64 -3.9 -3.63 3.78 2.03 -9.31 -2.87 1.46 4.88 3.46 -0.27 -2.67 5.99 2.51 6.13 3.15 1.33 -7.53 -3.11 -1.85 -0.28 -5.09 -7.38 -4.6
Globo Sphingolipid Metabolism%WikiPathways_20191210%WP1424%Homo sapiens -1.81 1.04 1.74 -3.63 -2.37 -3.1 4.24 2.21 0.09 0.14 3.96 0.85 3.62 -0.73 1.68 -0.63 -2.5 -3.74 2.5 1.35 -5.23 -1.23 1.14 2.26 1.68 0.63 -1.02 2.69 1.3 3.16 1.24 2.06 -4.41 -1.58 -1.04 0.04 -1.7 -2.04 -2.86
Urea cycle and metabolism of amino groups%WikiPathways_20191210%WP497%Homo sapiens -3.41 -0.49 0.65 -2.93 -1.71 -0.54 4.36 2.21 -0.72 1.54 4.28 0.45 4.24 -0.6 0.72 -0.23 -2.22 -1.81 1.09 1.81 -4.91 -2.92 0.63 3.45 -0.01 -0.34 -0.11 1.66 0.42 1.86 1.69 1.69 -2.21 -2.14 -0.64 1.27 -1.76 -0.36 -3.96
Non-homologous end joining%WikiPathways_20191210%WP438%Homo sapiens -1.76 -0.87 1.54 -1.93 -2.61 -0.27 2.72 1.11 -2.07 1.45 3.44 0.22 2.29 1.27 0.45 -0.59 -1.86 -2.49 1.52 1.42 -3.72 -2.16 0.75 0.39 0.05 -1.22 -0.57 2 0.21 2.91 2.11 2.01 -2.31 0.93 0.11 1.55 -0.72 -2.2 -3.15
One Carbon Metabolism%WikiPathways_20191210%WP241%Homo sapiens 0.48 -0.98 -2.5 5.33 0.55 2.69 0.08 1.58 2.25 -0.09 0.33 -0.42 -2.17 -1.82 -0.3 -0.08 0.67 0.57 -1.95 -2.82 3.18 0.88 -1.55 -0.85 1.95 1.92 0.73 2.55 -0.98 -4.77 1.76 -4.84 -1.07 -1.31 -1.61 -0.89 -1.22 3.67 1.07
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity%WikiPathways_20191210%WP3969%Homo sapiens -1.27 -1.97 -0.2 4.2 -0.59 2.42 -1.35 2.23 -2.06 1.84 -1.16 -2.51 -0.74 -0.81 0.12 -0.41 -0.28 -0.02 0.49 -0.3 3.56 -1.91 -0.14 0.37 -4.09 -0.11 3.04 1.67 -1.42 -3.57 0.44 -0.21 -0.47 -0.75 1.11 0.2 1.22 3.84 -0.43
Overview of nanoparticle effects%WikiPathways_20191210%WP3287%Homo sapiens -1.37 0.55 2.77 -4.47 -2.08 -1.93 4.4 1.48 0.11 0.45 3.26 0.97 5.35 -0.58 0.39 0.22 -1.92 -1.89 0.91 -0.02 -5.26 -1.7 1.02 3.04 0.91 0.1 0.16 1.39 0.93 4.03 0.24 0.86 -2.09 -1.86 -0.67 0.43 -1.17 -4.57 -2.39
Glycolysis and Gluconeogenesis%WikiPathways_20191210%WP534%Homo sapiens -7.55 -4.47 0.95 0.21 -5.71 -1.6 8.26 5.78 -3.11 2.92 9.12 -2.28 5.19 -1.68 0.87 -2.64 -5.16 -5.59 1.07 4.06 -4.39 -4.82 -1.46 4.96 3.46 -2.04 1.24 7.57 0.26 3.74 3.32 2.89 -4.86 -1.21 0.64 2.62 -2.13 -0.08 -8.33
Myometrial Relaxation and Contraction Pathways%WikiPathways_20191210%WP289%Homo sapiens -10.7 -4.93 -0.82 -0.47 -8.4 -1.88 9.07 6.34 0.62 3.77 8.29 0.71 10.24 2.16 2.3 -5 -8.3 -6.88 -0.79 3.96 -5.51 -6.74 -2.13 5.34 6.45 -0.41 1.49 6.68 0.37 6.79 3.87 3.48 -8.05 2.13 0.13 2.13 -2.61 -1.43 -11.25
Constitutive Androstane Receptor Pathway%WikiPathways_20191210%WP2875%Homo sapiens 4.23 0.84 -0.48 3.66 3.47 1.25 -5.39 -3.12 0.18 -1.99 -2.99 -0.83 -6.63 0.26 -0.38 3.29 3.51 2.08 -0.86 -0.97 5.13 3.22 -0.15 -4.05 -1.84 -0.15 -0.75 -2.32 -2.18 -2.85 -2.8 -2.1 2.57 0.26 -0.66 -0.79 1.69 2.89 5.72
Lung fibrosis%WikiPathways_20191210%WP3624%Homo sapiens 0.96 -1.96 -2.2 6.36 4.72 5.11 -7.85 -2.63 -0.28 -0.4 -7.31 -3.28 -7.98 1.29 -0.91 -0.43 2.6 2.63 -4.41 -1.52 8.67 3.23 -0.71 -5.53 -3.91 0.31 2.79 -4.57 -2.1 -5.28 -0.82 -2.09 6.1 3.05 2.5 0.23 4.67 7.71 3.25
Simplified Depiction of MYD88 Distinct Input-Output Pathway%WikiPathways_20191210%WP3877%Homo sapiens 3.49 1.16 1.21 -7.62 2.85 -0.64 0.6 -1.8 1.05 -0.81 -1.41 1.74 -0.15 -0.05 -1.1 1.08 3.62 0.74 1.24 0.97 -3.34 2 0.88 0.32 -2.7 1.26 -3.07 -3.01 2.19 1.09 -1.67 -0.15 2.23 -0.87 -2.71 -0.27 0.91 -3.27 4
Nanomaterial induced apoptosis%WikiPathways_20191210%WP2507%Homo sapiens -4.05 -1.28 1.48 0.46 -3.95 -2.13 3.62 3.2 -1.89 2.12 2.83 -1.55 4.55 -0.06 1.05 -0.79 -3.67 -2.13 0.74 0.45 -2.64 -3.1 -0.78 0.63 2.1 -2.37 1.01 3.11 -0.12 2.38 1.84 1.85 -3.94 1.05 2.46 0.89 -0.58 1.38 -4.18
Blood Clotting Cascade%WikiPathways_20191210%WP272%Homo sapiens -2.16 1.74 0.66 -4.03 -3.43 -3.68 6.23 1.95 -0.12 1.35 5.93 1.24 6.85 -0.54 0.3 -1.52 -3.05 -3.59 2.78 0.96 -6.73 -1.49 -0.03 3.12 2.02 -0.23 -2.08 3.39 1.45 5.92 1.28 2.17 -4.3 -1.7 -0.02 0.03 -3.07 -4.86 -2.74
Ethanol metabolism resulting in production of ROS by CYP2E1%WikiPathways_20191210%WP4269%Homo sapiens -0.54 0.2 0.14 -1.69 -2.08 -3.54 3.42 1.66 0.47 -1.18 4.45 1.58 2.08 -1.54 0.11 0.28 -0.65 -2.46 1.83 2.09 -3.49 -0.21 0.55 1.25 -0.34 -0.09 -1.01 0.98 1.28 1.07 0.43 1.93 -2.3 -2.69 -0.45 0.4 -1.53 -0.76 0.33
Insulin Signaling%WikiPathways_20191210%WP481%Homo sapiens -10.87 -5.11 0.29 -1.72 -7.57 -1.71 11.28 5.55 -1.12 2.7 9.37 0.5 10.95 1.48 2.68 -4.23 -8.26 -7.04 -0.49 6.15 -8.56 -5.58 -0.92 4.85 2.85 -1.09 0.89 7.5 0.88 8.09 3.82 5.97 -9.17 1.83 1.45 2.38 -3.04 -3.43 -11.52
Sulfation Biotransformation Reaction%WikiPathways_20191210%WP692%Homo sapiens -1.77 0.23 1.54 -2.73 -2.96 -0.89 3.84 2.47 -0.66 1.37 4.56 -0.21 3.22 -0.59 1.16 -2.18 -2.58 -1.89 0.88 1.29 -4.53 -3.04 0.99 2.55 1.5 -0.46 0.35 3.1 0.2 2.34 1.27 2.03 -2.95 -0.37 0.24 0.13 -2.2 -2.17 -3.1
Interactome of polycomb repressive complex 2 (PRC2) %WikiPathways_20191210%WP2916%Homo sapiens 1.84 0.38 -0.37 -0.13 2.93 0.02 -2.47 -2.06 0.8 -1.97 -1.99 -0.61 -3.71 -0.18 -0.48 1.78 3.33 0.57 -0.71 -0.35 2.96 2.55 1.15 -2.36 -2.11 1.25 -1.02 -0.7 0.23 -1.89 -2.34 -0.74 2.24 0.1 0.57 -0.46 0.67 -0.92 4.18
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling%WikiPathways_20191210%WP732%Homo sapiens -5.51 -2.93 -1.06 -0.36 -3.52 -1.98 4.86 3.51 0.5 0.51 4.45 1.38 4.76 0.84 0.75 -1.56 -3.62 -3.53 -0.68 1.29 -2.37 -2.93 -0.95 2.58 1.87 0.13 0.69 2.23 1.2 3.45 2.25 1.91 -4.55 0.1 -0.14 0.61 -1.61 0.66 -3.23
Nanoparticle triggered regulated necrosis%WikiPathways_20191210%WP2513%Homo sapiens -2.41 -0.86 -0.33 6.55 -2.34 0.74 -0.31 0.83 0.43 1.82 1.52 -0.88 0.54 1.01 1.52 -1.2 -2.34 0 -1.46 -0.21 2.93 -2.12 -2.18 -0.79 1.71 -0.95 1.85 1.01 -2.1 0.18 0.49 -0.73 -1.89 1.88 0.87 -0.54 -0.97 1.52 -2.8
Nuclear Receptors in Lipid Metabolism and Toxicity%WikiPathways_20191210%WP299%Homo sapiens -2.37 0.4 1.76 -4.79 -4.26 -4.59 8.48 3 -0.89 1.29 6.98 1.84 6.6 -1 1.79 -1.85 -4.13 -3.81 3.08 2.16 -5.68 -3.39 1.39 4.34 2.06 -0.61 -1.21 4.39 1.61 4.93 2.46 1.67 -4.51 -2.73 -0.23 -0.14 -4.46 -4.76 -4.83
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)%WikiPathways_20191210%WP2453%Homo sapiens -4.64 -2.42 0.06 -0.61 -3.39 -0.76 3.96 2.7 -3.43 0.53 4.82 -2.6 2.56 0.25 0.12 -0.93 -2.72 -2.54 -0.42 2.61 -1.92 -2.45 -1.2 2.21 3.1 -1.8 1.32 3.17 -0.81 2.58 0.9 2.56 -1.72 2.2 1.38 1.81 -0.6 1.54 -5.43
DNA IR-damage and cellular response via ATR%WikiPathways_20191210%WP4016%Homo sapiens -3.95 -0.01 2.13 -5.56 -4.93 -4.36 9.52 3.99 -1.43 2.23 6.49 0.94 8.27 -0.41 1.01 -3.16 -5.61 -4.3 2.36 3.73 -8.02 -3.81 0.61 4.11 2.17 -1.15 -0.37 4.64 1.94 6.77 3.02 2.17 -5.61 -0.29 0.13 1.2 -3.12 -4.84 -6.49
Leptin signaling pathway%WikiPathways_20191210%WP2034%Homo sapiens -6.79 -2.22 0.47 -2.8 -5.63 -0.85 7.27 5.63 -1.78 1 4.87 0.73 7.3 0.55 1.99 -1.81 -5.6 -4.8 0.43 3.07 -6.51 -4.77 -0.07 3.95 4.15 -0.47 1.61 3.92 1.09 5.36 1.01 2.58 -4.13 -0.26 0.19 1.78 -1.3 -2.27 -6.9
DNA Damage Response (only ATM dependent)%WikiPathways_20191210%WP710%Homo sapiens -4.71 -0.55 0.94 -7.05 -5.77 -3.85 11.69 4.88 -0.9 1.51 10.41 2.42 10.6 -0.33 1.59 -1.76 -5.96 -5.07 2.31 3.04 -10.27 -4.69 0.49 4.4 2.98 -0.55 -2.35 5.41 1.82 8.05 1.6 4.21 -6.86 -0.22 0.15 1.58 -4.75 -6.82 -7.63
Cytoplasmic Ribosomal Proteins%WikiPathways_20191210%WP477%Homo sapiens -14 -8.71 -4.42 6.58 -5.54 4.51 5.14 8.7 2.15 6.82 6.95 -6.17 6.13 -6.42 1.54 -4.32 -10.16 -1.62 -0.85 0.83 -2.27 -4.47 -2.92 6.36 15.8 1.49 2.84 10.44 -1.98 4.42 3.79 -1.86 -8.15 0.69 -0.81 -1.29 2.36 7.28 -18.85
Estrogen Receptor Pathway%WikiPathways_20191210%WP2881%Homo sapiens 0.06 0.44 0.19 -3.2 -2.34 -1.72 3.9 1.94 0.23 1.23 2.72 1.27 4.23 -1.29 -0.42 -0.81 -2.28 -1.44 1.1 0.44 -5.64 -1.98 0.46 2.03 1.59 0.4 -1.24 2.52 1.68 1.97 3.88 0.12 -1.75 -1.84 -1.6 -0.26 -1.07 -2.39 -1.14
Gastric Cancer Network 2%WikiPathways_20191210%WP2363%Homo sapiens 2.87 0.87 -0.28 1.15 2.79 1.07 -4.02 -2.94 0.47 -0.39 -4.49 -1.09 -5.71 1.09 -0.71 1.34 3.27 2.27 -1.21 -0.75 3.02 2.04 0.26 -2.1 -2.87 0.49 1.23 -4.77 -1.49 -2.46 -2.48 0.95 3.16 1.8 0.62 -0.01 2.9 1.88 2.21
Phytochemical activity on NRF2 transcriptional activation%WikiPathways_20191210%WP3%Homo sapiens -1.18 -1.51 -0.33 3.99 0.07 0.63 -4.2 -0.1 -1.57 1.92 -4.03 -2.2 0.53 3.74 -0.17 -0.15 -0.63 -0.12 -1.94 -1.13 3.36 -0.65 -0.09 -1.87 0.13 -1.07 2.61 -1.52 -0.52 1.34 0.02 -1.18 0.91 3.21 1.07 0.93 1.34 1.98 -1.62
IL-7 Signaling Pathway%WikiPathways_20191210%WP205%Homo sapiens -3.15 -0.93 0.11 -1.82 -2.83 -2.68 4.68 2.91 -0.51 -0.01 4.06 0.1 4.22 -1.24 1.51 0.11 -1.73 -2.85 1.48 1.84 -3.45 -1.83 0.73 1.39 -0.29 -1.15 -0.84 3.27 1.53 2.87 1.62 1.99 -3.3 -2.19 1.02 1.38 -1.37 -1.25 -3.4
Tryptophan metabolism%WikiPathways_20191210%WP465%Homo sapiens -2.86 -0.21 0.45 -3.91 -4.29 -4 8.39 2.34 -0.42 0.36 6.23 2.05 5.98 -0.69 0.74 -2.45 -3.95 -2.93 2.53 4.48 -6.66 -2.76 0.37 3.17 1.79 0.17 -1.92 4.33 1.37 5.42 3.83 3.21 -4.75 -1.82 -0.1 0.2 -3.89 -5.35 -4.49
Sphingolipid pathway%WikiPathways_20191210%WP1422%Homo sapiens -6.44 -3.6 -0.92 -0.52 -2.15 0.46 4.64 2.2 0.41 1.98 2.9 -0.02 2.7 2.6 1.58 -2.04 -3.92 -2.87 -3.04 1.31 -1.49 -1.93 -2.85 1.47 2.03 -0.38 0.99 2.54 -0.42 3.44 2.16 1.65 -2.97 4.26 0.22 2.12 -0.67 0.31 -5.74
Complement Activation%WikiPathways_20191210%WP545%Homo sapiens 0.27 0.14 0.83 -3.67 -0.28 -4.16 6.47 1.52 0.59 0.35 2.32 1.81 6.84 -1.65 -1.11 1.01 -0.65 -3.88 2.36 1.52 -6.61 0.07 0.52 2.16 -0.26 -0.21 -2.31 1.26 2.8 5.45 -0.05 1.48 -2.51 -3.06 -2.65 -0.64 -2.09 -3.82 -0.2
Alpha 6 Beta 4 signaling pathway%WikiPathways_20191210%WP244%Homo sapiens -2.91 -1.33 -0.46 -3.55 -2.94 -1.49 5.31 4.11 2.08 -0.65 6.36 2.64 3.81 -1.42 0.54 -1.22 -2 -2.41 0.78 0.57 -3.66 -2.83 -0.57 3.51 2.34 2.18 -0.6 4.46 2.15 1.18 -0.58 -0.15 -3.56 -2.65 -1.69 -0.63 -1.28 -0.85 -2.59
Sleep regulation%WikiPathways_20191210%WP3591%Homo sapiens -2.2 -0.17 0.87 -3.74 -5.9 -3.11 6.89 3.38 0.5 0.92 4.25 3 6.7 -0.69 1.56 -1.77 -3.93 -3.09 2.03 1.75 -5.88 -3.93 0.11 2.34 2.49 1.05 -1.07 2.52 2.49 4.96 1.37 1.4 -3.63 -2.8 -1.11 0.26 -1.6 -3.97 -2.25
Adipogenesis%WikiPathways_20191210%WP236%Homo sapiens -4.43 0.64 2.75 -8.43 -6.53 -5.34 12.68 4.64 -0.71 2.2 8.9 2.73 12.47 -0.81 1.34 -2.79 -5.75 -5.58 4.46 2.26 -12.1 -5.48 1.62 5.98 3.37 0.41 -1.81 6.08 3.35 8.34 2.52 1.89 -6.72 -4.44 -1.74 0.34 -4.32 -6.55 -5.42
Neovascularisation processes%WikiPathways_20191210%WP4331%Homo sapiens -2.64 -0.32 0.45 -4.05 -3.61 -2.32 6.29 2.63 -0.46 0.56 6.48 0.87 4.94 -0.8 1.25 -1.85 -3.11 -3.8 2.18 2.08 -4.48 -2.68 0.35 2.78 2.44 -0.07 0.23 3.69 0.91 3.5 0.89 1.61 -4.27 -0.23 -0.66 1.12 -2.74 -3.15 -4.03
TYROBP Causal Network%WikiPathways_20191210%WP3945%Homo sapiens 8.02 1.66 1.27 -11.86 5.22 -0.96 1.42 -5.09 4.28 -0.23 -6.19 4.94 6.11 2.56 -1.9 2.59 7.21 -2.1 1.49 -0.5 -7.65 3.53 3.1 1.19 -8.67 2.99 -4.56 -10.6 3.75 6.03 -2.29 -3.3 3.53 -0.83 -7.09 -3.47 3.1 -4.76 8.05
Serotonin and anxiety%WikiPathways_20191210%WP3947%Homo sapiens -2.68 -1.31 0.04 1.24 -1.92 -2.18 3.58 2.02 -2.01 1.21 2.73 -0.76 4.19 1.7 1 -0.08 -3.24 -2.76 -1.08 1.76 -0.16 -1.28 -1.72 0.32 1.39 -1.61 1.06 1.01 -0.59 2.99 0.81 1.88 -3.79 0.48 1.09 1.81 -1.89 -0.79 -2.47
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma%WikiPathways_20191210%WP4337%Homo sapiens -2.6 -3.02 -0.56 3.18 0.27 1.04 -2.2 0.7 -0.22 0.93 -0.68 -0.95 -0.9 1.64 1.05 -0.73 -2.3 -0.25 -1.92 -0.66 3.18 0.93 -1.06 -1.46 0.46 -0.63 2.93 0.15 -2 -0.17 -1.29 -0.31 0.31 3.26 1.65 1.44 1.06 1.98 -2.24
Statin Pathway%WikiPathways_20191210%WP430%Homo sapiens -1.51 0.58 0.59 -2.82 -3.56 -2.58 6.05 1.73 -0.39 1.23 4.67 1.45 6.02 -0.96 1.34 -0.06 -2.35 -1.54 3.16 0.77 -5.97 -2.86 0.91 3.26 0.95 0.44 -1.59 4.26 1.7 3.68 1.86 0.62 -4.99 -2.89 -0.92 -0.39 -3.65 -4.18 -2.05
Extracellular vesicle-mediated signaling in recipient cells%WikiPathways_20191210%WP2870%Homo sapiens 3.64 1.72 0.2 2.06 3.82 0.78 -4.64 -3.07 -0.63 -1.25 -3.86 -1.33 -3.07 -0.27 -1.21 2.42 3.2 1.99 0.64 -0.37 2.21 3.08 1.27 -3.15 -3.83 0 -0.47 -3.23 -1.09 -2.44 -2.09 -1.73 3.08 -1.56 0.92 0.12 2.58 1.36 4.21
Leptin Insulin Overlap%WikiPathways_20191210%WP3935%Homo sapiens -2.22 0.36 0.6 -2.48 -2.81 -1.04 7.24 1.74 -0.66 0.67 4.89 1.6 4.59 -0.19 1.05 -0.85 -3.4 -2.26 0.86 1.02 -4.29 -3.18 0.62 2.39 0.16 0.65 -0.49 3.38 1.05 2.76 0.94 1.12 -3.25 -2.03 -0.83 -0.81 -2.84 -2.1 -1.96
ATM Signaling Network in Development and Disease %WikiPathways_20191210%WP3878%Homo sapiens -5.67 -3.08 -0.97 2.37 -5.25 -0.89 5.03 4.97 -0.98 2.72 4.29 -1.93 6.78 0.97 1.7 -3.19 -5.25 -2.78 -1.55 0.57 -2.5 -4.32 -1.76 2.5 2.26 -1.56 2.29 4.24 -0.84 3.49 3.96 1.22 -3.59 2.36 0.5 0.94 -1.61 1.02 -6.46
Bone Morphogenic Protein (BMP) Signalling and Regulation%WikiPathways_20191210%WP1425%Homo sapiens 0.93 0.47 -0.12 -3.69 0.08 -0.86 3.53 -0.69 -0.58 -1.64 4.72 0.19 0.69 -0.4 -0.4 -0.03 -0.04 -0.78 1.2 -0.26 -3.98 0.67 2.67 1.12 0.39 0.07 -2.42 1.89 0.85 1.12 0.72 0.49 -1.4 -1.17 -0.1 0.18 -1.42 -2.23 0.24
Regulation of Actin Cytoskeleton%WikiPathways_20191210%WP51%Homo sapiens -7.67 -2.05 -0.57 -5.43 -6.87 -6.66 11.72 6.42 -0.29 3.29 10.97 1.92 10.28 0.49 1.76 -2.8 -6.67 -5.86 1.87 3.07 -9.03 -5.67 -1.14 6.39 4.34 -1.09 -0.38 6.71 2.62 8.62 3.96 3.79 -8.04 0.09 0.02 2.35 -5.17 -4.55 -10.75
Initiation of transcription and translation elongation at the HIV-1 LTR%WikiPathways_20191210%WP3414%Homo sapiens 5.49 2.38 0.26 0.44 3.36 -2 -2.49 -1.32 0.5 -2.01 0.44 0.95 -2.53 -2.72 -0.83 1.67 3.46 2.68 2.19 -0.87 3.41 2.19 2 -2.83 -2.62 -0.34 -2.3 -1.44 0.1 -3.36 -2.28 -2.17 1.2 -4 -0.91 -2.5 -1.01 -0.19 7.96
Tumor suppressor activity of SMARCB1%WikiPathways_20191210%WP4204%Homo sapiens -4.38 -1.77 -0.12 -1.16 -2.82 -3.16 4.56 1.69 0 1.15 3.39 0.54 5.22 0.73 1.39 -2.08 -2.86 -1.92 -0.33 1.38 -3.33 -1.7 -0.69 2.57 1.79 -0.29 -0.1 1.67 -0.15 3.19 2.65 1.18 -2.72 1.56 0.79 1.33 -1.04 -1.09 -5.06
Bladder Cancer%WikiPathways_20191210%WP2828%Homo sapiens 4.08 0.3 -0.58 3.54 3.85 2.39 -7.67 -2.9 0.47 0.05 -5.72 -1.79 -4.05 0.91 -1.66 1.92 3.38 3.77 -1.45 -1.79 5.26 2.19 0.02 -3.25 -3.64 -0.08 1.47 -3.99 -1.1 -4.23 -2.42 -2.32 5.32 0.86 -0.02 -1.23 3.29 2.98 3.82
miRNA Regulation of DNA Damage Response%WikiPathways_20191210%WP1530%Homo sapiens 4.73 0.81 -1.26 4.36 4.9 2.98 -8.41 -3.82 0.52 -1.8 -5.78 -1.08 -9.36 -1.17 0.18 2.48 6.27 3.53 -0.01 -1.7 7.23 4.57 0.85 -4.02 -3.69 1.32 -0.19 -4.9 -1.19 -5.5 -3.82 -2.63 5.31 -1.51 0.07 -1.22 2.44 3.62 6.88
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds%WikiPathways_20191210%WP3664%Homo sapiens -2.27 -0.28 -0.33 -2.22 -2.13 -2.05 5.61 0.47 0.74 1.03 4.45 1.66 3.04 -0.52 0.05 -0.53 -1.64 -1.71 0.42 1.66 -4.19 -0.73 -0.13 2.6 1.89 0.25 -1.54 2.04 0.65 2.59 1.36 1.53 -2.96 -0.44 -0.74 -0.08 -2.29 -2.37 -2.9
GPR40 Pathway%WikiPathways_20191210%WP3958%Homo sapiens -3.09 -2 0.13 2.01 -2.92 -0.03 1.84 -0.34 1.27 -0.85 1.04 1.74 -0.61 2.87 0.42 -1.35 -2.49 -1.46 -1.43 2.5 0.03 -2.17 -0.86 -0.39 1.82 -0.16 0.51 -0.4 -0.12 0.28 1.67 1.98 -1.61 4.45 1.68 0.85 -0.1 -1.7 -3.03
Development of pulmonary dendritic cells and macrophage subsets%WikiPathways_20191210%WP3892%Homo sapiens -0.06 0.68 0.86 -4.36 -1.49 -1.64 5.43 0.67 -0.23 -0.06 3.67 1.79 3.63 -0.27 0.48 -0.2 -1.23 -1.29 1.68 0.43 -4.74 -1.69 0.9 1.72 1.88 0.1 -1.27 1.68 1.4 3.49 0.81 -0.42 -2.24 -1.4 -1.78 -0.37 -2.35 -3.11 -1.12
Cell Differentiation - Index%WikiPathways_20191210%WP2029%Homo sapiens -1.15 1.54 0.65 -1.78 -2.15 -3.34 4.96 0.4 -0.03 0.96 4.07 0.77 4.4 -0.63 1.19 -1.5 -1.66 -1.76 2.16 0.84 -5.69 -1.36 0.65 2.25 0.67 0 -1.35 1.08 0.85 3.68 2.2 0.59 -3.47 -1.54 -0.98 0.3 -1.87 -2.86 -1.09
Photodynamic therapy-induced NF-kB survival signaling%WikiPathways_20191210%WP3617%Homo sapiens -1.98 0.69 2.38 -4.51 -3.85 -2.97 5.63 2.46 0.55 0.34 6.01 1.78 6.7 -1.37 1.68 -0.46 -2.76 -2.55 2.37 2.01 -5.32 -2.94 1.23 3.17 2.03 -0.1 -0.94 3.52 1.62 4.23 0.52 0.71 -4.39 -2.05 -1.29 0.12 -3.71 -5.03 -3.56
ESC Pluripotency Pathways%WikiPathways_20191210%WP3931%Homo sapiens -2.93 1.47 1.42 -8.44 -4.84 -5.65 11.06 2.94 -0.37 1.5 8.73 3.07 10.85 -1.22 0.91 -1.25 -4.12 -4.66 4.2 3.24 -11.24 -3.33 1.09 4.83 1.87 -1.02 -2.98 5.29 2.06 9.12 2.38 3.06 -6.9 -1.77 -0.69 0.43 -4.3 -7.55 -6.24
NO/cGMP/PKG mediated Neuroprotection%WikiPathways_20191210%WP4008%Homo sapiens 3.13 -0.91 -2.42 5.06 4.81 3.92 -8.12 -2.68 0.99 -0.56 -6.74 -0.41 -7.3 0.69 -1.67 2.28 4.2 3.75 -3.31 -2.69 7.36 3.47 -0.43 -4.02 -2.27 0.9 1.18 -3.62 -1.34 -5.32 -2.43 -3 5.5 0.41 -0.03 -0.66 3.27 4.84 4.17
BDNF-TrkB Signaling%WikiPathways_20191210%WP3676%Homo sapiens -5.13 -1.99 0.31 -1.6 -3.33 -1.43 5.6 4.32 0.31 0.06 5.35 0.81 3.94 0.57 1.5 -1.66 -3.5 -2.58 0.1 3.03 -4.29 -3.6 -1.42 2.04 2.21 0.41 0.01 4.64 0.9 1.81 2.86 2.1 -4.42 0.06 -0.35 0.51 -2.36 -0.85 -4.97
Regulation of Apoptosis by Parathyroid Hormone-related Protein%WikiPathways_20191210%WP3872%Homo sapiens -2.13 0.7 1.23 -4.04 -2.43 -1.99 5.72 2.43 -1.65 1.85 3.97 0.72 3.85 0.57 0.88 0.42 -2.14 -2.71 2.51 0.49 -3.99 -2.02 0.79 1.27 0.22 -1.12 -0.53 2.42 0.73 3.7 0.23 1.07 -2.87 -2.96 0.52 1.06 -1.28 -2.74 -2.74
Mammary gland development pathway - Involution (Stage 4 of 4)%WikiPathways_20191210%WP2815%Homo sapiens -2.74 -1.58 -0.03 1.86 -1.26 1.25 -1.77 2.89 -0.1 1.79 -0.37 -0.7 0.85 0.23 1.61 -2.12 -0.74 -1.27 -1.84 -0.65 3.03 -1.55 -0.43 -1.11 1.96 0.04 1.13 -0.08 -0.05 0.04 1.49 -1.97 0.38 0.74 0.71 0.16 -0.07 2.16 -1.89
IL-2 Signaling Pathway%WikiPathways_20191210%WP49%Homo sapiens 4.3 0.69 -0.01 3.4 3.86 3.08 -5.49 -4.32 -0.21 -0.3 -5.55 -1.71 -6.31 1.57 -0.51 0.65 3.12 3.13 -1.79 -4.45 4.65 2.64 -0.93 -2.62 -1.08 0.61 1.29 -3.06 -1.68 -3.12 -0.93 -2.25 3.95 2.32 -0.22 -0.84 1.61 2.31 4.22
Steroid Biosynthesis%WikiPathways_20191210%WP496%Homo sapiens -1.7 0.52 0.66 -2.83 -2.37 -2.02 4.85 0.9 -0.41 0.6 5.17 0.74 4.35 -0.4 1.34 -0.71 -2.53 -1.86 2.49 0.67 -4.36 -2.34 1.49 1.87 1.31 -0.65 -1 1.63 0.84 3.23 1.87 0.66 -3.31 -0.84 -0.07 0.36 -2.71 -2.84 -2.62
Leptin and adiponectin%WikiPathways_20191210%WP3934%Homo sapiens -3.08 -1.19 0.21 0.02 -2.52 0.29 3.33 2.2 -0.61 1.62 3.43 -0.27 3.75 -0.5 0.56 -2.29 -2.28 -2.15 -0.27 0.75 -3.63 -2.09 0.39 1.93 2.03 0.69 0.6 3.47 0.79 2.17 2.41 0.1 -2.27 -1.02 -0.21 -0.25 -1.13 -1.35 -3.61
Notch Signaling Pathway Netpath%WikiPathways_20191210%WP61%Homo sapiens 7.3 5.26 0.45 -4.37 2.64 -2.01 -3.56 -2.42 1.28 -1.35 -0.63 0 -3.56 -0.1 0.15 2.53 5.42 5.19 2.17 -2.43 0.23 1.65 2.52 -3.86 -3.82 0.53 -1.91 -2.48 -0.2 -1.83 -3.72 -2.61 2.16 -1.87 -0.74 -4.03 0.01 -0.53 8.53
NAD+ metabolism%WikiPathways_20191210%WP3644%Homo sapiens -2.19 -0.97 -1.35 -1.24 -1.31 -1.04 3.83 0.58 0.65 0.25 1.94 1.22 2.9 2.33 -1.63 -0.9 -1.99 -1.52 -1.7 -0.13 -2.01 -1.53 -1.02 1.28 1.33 0.53 0.08 0.33 0.68 2.78 0.78 1.46 -1.46 3.37 -0.28 0.8 0.04 -1.74 -3.15
Prader-Willi and Angelman Syndrome%WikiPathways_20191210%WP3998%Homo sapiens 3.93 0.53 -0.82 5.17 4.64 5.14 -9.01 -3.04 0.64 -1.38 -7.49 -1.83 -8.78 0.04 -1.95 2.13 4.1 5.55 -2.8 -2.51 7.3 3.39 0.06 -5.41 -3.21 -0.14 1.44 -5.65 -1.28 -7.22 -1.83 -3.77 7.22 1.96 0.08 -1.06 3.61 5.89 6.35
Structural Pathway of Interleukin 1 (IL-1)%WikiPathways_20191210%WP2637%Homo sapiens 7.46 2.38 -0.83 -2.43 5.5 0.83 -5.28 -2.92 1.41 -1.06 -3.6 0.18 -5.34 -1.39 -2.07 3.31 6.64 4.29 1.29 -4.01 2.35 3.64 1.19 -2.2 -4.27 1.8 -2.59 -2.99 0.78 -3.82 -3.48 -3.24 4.99 -2.91 -1.27 -1.84 2.05 -0.79 8.23
Mitochondrial Gene Expression%WikiPathways_20191210%WP391%Homo sapiens -1.48 1.1 1.53 -4.93 -3.19 -1.48 4.16 1.9 -0.54 1.48 3.52 1.47 5.36 0.02 1.47 -1.42 -2.06 -2.73 2.44 1.03 -6.43 -1.21 0.28 2.84 1.79 0.46 -1.09 2.51 1.71 3.27 -0.26 1.77 -2.84 -1.19 -0.76 0.38 -2.66 -3.57 -2.66
Canonical  and Non-canonical Notch signaling%WikiPathways_20191210%WP3845%Homo sapiens -5.27 -4.42 0.63 2.77 -3.33 3.55 1.34 2.75 -1.18 1.2 0.23 0.07 2.17 0.3 0.33 -1.51 -3.63 -3.37 -0.18 2.58 0 -2.35 -0.72 2.57 2.53 -0.78 1.73 1.32 -0.52 -0.24 1.11 2.72 -2 1.09 0.05 2.81 0.86 1.36 -6.57
Mesodermal Commitment Pathway%WikiPathways_20191210%WP2857%Homo sapiens -8.6 -0.76 2.1 -4.49 -7.97 -2.86 12.4 5.17 -0.19 3.49 8.7 0.93 11.67 0.42 2.33 -5.01 -8.37 -4.64 2.2 3.46 -9.87 -5.93 0.16 6.69 3.58 -1.12 -0.27 6.21 1.59 8.63 3.48 3.63 -7.77 -1.09 -1.28 0.67 -3.81 -4.47 -9.01
PPAR Alpha Pathway%WikiPathways_20191210%WP2878%Homo sapiens 2.39 -0.57 -0.57 2.83 3.24 2.16 -6.06 -2.55 0.14 -1.6 -3.69 -0.79 -6.49 0.32 -1.23 1.57 2.78 2.05 -1.97 -0.82 6.22 2.29 -0.22 -2.54 -2.37 -0.48 0.53 -3.29 -1.95 -3.41 -1.87 -0.64 3.32 2.08 1.88 0.11 2.5 3.71 3
Striated Muscle Contraction Pathway%WikiPathways_20191210%WP383%Homo sapiens -1.52 1.07 1.89 -7.56 -3.97 -4.47 8.13 3.58 -0.18 1.69 6.1 2.12 8.31 -0.94 1.96 -2.1 -4.04 -3.61 3.79 1.79 -8.48 -3.42 0.29 4.65 3.22 -0.32 -1.87 3.41 2.09 6.46 2.58 1.54 -5.3 -3.31 -0.83 0.66 -4.23 -5.36 -3.81
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ%WikiPathways_20191210%WP3849%Homo sapiens -4.09 -1.46 0.14 1.26 -2.74 1.23 1.43 1.9 0.46 0.46 0.37 -0.59 0.51 0.75 0.96 -2 -3.25 -1.42 -1.67 0.97 -0.59 -1.57 -0.98 1.44 3.31 0.08 1.65 2.21 -0.82 0.25 1.9 1.39 -0.87 2.78 0.64 1.19 -0.26 0.06 -5.03
PPAR signaling pathway%WikiPathways_20191210%WP3942%Homo sapiens 3.6 -0.26 -1.49 4.86 4.72 3.79 -9.31 -3.42 -1.18 -2.21 -7 -2.59 -8.09 0.76 -1.31 2.8 5.01 3.23 -3.38 -1.86 8.7 4.59 -0.13 -3.45 -3.65 -0.45 1.05 -5.13 -2.18 -5.79 -2.57 -1.67 5.31 1.91 2.26 0.25 3.49 5.79 5.02
Selenium Metabolism and Selenoproteins%WikiPathways_20191210%WP28%Homo sapiens 2.49 1.58 -0.85 1.93 2.87 2.3 -5.19 -1.94 0.71 0.4 -3.95 -0.61 -6.65 1.5 -1.65 0.53 2.56 3.7 -1.54 -2.36 3.81 2.34 0.05 -3.07 -2.1 0.4 0.62 -2.59 -0.5 -3.44 -1.62 -1.41 3.24 1.63 -0.97 -0.46 2.32 2.84 3.08
Vitamin A and Carotenoid Metabolism%WikiPathways_20191210%WP716%Homo sapiens 2.68 -0.2 -0.92 3.01 3.36 4.02 -7.83 -1.32 0.16 -0.99 -5.36 -1.92 -5.6 0.49 -1.38 2.04 2.97 2.87 -2.09 -1.51 5.48 2.97 -1.44 -2.23 -2.38 0.32 1.44 -2.97 -1.65 -5.02 -1.86 -1.87 4.57 1.65 -0.59 -1.34 2.98 3.9 5.58
PDGF Pathway%WikiPathways_20191210%WP2526%Homo sapiens -5.98 -3.76 -0.19 1.74 -3.07 1.6 1.96 4.44 -0.06 1.08 2.77 -0.45 2.03 0.22 1.63 -2.02 -5.17 -3.72 -0.98 1.87 -0.92 -2.89 -1.22 2.62 3.08 0.52 2.74 3.13 -0.54 1.05 0.47 2.53 -2.92 1.27 1.2 1.93 -0.55 1.71 -7.17
Angiogenesis%WikiPathways_20191210%WP1539%Homo sapiens -0.02 -0.7 -0.85 -1.92 -1.06 -0.95 5.76 2.16 1.29 -2.1 7.03 1.55 0.03 -0.82 -1.54 -0.29 -0.72 -0.62 0.86 0.93 -3.15 -1.35 -0.31 1.56 2.51 1.13 -2.82 4.19 0.24 -1.49 1.69 1.28 -2.53 -0.69 -1.87 -1.07 -2.29 -2.23 -0.83
EDA Signalling in Hair Follicle Development%WikiPathways_20191210%WP3930%Homo sapiens 0.5 -0.69 -1.71 3.05 2.2 3.62 -4.82 -1.12 0.47 -0.25 -3.25 -0.71 -3.9 0.3 -0.3 1.02 1.89 0.66 -2.11 -0.83 4.61 1.67 -0.53 -1.64 -2.23 0.75 1.52 -1.69 -0.8 -3.91 -1.47 -0.98 3.02 1.68 0.56 -0.72 1.92 2.75 1.49
Regulation of toll-like receptor signaling pathway%WikiPathways_20191210%WP1449%Homo sapiens -6.65 -0.45 2.83 -4.69 -7.91 -6.73 11.5 6.19 -2.66 2.06 10.76 2.19 10.89 -0.38 2.65 -3.41 -6.53 -4.83 3.55 4.05 -8.92 -6.34 1.07 5.26 5.69 -1.85 -0.92 8.47 2.38 8.67 2.91 4.05 -10.47 -2.24 0.46 0.45 -6.5 -5.89 -8.69
IL17 signaling pathway%WikiPathways_20191210%WP2112%Homo sapiens 2.13 -0.62 -1.13 2.71 3.27 1.94 -5.27 -2.75 0.49 -0.18 -4.41 -2.39 -5.52 1.06 -0.63 0.86 2.57 2.46 -1.89 -2.1 5.6 2.82 -0.94 -3.05 -3.17 0.38 1.14 -2.34 -1.24 -3.3 -1.4 -0.93 4.09 1.46 1.37 0.52 3.22 2.11 3.05
TLR4 Signaling and Tolerance%WikiPathways_20191210%WP3851%Homo sapiens 3.06 1.52 1.5 -9.42 0.53 -0.11 2.11 -0.37 0.34 -0.86 1.13 2.79 1.71 -1.53 -1.06 1.25 2.74 -0.69 3.24 1.93 -4.35 0.61 2.73 0.71 -2.09 0.09 -2.69 -0.86 2.17 2.39 -2.22 1.28 0.11 -3.6 -1.92 -1.26 -1.37 -3.12 3.58
Oncostatin M Signaling Pathway%WikiPathways_20191210%WP2374%Homo sapiens 7.11 3.09 0.26 1.11 4.83 2.64 -6.57 -4.78 0.04 -1.04 -6.01 -0.91 -6.04 -0.75 -2.26 2.15 5.93 4.27 0.24 -2.05 2.82 4.56 0.69 -3.6 -2.56 -0.24 -0.38 -4.96 -0.36 -5.04 -2.12 -1.87 5.48 -0.57 -0.78 -0.99 1.95 1.59 5.13
ncRNAs involved in Wnt signaling in hepatocellular carcinoma%WikiPathways_20191210%WP4336%Homo sapiens -4.56 0.45 2 -5.67 -4.84 -0.89 9.61 3.38 -0.16 1.65 5.91 2.02 9.52 -0.83 0.67 -2.68 -4.94 -2.61 2.68 2.86 -9.59 -4.13 0.97 4.34 3.14 -0.49 -1.69 3.97 1.75 6.66 2.68 2.27 -5.2 -0.84 -1.2 0.79 -3.61 -5.95 -7.42
ERK Pathway in Huntington's Disease%WikiPathways_20191210%WP3853%Homo sapiens -3.24 -1.33 0.43 0.19 -3.03 1.34 2.93 3.25 -0.84 0.67 1.64 0.81 3.4 -0.65 0.75 -1.33 -2.49 -1.56 0.03 0.31 -2.42 -2.38 -0.78 1.54 4 -0.85 0.5 3.14 0.66 1.68 2.32 -0.42 -2.8 1.33 -0.15 -0.93 -2.29 -0.19 -3.23
miRNA targets in ECM and membrane receptors%WikiPathways_20191210%WP2911%Homo sapiens -2.12 -2.57 2.11 5.27 -0.99 3.8 -2.72 -1 -0.39 -0.87 -3.26 -2.11 -2.23 2.26 -0.27 -1.12 -0.79 0.28 1.27 4 5.15 -0.73 -0.28 -0.99 1.82 -0.98 1.49 -3.68 -3.19 -1.78 -0.55 1.36 -1.76 3.96 -0.08 1.02 0.33 3.3 -2.98
Regulation of Microtubule Cytoskeleton%WikiPathways_20191210%WP2038%Homo sapiens -3.88 -0.1 0.51 -2.08 -4.52 -1.25 6.59 3.97 -0.15 2.18 5.58 1.49 6.58 -0.19 1.09 -1.52 -3.7 -2.81 0.95 0.8 -5.86 -3.82 -0.87 2.67 3.58 0.07 -1.2 4.12 0.84 3.13 2.84 1.36 -4.56 -1.17 -0.65 -0.49 -2.95 -1.33 -5.22
Pregnane X Receptor pathway%WikiPathways_20191210%WP2876%Homo sapiens 3.19 -0.26 -0.78 4.09 2.69 1.89 -5.78 -3.04 0.19 -0.76 -4.3 -1.4 -6.74 0.61 -0.33 2.47 3.88 2.02 -1.62 -1.63 5.34 2.83 -0.01 -4.79 -1.3 0.09 0.13 -2.79 -1.6 -3.03 -2.77 -2.1 3.49 1.18 -0.55 -0.46 2.72 4.47 4.78
Non-genomic actions of 1,25 dihydroxyvitamin D3%WikiPathways_20191210%WP4341%Homo sapiens 5.64 1.49 -0.92 3.29 5.65 4.8 -8.89 -3.54 0.09 -1.28 -8.17 -1.23 -7.94 -0.42 -2.39 2.81 4.83 4.7 -1.9 -2.78 6.42 4.67 0.21 -4.68 -3.18 0.59 0.09 -6.14 -1.51 -4.88 -3.15 -3.06 6.97 -1.16 0.26 -0.19 4.36 4.4 6.11
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling%WikiPathways_20191210%WP3850%Homo sapiens -1.49 -0.83 -0.42 -2.9 -2.43 -1.53 6 2 1.1 0.57 4.77 1.66 4.57 -0.68 0.73 -1.76 -1.58 -2.61 0.64 -0.33 -3.16 -1.7 0.21 3.16 0.01 1.31 -0.84 4.81 1.46 1.6 1.61 -0.59 -2.46 -2.76 -1.58 -1.23 -1.37 -1.9 -2.04
Amino Acid metabolism%WikiPathways_20191210%WP3925%Homo sapiens -8.68 -4.4 0.06 -4.5 -6.54 -2.32 9.51 5.8 -1.48 2.58 8.24 0.35 8.15 0 1.1 -3.04 -5.89 -5.31 -0.04 5.16 -8.01 -5.63 -1.4 5.35 4.1 -0.23 0.97 5.57 1.99 7.38 2.21 3.81 -4.59 -0.03 0.31 2.64 -1.81 -0.58 -10.82
Notch Signaling%WikiPathways_20191210%WP268%Homo sapiens -7.26 -3.56 0.32 3.03 -3.18 4.5 3.29 1.3 -1.24 1.25 0.19 -1.14 3.18 -0.12 -0.71 -2 -5.1 -2.99 -0.67 2.61 -1.76 -3.37 -0.24 3.98 2.94 -0.69 2.83 1.44 -0.16 1.26 2.91 3.58 -2.85 1.39 0.86 3.61 0.86 -0.46 -7.84
Nanoparticle-mediated activation of receptor signaling%WikiPathways_20191210%WP2643%Homo sapiens -5.79 -3.29 -0.23 0.79 -4.19 0 4.31 3.57 -0.24 0.42 4.61 0.31 3.32 -0.01 1.95 -2.75 -3.82 -3.61 -0.8 3.19 -2 -3.18 -0.54 2.95 2.65 -0.1 1.22 3.96 1.08 1.79 1.56 2.57 -4.25 0.91 0.38 1.17 -1.73 -0.17 -6.01
Toll-like Receptor Signaling related to MyD88%WikiPathways_20191210%WP3858%Homo sapiens 4.75 0.74 0.52 -8.48 4.04 0.11 -0.85 -2.19 1.48 -0.91 -2.91 1.86 -0.38 -0.85 -1.81 1.84 4.66 0.26 2.06 -0.23 -3.32 3.28 1.45 0.4 -3.64 1.83 -3.11 -3.9 2.07 0.78 -2.23 -0.23 3.1 -2.01 -2.58 -0.75 1.42 -1.88 5.6
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression%WikiPathways_20191210%WP3879%Homo sapiens -5.43 -1.35 0.05 -0.27 -2.58 -0.28 4.04 2.54 -0.81 0.74 1.69 -0.06 4.15 1.51 1.42 -1.88 -3.56 -2 -0.64 1.72 -2.99 -2.3 0.12 1.73 2.22 -1.4 0.97 2.23 -0.41 3.08 1.41 1.71 -2.89 1.7 0.53 1.43 -0.83 -0.73 -4.58
Ectoderm Differentiation%WikiPathways_20191210%WP2858%Homo sapiens -8.17 -3.4 1.17 -2.64 -6.91 -2.89 11.34 5.72 -0.25 3.67 8.11 1.63 11.52 0.99 2.03 -4.95 -7.12 -7.04 0.32 2.49 -7.11 -5.44 -1.83 5.05 5.55 0.01 -0.14 5.37 1.53 7.96 3.61 3.34 -6.73 1.06 -0.51 1.41 -4.88 -3.73 -10.17
Physiological and Pathological Hypertrophy  of the Heart%WikiPathways_20191210%WP1528%Homo sapiens -2 -0.55 0.58 -3.96 -2.59 -1.04 5.13 2.39 -0.01 1.7 3.4 0.83 5.84 0.18 0.99 -1.32 -2.71 -1.53 0.86 1.02 -4.49 -2.34 0.39 2.66 1.21 -0.32 0.22 2.17 0.73 3.61 1.28 0.84 -2.98 -0.71 -1.07 -0.14 -2.31 -2.8 -3.19
Integrin-mediated Cell Adhesion%WikiPathways_20191210%WP185%Homo sapiens -8.77 -3.69 0.22 0.6 -6.38 -1.46 6.62 4.71 -0.09 2.32 5.43 0.03 7.41 0.34 2.14 -2.91 -6.81 -4.9 0.6 3.26 -3.39 -5.59 -0.79 3.57 3.69 -0.82 0.92 5.72 0.63 4.62 4.21 3.07 -6.26 1.35 1.48 2.33 -1.66 -0.9 -10.85
Preimplantation Embryo%WikiPathways_20191210%WP3527%Homo sapiens -3.81 -0.89 1.06 -2.91 -3.54 -2.87 6.26 1.12 -0.86 1.73 5.36 0.48 7.18 1.14 1.01 -1.49 -3.51 -3.44 2.39 2.38 -6.66 -2.74 0.1 4.5 3.25 -0.75 -1.11 2.4 0.39 5.14 1.72 2.86 -4.7 -0.46 -0.28 -0.13 -1.53 -3.97 -4.81
Dopaminergic Neurogenesis%WikiPathways_20191210%WP2855%Homo sapiens -5.1 -2.22 -1.16 -2.36 -4.68 -3.57 6.97 2.26 3.09 1.54 4.48 3.93 6.69 1.95 0.54 -2.75 -4.67 -3.95 -0.01 0.69 -5.89 -3.9 -1.18 4.01 2.84 1.58 -1.06 2.89 2.35 5.09 1.47 2.28 -5.39 1.31 -0.54 0.79 -1.26 -2.37 -4.72
Human Complement System%WikiPathways_20191210%WP2806%Homo sapiens -3.72 1.06 1.59 -7.33 -5.2 -6.35 12.17 5.61 -0.56 2.24 9.35 2.36 12.25 -1.96 0.66 -1.9 -4.76 -5.5 4.84 2.77 -12.03 -3.02 0.94 5.45 2.8 -0.18 -2.73 6.57 2.87 8.3 3.35 3.35 -7.63 -4.74 -2.46 -0.05 -6.33 -7.07 -5.05
Mammary gland development pathway - Puberty (Stage 2 of 4)%WikiPathways_20191210%WP2814%Homo sapiens -0.75 -1.51 0.36 3.83 0.8 1.65 -3.88 -1 -1.41 -0.48 -2.27 -1.85 -3.04 0.67 -0.14 0.65 1.07 0.25 -0.36 1.24 5.21 1.65 0.26 -2.64 -1.13 -1.02 0.58 -1.92 -2.28 -3.41 -1.33 1.02 0.65 2.85 2.15 0.33 0.95 3.97 0.29
Novel intracellular components of RIG-I-like receptor (RLR) pathway%WikiPathways_20191210%WP3865%Homo sapiens 4.19 0.69 -1.95 1.4 4.71 2.24 -7.29 -2.32 1.39 -0.71 -7.08 -0.86 -5.55 -0.96 -1.03 2.87 4.35 2.38 -0.18 -3.47 5.15 3.1 0.86 -3.45 -3.01 1.58 0.2 -6.26 0 -4.25 -2.81 -2.76 5.72 -0.54 0.53 -0.5 3.53 3.83 6.24
Monoamine GPCRs%WikiPathways_20191210%WP58%Homo sapiens -1.42 0.54 0.79 -5.21 -3.32 -4.44 9.17 2.39 0.82 1.27 7.63 3.29 6.86 -0.06 1.82 -2.52 -3.64 -4.26 3.44 1.96 -7.34 -3.01 0.79 3.97 1.6 -0.14 -1.79 2.29 2.43 5.19 0.95 1.82 -5.97 -2.36 -0.96 0 -4.25 -5.87 -2.47
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway%WikiPathways_20191210%WP3670%Homo sapiens -0.9 -2.75 -0.05 3.52 -0.14 1.49 -4.1 -2.43 -0.31 -0.03 -3.01 -1.58 -2.18 3 0.14 0.38 0.77 0.94 -2.04 -0.13 4.32 -0.69 -1.64 -2.55 0.41 -0.28 2.4 -2.52 -0.88 -0.78 -0.79 -0.05 2.17 4.68 0.82 0.87 1.97 3.02 -1.06
Metapathway biotransformation Phase I and II%WikiPathways_20191210%WP702%Homo sapiens -6.04 0.72 1.91 -9.36 -7.77 -6.64 15.53 6.82 -1.66 2.7 13.21 3.01 15.06 -1.06 2.61 -4.54 -7.32 -5.9 4.95 3.6 -12.74 -6.56 0.67 8.02 3.91 -0.85 -1.82 8.81 3.28 9.04 5.86 2.57 -10.56 -4.42 -0.41 0.47 -7.6 -8.8 -8.71
Cell-type Dependent Selectivity of CCK2R Signaling%WikiPathways_20191210%WP3679%Homo sapiens -3.76 -2.12 -1.78 -0.29 -1.81 -2.26 3.9 1.72 3.75 1.49 3.38 1.07 1.42 1.62 0.89 -1.5 -2.57 -1.85 -1.14 -1.04 -1.23 -1.72 -1.64 2.13 1.2 0.86 -1.4 3.43 -0.64 1.89 3.19 0.74 -2.33 1.01 -0.38 -0.57 -1.58 -0.19 -1.92
Energy Metabolism%WikiPathways_20191210%WP1541%Homo sapiens 4.88 0.65 -1.32 3.32 4.11 0.88 -6.3 -2.45 0.78 -2.66 -3.32 -1.81 -7.26 -0.64 -1.03 2.49 5.34 3.71 -0.22 -2.37 7.27 1.77 0.31 -3.77 -1.76 -0.68 -0.12 -2.37 -2.61 -5.69 -1.42 -3.16 4.07 -0.23 -0.12 -2.27 2.97 4.35 6.71
Endoderm Differentiation%WikiPathways_20191210%WP2853%Homo sapiens -7.98 -1.79 1.94 -6.46 -7.41 -2.98 12.58 5.09 -1.7 3.89 9.24 0.88 11.54 1.01 2.04 -4.39 -7.98 -5.44 1.7 3.51 -9.45 -6.53 0 5.47 2.76 -0.68 0.53 6.09 1.6 8.65 3.98 5.21 -7.12 0.52 -0.86 1.68 -4.33 -5.88 -8.91
Glycerophospholipid Biosynthetic Pathway%WikiPathways_20191210%WP2533%Homo sapiens -5.84 -1.89 -0.29 1.29 -4.27 -0.89 3.88 3.91 -0.85 0.66 2.73 -1.12 3.95 1.04 1.26 -3.06 -3.5 -2.77 -0.2 1.11 -0.08 -3.52 -0.57 2.9 1.75 -0.29 1.48 3.5 0.63 1.89 0.65 -0.25 -2.08 -0.12 0.82 2.03 0.08 0.98 -4.97
Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex%WikiPathways_20191210%WP3657%Homo sapiens -4.45 -0.6 0.39 -3.04 -4.22 -2.05 5.5 3.27 -1.64 1.24 3.61 0.17 6.03 -0.45 1.53 -2.37 -3.98 -2 1.14 1.04 -4.38 -2.65 0.38 3.57 1.19 -0.87 0.4 2.63 1.64 3.24 0.87 2.09 -2.36 -0.8 0.82 2.01 -1.32 -2.06 -3.53
MAPK Cascade%WikiPathways_20191210%WP422%Homo sapiens -6.13 -3.98 -0.02 -1.08 -4.06 -0.68 5.01 3.97 -0.31 0.89 3.9 0.29 4.46 0.2 1.47 -2.14 -4.03 -4.6 -0.28 3.51 -3.32 -2.53 -0.6 2.53 1.95 -0.26 1.96 4.32 1.03 2.82 1.82 3.34 -4.39 0.69 0.8 1.46 -1.63 -0.51 -5.87
Glycogen Synthesis and Degradation%WikiPathways_20191210%WP500%Homo sapiens -6.77 -3.01 -0.9 -0.67 -4.94 -1.15 6.17 4.63 -0.67 1.14 6.05 -0.18 3.38 0.72 1.22 -3.64 -4.76 -3.8 0.53 1.89 -3.11 -4.08 -0.82 3.28 2.96 0.43 0.5 4.4 0.96 2.99 1.77 2.37 -4.08 1.06 1.84 1.6 -1.28 -0.18 -5.84
Fatty Acid Beta Oxidation%WikiPathways_20191210%WP143%Homo sapiens -4.72 -1.49 0.42 1.04 -3.82 -0.48 7.77 2.5 -0.15 1.12 6.01 0.5 2.06 -0.54 0.55 -2.04 -3.69 -2.02 0.51 1.7 -3.49 -2.93 -1.33 2.45 1.81 -0.35 -0.1 3.96 -0.17 2.42 2.08 2.07 -2.99 0.15 -0.18 0.81 -2.52 -1.68 -5.26
MAPK Signaling Pathway%WikiPathways_20191210%WP382%Homo sapiens -9.6 -2.34 0.23 -5.59 -8.29 -5.45 13.89 6.07 0.18 3.61 9.78 3.04 14.08 2.58 2.59 -4.19 -9.61 -6.91 1.63 3.74 -12.39 -5.68 -2.05 7.41 6.52 -1.19 -0.02 6.9 2.4 11.58 4.19 5.14 -10.8 2.25 -0.97 0.75 -4.46 -5.85 -13.16
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM%WikiPathways_20191210%WP3959%Homo sapiens -3.96 -0.72 0.96 -2.78 -4.49 -3.58 9.43 3.54 -1.48 2.08 6.58 0.72 8.05 0.1 0.96 -2.04 -5.09 -4 1.42 2.17 -6.17 -4.14 -0.87 3.14 1.96 -1.61 -0.38 5.38 0.86 6.18 2.37 1.28 -5.78 0.25 0.18 1.12 -2.67 -2.95 -6.01
Osteoblast Signaling%WikiPathways_20191210%WP322%Homo sapiens -1.51 -0.19 1.21 -1.06 -1.43 -3.47 3.31 2.26 0.32 0.18 3.75 1.27 3.74 -0.58 1.28 -1.28 -2.51 -1.65 2.32 1.71 -4.41 -0.99 0.03 2.14 0.8 -0.03 -1.11 3.56 1.13 2.39 1.43 1.47 -3.09 -2.09 -0.11 -0.32 -2.23 -3.21 -3.04
Prolactin Signaling Pathway%WikiPathways_20191210%WP2037%Homo sapiens -9.83 -4.36 0.12 1.94 -4.12 0.76 4.06 4.05 -1.85 2.14 4.07 -0.82 4.35 1.54 2.3 -3.57 -6.3 -4.96 -1.76 2.1 -0.44 -3.38 -0.95 3.3 3.39 -1.2 3.29 3.76 -0.85 3.98 2.1 3.16 -4.62 3.3 1.67 3.2 -1.51 1.75 -9.78
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway%WikiPathways_20191210%WP4577%Homo sapiens -5.19 -3.29 0 1.63 -4.79 -1.97 3.57 4.88 -1.31 3.1 4.49 0.1 5.62 0.72 2.39 -2.64 -3.09 -3.29 -1.13 1.01 -2.2 -4.13 -0.67 2.89 1.27 -1.39 1.79 4.05 -0.16 2.61 2.15 0.1 -3.52 0.78 0.73 1.08 -1.16 1.71 -6.76
Osteopontin Signaling%WikiPathways_20191210%WP1434%Homo sapiens -3.7 -0.68 0.63 0.1 -2.94 -1.05 3.3 2.15 -0.04 -0.68 2.87 0.4 2.3 0.03 0.64 -1.05 -2.81 -2.13 -0.22 2.28 -2.07 -1.57 -0.1 1.42 2.88 -0.36 0.44 3.16 -0.23 1.73 1.42 1.62 -3.28 1.05 0.26 0.74 -2.48 0.14 -4.18
Cori Cycle%WikiPathways_20191210%WP1946%Homo sapiens -4.77 -2.52 1.51 -1.22 -3.25 -1.78 6.95 3.76 -1.33 2.38 5.7 -0.55 4.82 -1.07 0.01 -1.5 -3.59 -3.59 1.27 2.93 -3.55 -3.17 -0.79 3.51 2.07 -0.79 -0.07 4.49 0.8 2.8 1.6 2.44 -3.64 -1.3 -1.06 0.77 -1.86 -1.11 -5.31
Circadian rhythm related genes%WikiPathways_20191210%WP3594%Homo sapiens -6.44 0.81 1.03 -9.68 -8.55 -6.39 16.55 5.47 -0.96 2.47 11.84 4.51 14.25 -0.18 2.46 -3.96 -7.58 -6.72 4.59 3.34 -14.03 -6.08 0.09 7.04 4.9 -0.14 -2.71 7.4 2.71 10.95 2.94 4.85 -8.98 -3.02 -1.02 0.5 -5.89 -7.85 -8.52
G13 Signaling Pathway%WikiPathways_20191210%WP524%Homo sapiens -5.34 -2.2 -1.08 1.66 -4 -2.04 3.72 4.07 -0.57 0.33 5.12 -0.89 5.05 0.63 1.21 -1.89 -4.6 -2.8 -0.52 1.36 -0.96 -4.05 -0.86 2.62 4.69 -0.94 0.89 3.78 0.06 2.06 2.05 1.05 -3.2 1.36 0.56 2.81 -1.94 -0.73 -6.48
Cholesterol Biosynthesis Pathway%WikiPathways_20191210%WP197%Homo sapiens 4.91 4.03 0.2 1.56 3.79 2.87 -0.02 -1.23 3.92 -1.77 -2.4 2.81 -1.1 -3.17 -2.67 0.86 2.23 2.53 -0.06 -1.9 1.31 2.12 0.3 -2.53 -1.78 1.87 -1.3 -2.12 1.29 -3.4 -2.16 -4.34 0.04 -4.92 -3.89 -1.04 -0.05 0.1 5.1
Follicle Stimulating Hormone (FSH) signaling pathway%WikiPathways_20191210%WP2035%Homo sapiens 6.04 1.32 -0.05 1.94 3.8 0.78 -5.27 -3.03 -0.57 -1.38 -4.37 -0.31 -4.86 0.46 -1.7 2.87 3.89 2.03 -0.11 -2.83 3.54 2.96 0.07 -2.69 -2.44 -0.44 -0.48 -4.55 -0.91 -3.33 -2.06 -0.36 4.26 0.84 0.69 -0.69 1.17 0.58 5.18
Heart Development%WikiPathways_20191210%WP1591%Homo sapiens -2.5 0.51 1.63 -4.77 -3.84 -3.43 7.59 2.16 -0.54 0.86 5.1 1.49 7.36 -1.4 0.7 -1.79 -3.18 -4.04 3.64 3.07 -7.12 -1.92 1.71 3.38 2.41 -0.37 -1.91 3.9 2.19 5.21 1.76 1.7 -5.67 -2.08 -0.05 -0.18 -2.98 -4.55 -4.05
Irinotecan Pathway%WikiPathways_20191210%WP229%Homo sapiens -3.44 0.08 -0.58 -3.17 -1.33 -1.41 3.94 2.71 -0.35 0.8 1.58 0.76 3.19 0.23 0.45 -1.49 -1.52 -1.33 0.22 0.17 -2.17 -1.79 -0.39 4.13 0.54 0.1 0.98 1.44 0.89 1.68 1.07 0.87 -1.42 -0.94 1.64 -0.05 -1.31 -2.19 -2.59
Fluoropyrimidine Activity%WikiPathways_20191210%WP1601%Homo sapiens 4.13 0.23 -0.92 2.09 3.82 2.68 -3.19 -2.91 1.42 -0.86 -3.68 -0.55 -3.47 -0.4 -1.27 2.34 3.07 1.36 -1.33 -1.3 3.68 3.23 0.83 -2.4 -3.91 -1.29 -0.56 -3.17 -1 -3.3 -1.17 -0.95 4.09 -0.43 -1.13 -1.39 0.57 1.53 5.5
Pathogenic Escherichia coli infection%WikiPathways_20191210%WP2272%Homo sapiens 8.72 4.08 -0.43 -3.17 6.72 0.76 -5.71 -7.13 0 -2.47 -5.24 1.67 -2.2 -0.13 -1.08 3.62 5.84 4.02 1.36 -3.26 2.73 6.05 0.73 -5.02 -6.01 -0.37 -1.84 -4.62 0.62 -0.87 -3.95 -0.88 2.77 -1.06 0.02 -3.5 0.4 -0.91 9.74
Serotonin and anxiety-related events%WikiPathways_20191210%WP3944%Homo sapiens -0.81 -0.2 0.76 -1.11 -2.72 -3.36 4.31 1.42 -0.14 0.69 3.34 2.1 4.25 1 0.46 0.45 -2.23 -2.36 0.57 1.48 -2.56 -1.07 -0.48 0.55 1.43 -1.03 -0.11 0.26 0.16 2.84 0.71 1.78 -3.6 -0.9 -0.34 0.34 -1.44 -2.02 -2.42
Aryl Hydrocarbon Receptor Pathway%WikiPathways_20191210%WP2873%Homo sapiens 1.14 -1.02 -1.9 4.93 3.58 3.13 -7.05 -2.92 0.68 -0.36 -6.92 -1.74 -6.4 1.28 0.22 1.13 2.84 1.81 -2.77 -2.24 6.56 3.01 -0.97 -3.05 -2.16 0.2 1.77 -3.04 -1.76 -3.36 -2.88 -0.62 4.14 2.13 1.53 0.41 2.99 5.18 2.51
PDGFR-beta pathway%WikiPathways_20191210%WP3972%Homo sapiens -4.17 -3.3 -0.02 -1.1 -2.82 -0.45 4.46 3.1 0.67 0.77 3.35 1.08 3.84 1.03 0.98 -1.02 -4.53 -4.04 -0.27 2.97 -3.21 -2.58 -0.83 2.73 1.08 0.75 0.3 0.76 -0.1 2.52 1.79 3.55 -3.69 1.56 0.06 1.01 -1.75 0.34 -4.82
Folate Metabolism%WikiPathways_20191210%WP176%Homo sapiens 3 -0.06 -1.23 5.78 4.86 6.07 -9.52 -3.02 0.97 -0.86 -7.26 -2.13 -7.77 0.96 -1.92 0.66 3.45 4.72 -3.42 -3.16 8.31 3.36 -0.53 -4.1 -2 0.03 2.51 -4.6 -1.22 -5.92 -1.78 -4.09 6.12 0.95 -1.42 0.21 3.54 6.73 3.8
Photodynamic therapy-induced unfolded protein response%WikiPathways_20191210%WP3613%Homo sapiens 1.36 -1.08 -2.32 3.42 1.08 1.2 -2.43 -2.02 -0.41 -0.04 -3.03 -0.93 -1.78 5.55 0.9 -0.29 0.96 2.03 -1.97 -2.95 4.17 0.25 -1.87 -1.58 -1.08 -1.3 1.31 -0.8 -2.19 -3.47 0.85 -5.38 2.6 5.7 1.6 -1.94 1.09 4.28 0.52
Senescence and Autophagy in Cancer%WikiPathways_20191210%WP615%Homo sapiens -5.23 -0.83 1.46 -4.74 -6.42 -3.43 11.2 4.39 -1.01 1.62 9.22 2.09 8.12 -1.54 1.57 -3.19 -5.43 -4.13 3.62 3.18 -8.65 -4.59 1.79 5.3 2.16 -0.55 -1.69 6.56 2.2 5.22 3.05 2.64 -6.68 -3.24 -0.41 0.99 -4.06 -4.7 -5.82
Kennedy pathway from Sphingolipids%WikiPathways_20191210%WP3933%Homo sapiens -4.22 -1.13 0.24 0.56 -3.38 -0.64 1.33 3.17 0.42 1.02 0.35 -0.86 3.65 0.71 0.98 -2.82 -1.54 -1.9 -0.4 0.03 -0.24 -3.6 -1.04 1.98 0.64 -0.13 1.8 2.13 0.16 1.57 0.22 -1.07 -0.11 0 -0.23 1.43 0.34 3.31 -2.72
Dopamine metabolism%WikiPathways_20191210%WP2436%Homo sapiens -4.04 -1.78 -0.5 0 -2.77 -0.69 2.75 1.7 1.64 0.59 2.16 1.5 2.76 1.27 0.94 -1.47 -3.44 -3.08 -1.02 1.61 -2.59 -2.55 -1.18 1.33 1.44 0.57 0.81 1.68 1.22 3.74 0.23 2.96 -3.35 1.49 0.93 0.7 -0.61 0.02 -4.98
Endometrial cancer%WikiPathways_20191210%WP4155%Homo sapiens -6.5 -2.35 -0.69 -2.84 -4.09 -1.82 7.14 4.46 0.26 0.65 6.38 0.97 6.48 -0.55 0.74 -1.51 -4.16 -3.51 -0.28 2.86 -5.16 -2.95 -1.16 3.01 2.54 -0.13 -0.68 5.02 1.64 5.75 1.85 2.71 -5.23 0.99 -0.29 0.83 -1.81 -1.71 -6.87
BMP Signaling Pathway in Eyelid Development%WikiPathways_20191210%WP3927%Homo sapiens 1.97 0.51 -0.27 3.15 2.4 0.97 -4.33 -2.73 -0.01 -0.28 -4.41 -1.91 -5.09 1.57 -0.11 1.55 2.53 2.8 -1.25 -1.29 3.56 1.55 -0.22 -2.92 -2.99 0.15 0.96 -3.9 -1.73 -2.37 -1.24 -1.16 3.72 2.56 1.53 0.06 1.88 1.56 3.24
MicroRNAs in cardiomyocyte hypertrophy%WikiPathways_20191210%WP1544%Homo sapiens -5.23 -1.6 1.39 -4.52 -5.34 -1.85 7.61 3.62 -1.55 1.78 6.7 0.53 8.93 0.33 2.02 -1.56 -5.16 -3.83 2.43 3.32 -7.25 -4.51 0.33 4.47 0.51 -1.35 -0.45 5.17 1.17 7 1.69 4.37 -6.8 0.14 0.05 1.14 -3.04 -3.44 -7.21
G1 to S cell cycle control%WikiPathways_20191210%WP45%Homo sapiens 5.53 0.92 -1.49 5.07 4.47 3.1 -7.66 -2.92 -0.14 -1.08 -5.85 -0.73 -5.27 -0.25 -1.39 1.38 4.65 3.92 -1.77 -1.2 6.43 4.13 -0.49 -3.82 -2.51 -0.55 0.16 -4.86 -2.32 -4.42 -4.08 -3.07 4.6 0.07 -1.08 -1.7 2.58 4.75 6.86
Integrated Cancer Pathway%WikiPathways_20191210%WP1971%Homo sapiens -3.54 -0.3 1.04 -1.97 -4.12 -2.73 6.04 3.37 -1.46 1.62 3.94 -0.48 8.2 -0.1 0.36 -1.17 -5.45 -3.26 0.95 1.26 -4.41 -3.49 -0.68 2.2 2.34 -1.35 0.59 2.98 1.13 5.38 2.59 1.24 -3.99 -0.4 0.16 1.38 -1.61 -1.87 -4.38
GPCRs, Other%WikiPathways_20191210%WP117%Homo sapiens -2.9 1.29 2.76 -8.18 -4.98 -6.52 10.61 5.24 -0.41 2.21 10.46 2.94 10.5 -0.95 1.66 -2.89 -4.66 -4.08 5.3 2.26 -10.99 -4.37 1.6 5.97 4.24 -0.27 -2.68 4.84 3.28 7.86 2.54 1.57 -7.33 -3.93 -2.18 -0.13 -5.82 -8.8 -5.08
AMP-activated Protein Kinase (AMPK) Signaling%WikiPathways_20191210%WP1403%Homo sapiens 5.33 1.66 -1.03 3.08 5.1 2.93 -7.54 -4.1 -0.23 -2.74 -6.13 -0.53 -8.67 -0.44 -2.07 2.86 4.75 4.67 -1.13 -1.71 6.97 4.43 -0.23 -4.3 -2.5 -0.27 0.51 -5.35 -1.53 -5.92 -3.37 -1.83 6.28 1.8 -0.56 -1.26 2.48 3.48 7.13
Tamoxifen metabolism%WikiPathways_20191210%WP691%Homo sapiens -2.68 0.82 0.93 -4.24 -3.2 -3.28 6.31 3.09 -0.28 1.05 4.65 1.02 6.81 -1.07 0.87 -1.94 -3.05 -1.55 2.36 0.63 -5.69 -3.35 0.73 3.93 1.65 -0.85 -1.4 3.83 1.52 4.05 4.53 1.47 -4.43 -1.78 0.21 0.03 -3.41 -4.67 -3.65
T-Cell Receptor and Co-stimulatory Signaling%WikiPathways_20191210%WP2583%Homo sapiens -2.12 0.47 0.35 -3.29 -2.77 -2.75 7 1.1 -0.51 0.68 6.74 1.15 5.53 -0.26 1.07 -1.18 -3.38 -2.13 1.28 3.47 -6.32 -2.4 1.03 2.52 1.44 -0.08 -1.3 3.35 1.65 3.59 0.69 2.23 -4.72 -1.01 -0.47 0.02 -2.87 -3.17 -4.6
Target Of Rapamycin (TOR) Signaling%WikiPathways_20191210%WP1471%Homo sapiens 5.16 2.28 -0.56 0.15 4.53 1.15 -4.29 -3.7 2.08 -1.98 -3.96 0.64 -3.69 -0.89 -1.91 2.17 3.25 3.25 -0.05 -1.89 3.4 3.22 -0.48 -2.55 -1.12 0.2 -0.92 -4.05 -0.25 -2.02 -2.42 -1.57 3.35 -0.18 -2.18 -1.91 1.58 0.37 5.8
Prion disease pathway%WikiPathways_20191210%WP3995%Homo sapiens 5.81 2.12 0.55 -1.87 2.71 1.12 -2.49 -4.03 2.13 -1.92 -1.25 1.99 -3.64 -0.52 -2.37 1.43 3.87 2.39 1.72 0.01 -0.51 2.85 1.65 -1.7 -1.8 0.3 -3.27 -3.24 0.38 -2.43 -1.07 0.29 1.87 -1.07 -1.47 -2.13 0.06 -1.99 5.53
Signaling Pathways in Glioblastoma%WikiPathways_20191210%WP2261%Homo sapiens -6.84 -2.46 0.11 -3.72 -4.97 -2 9.63 4.99 0.9 1.21 7.31 1.76 8.9 -0.46 1.29 -3.17 -5.47 -4.81 0.49 2.49 -6.99 -4.06 -0.29 5.55 2.84 0.2 -0.73 5.51 2.08 5.59 2.85 2.82 -6.31 -0.79 -1.04 0.85 -2.95 -3.17 -7.15
Proteasome Degradation%WikiPathways_20191210%WP183%Homo sapiens -8.62 -6.04 2.42 -3.13 -6.03 -2.54 4.13 0.64 -7.02 -0.57 6.59 -3.31 -2.89 1.15 1.17 -1.26 -3.07 -5.55 2.57 6.79 -2.49 -3.82 -0.48 3.47 0.57 -2.74 3.48 5.44 -0.74 0.86 0.47 8.54 -2.31 3.45 5.89 8.39 2.39 2.04 -7.83
Inflammatory Response Pathway%WikiPathways_20191210%WP453%Homo sapiens -2.21 1.21 0.98 -4.88 -3.43 -5.08 7.8 2.66 -0.81 1.57 5.77 1.91 7.49 -1.3 1.56 -2.37 -3.71 -2.33 3.16 1.76 -5.05 -2.63 0.78 3.78 1.85 -0.82 -1.47 4.01 2.34 4.59 1.86 0.86 -3.98 -2.67 -0.24 -0.54 -4.36 -4.41 -3.66
Association Between Physico-Chemical Features and Toxicity Associated Pathways%WikiPathways_20191210%WP3680%Homo sapiens 6.62 3.24 -0.32 1.39 4.63 2.13 -7.16 -4 1.22 -0.43 -8.23 -0.42 -7.69 -0.4 -0.83 2.62 5.2 4.4 0.32 -3.66 4.98 3.9 0.71 -2.85 -2.32 0.77 0.25 -3.79 -0.37 -5.38 -2.33 -4.1 5.24 -1.22 -1.04 -2.84 2.73 1.13 7.91
GPCRs, Class B Secretin-like%WikiPathways_20191210%WP334%Homo sapiens -2.23 0.76 0.98 -4.28 -2.86 -3.61 5.54 1.42 -0.41 -0.06 4.5 2.09 5.06 0.07 1.31 0.43 -3.01 -2.31 2.34 2.4 -5.6 -2.6 0.97 2.03 1.99 -0.99 -1.56 2.96 1.32 4.85 2.05 1.43 -3.6 -1.43 0.1 0.37 -2.3 -4.58 -3.55
IL-9 Signaling Pathway%WikiPathways_20191210%WP22%Homo sapiens -2.94 -1.2 -0.14 -2.45 -2.89 -2.17 4.75 3.02 -0.1 -0.37 2.47 0.32 3.96 -0.4 0.83 -0.31 -1.22 -2.35 1.27 2.12 -3.76 -1.84 0.74 2.69 0.68 -0.77 -0.24 2.04 1.2 2.64 1.16 2.99 -3.6 -0.88 0.84 0.77 -1.93 -1.31 -3.61
Oxidative Stress%WikiPathways_20191210%WP408%Homo sapiens -2.07 -1.99 -2.56 5.18 2.46 3.48 -4.9 -0.65 -1.21 0.58 -2.83 -2.2 -3.93 2.39 0.35 -0.87 0.59 1.38 -3.77 -1.7 7.79 1.11 -1.11 -1.6 -0.28 -0.9 2.35 -0.2 -1.88 -2.31 -1.27 -0.96 1.39 3.16 0.94 1.37 1.29 3.49 -0.12
Endochondral Ossification%WikiPathways_20191210%WP474%Homo sapiens -2.37 0.34 0.68 -6.52 -4.37 -3.69 8.44 3.29 -0.15 2.77 6.41 2.67 6.89 0.1 0.8 -1.27 -3.77 -3.54 2.32 0.93 -7.79 -2.95 -0.06 3.75 2.69 0.13 -1.55 3.68 1.78 5.8 2.67 1.14 -5.15 -1.33 -1.27 0.74 -3.19 -4.97 -4.09
Complement and Coagulation Cascades%WikiPathways_20191210%WP558%Homo sapiens 2.64 -1.08 -1.3 5.33 3.98 5.03 -9.94 -3.39 0.22 -1.63 -6.63 -2.52 -10.05 1.27 -1.04 1.51 4 5.16 -3.92 -1.62 9.85 2.38 -0.58 -4.47 -2.23 0.74 2.83 -4.81 -3.04 -8.36 -2.3 -2.42 5.97 3.73 1.42 0.24 4.19 6.74 4.1
Cell Cycle%WikiPathways_20191210%WP179%Homo sapiens -8 -2.04 0.44 -4.39 -6.63 -3.71 10.49 5.87 -0.31 3.33 7.9 1.06 10.62 0.37 1.21 -3.97 -7.55 -5.46 0.97 2.23 -7.67 -5.66 -0.44 5.96 3.38 0.51 0.44 6.63 2.01 7.2 4.45 2.45 -6.86 0.02 -0.14 1.71 -2.55 -3.79 -10.08
Endothelin Pathways%WikiPathways_20191210%WP2197%Homo sapiens -3.62 -1.18 0.64 -5.01 -3.17 -1.52 7.76 2.87 0.39 0.96 5.78 0.83 5.04 0.34 2.25 -2.06 -3.52 -3.77 0.75 3.28 -5.37 -2.47 0.14 2.23 1.55 0.51 -0.81 4.01 1.14 3.19 1.56 1.97 -4.16 -1.15 -0.3 0.91 -2.24 -3.37 -4.39
Matrix Metalloproteinases%WikiPathways_20191210%WP129%Homo sapiens -1.23 0.97 2.79 -4.72 -3.61 -4.34 8.28 1.46 -0.92 0.85 5.73 1.58 6.39 -1.14 1.24 -2.1 -3.05 -2.73 3.48 1.8 -6.59 -2.44 2.59 3.17 1.8 -0.66 -1.73 3.44 0.91 5.88 1.79 0.96 -3.97 -2.11 -0.82 -0.41 -3.99 -5.4 -3.18
Oxidation by Cytochrome P450%WikiPathways_20191210%WP43%Homo sapiens 3.32 -0.6 -1.78 7.33 4.72 6.06 -10.6 -3.92 1.19 -1.78 -8.35 -2.68 -10.07 1.05 -1.72 2.59 5.21 3.93 -4.1 -3.27 9.22 3.87 -0.63 -5.52 -2.75 1.14 1.62 -5.38 -2.89 -6.63 -4.33 -2.83 6.97 3.33 0.51 -0.08 5.26 6.59 6.01
Apoptosis%WikiPathways_20191210%WP254%Homo sapiens -5.28 -0.61 2.67 -2.45 -6.45 -5.02 8.82 5.29 -2.19 2.72 7.63 0.25 8.97 -0.58 2.89 -3.26 -6.68 -4.76 1.5 2.68 -6.83 -4.92 -0.11 4.16 3.42 -2.2 -0.3 6.53 0.37 6.61 3.34 3.56 -7.12 -1.24 1.83 1.8 -3.96 -3.95 -7.15
Common Pathways Underlying Drug Addiction%WikiPathways_20191210%WP2636%Homo sapiens 5.48 1.32 0.67 1.86 4.29 2.5 -6.34 -4.21 -0.29 -2.21 -3.57 -0.37 -5.01 -0.17 -1.22 2.44 4.28 2.99 -0.16 -1.74 4.37 4.62 0.32 -3.85 -3.6 -0.15 -1.05 -3.34 -0.91 -4.32 -2.11 -2.04 5.57 0.16 1.24 -1.28 1.49 -0.38 4.72
IL-6 signaling pathway%WikiPathways_20191210%WP364%Homo sapiens 6.1 3.02 0.48 1.21 4.55 -0.51 -2.96 -5.04 0.46 -0.81 -2.59 -0.68 -4.6 -0.06 -0.64 1.45 4.5 3.41 0.18 -2.39 3.26 4.03 0.49 -3.13 -3.06 -0.35 -2.1 -2.84 -0.92 -3.33 -0.1 -2.5 3.1 -0.52 -0.69 -1.55 0.03 -0.02 5.12
Nuclear Receptors%WikiPathways_20191210%WP170%Homo sapiens -3.35 -0.55 1.61 -4.44 -4.21 -3.1 6.62 2.52 0.09 1.84 4.43 2.4 8.2 0 0.57 -1.3 -4.46 -3.41 1.99 2.27 -7.01 -4.12 0.13 3.41 3.53 -0.08 -0.83 3.11 3.23 5.16 1.73 2.21 -4.01 -0.73 -0.95 0.39 -3.1 -5.09 -4.67
Type II diabetes mellitus%WikiPathways_20191210%WP1584%Homo sapiens 3.15 1.42 -1.11 2.41 3.32 1.38 -5.13 -3.71 0.14 -0.89 -5.18 -1.35 -4.27 -0.05 -1.1 2.02 3.05 2.78 -0.59 -0.81 4.4 3.42 -0.74 -2.49 -1.52 -0.49 0.29 -3.82 -1.32 -3.44 -1.36 -1.8 3.79 1.18 0.28 0.1 1.97 2.27 3.78
p38 MAPK Signaling Pathway%WikiPathways_20191210%WP400%Homo sapiens 4.85 1.85 0.09 -4.53 4.61 0.18 -0.02 -1.98 0.45 -3.56 -0.62 0.89 -4.02 -1.75 -2.16 2.47 4.61 2.98 2.17 -0.41 -0.5 2.77 2.33 -0.92 -2.8 1.58 -2.88 -1.11 1.37 -3.54 -2.4 -1.37 2.15 -3.13 -1.19 -1.11 0.89 -1.72 5.49
Iron metabolism in placenta%WikiPathways_20191210%WP2007%Homo sapiens 1.08 -0.18 -0.96 -1.86 0.54 -0.11 2.86 0.98 1.81 -0.53 1.68 2.26 1.93 -0.42 -2.32 0.52 1.53 0.14 -0.96 -2.2 -3.06 0.15 -0.66 1.79 0.9 1.1 -2.12 1.86 2.01 0.29 1.37 0.04 -0.31 -1.52 -3.89 -1.44 -0.7 -2.09 0.49
Aryl Hydrocarbon Receptor Netpath%WikiPathways_20191210%WP2586%Homo sapiens 6.12 2.62 -0.27 -2.12 4.13 -1.57 -5.13 -5.44 0.69 -1.78 -5.1 0.1 -2.53 0.13 -1.05 3.79 5.71 3.22 1.04 -1.36 2.38 2.63 0.58 -2.38 -4.15 0.26 -1.24 -3.99 -0.3 -1.15 -3.53 -1.73 4.86 -1.15 0.08 -0.77 2.67 -1.36 7.1
TNF alpha Signaling Pathway%WikiPathways_20191210%WP231%Homo sapiens -9.57 -5 0.15 1.41 -7.53 -1.1 5.49 5.47 -1.37 2.56 5.96 -0.58 6.93 0.94 2.55 -3.89 -6.52 -6.14 -0.79 3.51 -3.24 -5.22 -1.07 3.67 4.03 -1.55 3.24 5.21 -0.4 5.15 2.51 4.12 -6.02 2.75 2.46 3.3 -1.88 -0.1 -9.46
Nucleotide Metabolism%WikiPathways_20191210%WP404%Homo sapiens -4.78 -2.92 0.26 -1.85 -2.79 -1.86 4.22 2.38 -0.25 0.02 1.95 0.26 1.5 0.26 0.45 -1.25 -3.09 -2.02 -0.62 2.81 -2.31 -1.84 -0.88 3.52 1.97 0.87 1.33 1.25 0.25 2.87 0.77 2 -2.88 0.26 2.27 2.45 -0.08 -0.48 -4.03
Apoptosis Modulation and Signaling%WikiPathways_20191210%WP1772%Homo sapiens -7.43 -1.47 1.59 0.97 -7.33 -3.26 7.85 6.55 -2.57 3.51 7 -0.9 8.95 0.36 2.72 -4.21 -7.22 -4.33 0.9 2.18 -5.59 -6.06 -0.26 3.5 3.89 -2.79 1.59 5.11 0 5.44 4.51 2.03 -7.11 0.31 1.25 1.84 -3.03 -0.25 -8.24
Differentiation of white and brown adipocyte   %WikiPathways_20191210%WP2895%Homo sapiens -1.39 0.72 0.62 -4.3 -2.68 -2.27 6.47 1.71 -0.26 -0.1 5.39 1.21 4.3 -0.96 0.27 -1.59 -1.74 -2.33 2.12 1.33 -5.04 -2.55 1.7 2.42 2.21 0.43 -1.89 3.75 1.8 3.25 0.99 0.88 -2.58 -2.66 -0.56 -0.44 -2.49 -4.25 -1.48
Drug Induction of Bile Acid Pathway%WikiPathways_20191210%WP2289%Homo sapiens -2.13 0.97 1.25 -3.09 -2.92 -2.79 5.85 3.04 -1.03 0.71 5.51 1.69 3.55 -0.74 0.55 -1.42 -2.82 -3.04 2.19 2.15 -4.94 -2.44 0.92 3.68 1.19 -0.51 -0.86 2.28 0.79 3.23 1.27 1.75 -2.98 -0.87 0.43 -0.29 -3.23 -3.4 -3.53
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway%WikiPathways_20191210%WP2018%Homo sapiens 3.96 1.04 -1.36 3.3 3.9 3.56 -6.36 -3.23 -0.12 -0.3 -5.97 -0.6 -7.14 -0.77 -1.09 1.67 3.77 3.91 -1.64 -2.26 6.63 3.3 0.16 -3.53 -1.34 0.94 0.64 -4.24 -1.18 -5.07 -0.83 -3.25 4.95 -1.24 0.17 -1.04 1.79 3.08 5.79
Wnt Signaling%WikiPathways_20191210%WP428%Homo sapiens -6.41 -1.22 1.13 -5.9 -5.46 -1.67 10.81 3.86 -0.31 2.12 7.37 1.82 10.34 0.6 1.16 -2.83 -5.72 -4.21 1.63 3.18 -9.38 -4.73 -0.14 4.7 3.79 -0.78 -0.37 4.37 1.37 8.23 3.08 4.28 -6.43 0.85 -1.28 1.35 -4.04 -5.46 -9.72
Estrogen signaling pathway%WikiPathways_20191210%WP712%Homo sapiens -4.16 -1.17 1.22 -2.5 -3.88 0.14 5.11 4.12 -1.14 1.03 4.18 0.73 5.55 -0.23 0.64 -1.47 -3.4 -2.27 0.37 2.46 -4.73 -2.39 0.07 2.18 3.89 -1.18 0.29 2.82 0.29 3.14 1.11 2.96 -3.9 -0.03 -1.19 -0.21 -2.3 -1.25 -4.87
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation%WikiPathways_20191210%WP314%Homo sapiens 4.07 1.37 -1.24 0.05 5.44 3.22 -4.79 -3.71 1.46 -3.08 -5.82 -0.71 -6.93 -0.61 -1.91 3.05 5.48 3.65 -0.14 -1.98 3.92 3.29 1.15 -1.26 -2.08 2.33 -0.42 -2.36 0.3 -5.34 -2.88 -2.06 4.93 -2.21 -1.79 -1.35 1.05 1.38 6.54
Hypertrophy Model%WikiPathways_20191210%WP516%Homo sapiens -1.68 -0.19 1.04 -2.6 -3.69 -2.27 4.43 3 -0.86 1.27 3.68 0.69 5.13 -0.26 1.06 -1.17 -2.27 -1.85 1.95 -0.09 -4.16 -2.77 -0.07 3.26 2.11 -0.25 -0.23 2.5 1 2.98 2.35 0.4 -3.67 -1.88 -0.66 0.6 -1.63 -2.13 -3.09
Hedgehog Signaling Pathway Netpath%WikiPathways_20191210%WP47%Homo sapiens -0.78 -0.69 0.98 -2.43 -1.59 -3.77 3.49 -0.65 -1.61 0.33 0.61 0.21 3.06 1.75 -0.41 -0.31 -1.55 -1.92 1.39 2.6 -3.46 -0.87 1.27 1.11 0.96 -0.2 -1.17 -1.02 0.34 3.33 2.3 2.5 -1.81 0.88 1.13 1.95 -0.22 -3.25 -2.47
Cannabinoid receptor signaling%WikiPathways_20191210%WP3869%Homo sapiens -5.24 -1.54 -0.07 -0.02 -4.14 -1.94 5.36 3.02 0.22 1.42 4.15 -0.4 5.5 0.65 0.91 -2.57 -3.86 -2.27 0.28 2.29 -4.01 -3.49 -0.07 2.8 1.84 -0.59 1.06 4.2 -0.03 3.22 2.68 2.16 -5.77 1.27 0.37 0.96 -2.39 -0.55 -5.42
Retinoblastoma Gene in Cancer%WikiPathways_20191210%WP2446%Homo sapiens -3.82 0.68 1.51 -6.82 -3.87 -4.59 8.72 2.25 -0.94 1.26 6.27 2.26 8.57 0.29 1.43 -1.79 -4.73 -3.55 1.81 1.74 -9.58 -3.82 0.7 4.66 2.88 -0.19 -1.03 4.47 1.51 6.25 3.82 2.47 -4.91 -0.81 1.14 1.09 -3.08 -6 -6.27
SREBF and miR33 in cholesterol and lipid homeostasis%WikiPathways_20191210%WP2011%Homo sapiens -4.52 -1.74 -0.31 -0.12 -4.52 -3.21 2.02 4.71 -1.1 1.91 2.15 -1.25 4.37 0.88 2.23 -1.64 -3.01 -0.94 1.06 0.07 -3.2 -3.43 0.35 2.29 2.12 -0.19 1.16 3.32 -0.33 2.17 1.93 0.74 -1.36 0.99 0.82 0.2 -0.43 0.1 -4.29
ACE Inhibitor Pathway%WikiPathways_20191210%WP554%Homo sapiens -2.17 0.36 1.62 -2 -2.56 -3.87 6.23 2.26 -0.57 1.12 3.91 1.55 5.97 0.26 0.7 -1.53 -2.56 -2.87 2.73 2.01 -6.36 -2.18 -0.2 3.21 1.61 -0.6 -0.95 1.63 1.46 4.62 0.89 1.37 -3.66 -2.03 -0.69 -0.35 -2.17 -2.76 -3.42
Cardiac Progenitor Differentiation%WikiPathways_20191210%WP2406%Homo sapiens -2.52 0.34 1.78 -4.9 -4.25 -2.47 9.46 2.93 -0.33 1.68 5.64 1.85 9.53 -0.64 1.61 -2.14 -3.7 -4.9 2.39 2.26 -7.66 -3.45 0.09 3.74 1.68 0.68 -1.13 4.91 1.52 6.28 1.88 0.47 -5.8 -1.94 -1.28 -0.03 -4.21 -5.25 -4.1
Pathways Affected in Adenoid Cystic Carcinoma%WikiPathways_20191210%WP3651%Homo sapiens -7.9 -3.93 0.45 -0.68 -4.83 -0.74 5.68 5.23 -0.41 2.16 4.58 0.3 8.12 0.39 0.44 -3.48 -6.8 -5.02 -1.74 1.99 -4.18 -2.78 -2.19 3.76 3.75 -0.5 2.57 3.48 0.53 4.13 3.07 2.47 -3.11 0.3 -0.19 2.88 0.12 -0.36 -7.55
miRNA regulation of prostate cancer signaling pathways%WikiPathways_20191210%WP3981%Homo sapiens 6.22 2.96 0.39 0.19 3.17 -1.05 -4.08 -3.47 0.17 -1.25 -2.42 -0.04 -4.78 -1.34 -0.65 2.13 5.51 3.12 0.74 -1.94 3.4 2.65 0.44 -2.6 -2.52 0.47 -1.16 -2.48 -1.32 -3.61 -2.02 -2.67 3.61 -2.21 -0.5 -1.68 0.63 0.53 7.48
Human Thyroid Stimulating Hormone (TSH) signaling pathway%WikiPathways_20191210%WP2032%Homo sapiens 9.64 4.5 1.4 -0.79 5.55 -1.45 -4.1 -6.48 0.62 -3.74 -3.06 0.9 -6.37 -0.62 -2.25 3.29 5.62 4 2.26 -1.16 1.2 5.02 1.62 -4.01 -2.74 0.15 -3.09 -5.56 0.4 -3.16 -3.22 -0.21 4.37 -0.75 -0.15 -1.97 0.53 -3.12 6.9
Cardiac Hypertrophic Response%WikiPathways_20191210%WP2795%Homo sapiens 2.19 -0.21 -1.95 4.41 4.24 2.71 -5.98 -2.9 1.13 -0.17 -5.4 -1.39 -6.28 0.71 -1.93 1.07 3.78 2.78 -2.99 -3.43 6.93 2.52 -1.04 -2.63 -1.56 1.09 1.4 -3.9 -0.96 -6.16 0.5 -3.72 5.71 0.85 0.08 -0.18 2.52 3.61 4.56
Canonical and Non-Canonical TGF-B signaling%WikiPathways_20191210%WP3874%Homo sapiens -0.1 -0.64 1 5.68 0.43 2.77 -2.93 0.45 -1.68 0.18 -2.65 -1.51 -3.91 -0.58 -0.5 -0.49 -0.62 0.64 -0.33 -0.05 7 0.24 -0.57 -2.06 1.15 -0.13 0.42 -0.93 -1.73 -2.33 -0.52 -1.26 1.56 1.24 0.94 -0.72 1.44 1.84 -0.74
EPO Receptor Signaling%WikiPathways_20191210%WP581%Homo sapiens -3.57 -1.44 -0.37 -2.35 -2.71 -2.19 4.83 3.27 0.01 -0.17 6.29 2.53 4.43 -0.14 0.21 -0.49 -3.59 -3.09 0.8 1.62 -4.03 -2 0.72 2.61 0.36 1.12 -0.79 2.52 0.95 3.28 0.71 1.57 -4 -1.42 -0.45 -0.29 -1.47 -0.87 -2.38
Apoptosis-related network due to altered Notch3 in ovarian cancer%WikiPathways_20191210%WP2864%Homo sapiens -6.67 -4.14 -1.24 5.33 -2.96 2.12 -0.7 1.38 -0.51 3.55 -2.12 -1.86 0.91 4.83 2.27 -2.6 -5.12 -2.04 -4.55 0.05 2.7 -1.53 -4.07 0.95 3.31 -1.09 4.58 0.04 -2.05 2.77 1.55 -0.68 -1.48 7.42 3.21 2.96 0.4 2.48 -7.38
Parkin-Ubiquitin Proteasomal System pathway%WikiPathways_20191210%WP2359%Homo sapiens -9.71 -6.88 1.71 0.6 -7.35 -1.9 6.09 4.81 -4.35 1.02 6.36 -2.59 0.98 0.85 1.14 -2.51 -4.9 -6.02 0.74 6.71 -3.69 -5.61 0.28 5.05 3.16 -2.02 1.97 4.42 -0.35 2.26 2.51 6 -2.39 3.17 3.29 5.42 0.74 1.11 -10.14
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway%WikiPathways_20191210%WP2380%Homo sapiens -11.39 -3.71 -0.62 0.07 -8.19 -1.78 8.77 6.9 -0.71 3.37 8.54 -0.01 10.56 1.39 3 -4.38 -8.41 -6.16 -2.14 2.87 -6.04 -6.54 -1.87 5.83 4.83 -0.5 2.33 7.35 -0.13 6.52 3.52 3.83 -8.15 1.96 1.36 2.58 -3.13 -0.65 -11.09
Triacylglyceride Synthesis%WikiPathways_20191210%WP325%Homo sapiens 1.79 -0.43 -1.83 2.29 3.43 1.78 -5.39 -1.89 -0.54 -1.52 -4.31 -2.59 -3.83 0.38 -0.3 2.3 2.93 1.14 -1.58 -0.56 4.12 2.28 -0.72 -1.76 -2.61 -0.45 1.39 -1.74 -0.52 -1.64 -2.04 -0.78 2.43 1.4 0.66 0.13 2.58 3.27 2.74
Ebola Virus Pathway on Host%WikiPathways_20191210%WP4217%Homo sapiens -10.94 -4.27 0.62 1.21 -6.82 1.93 6.88 5.95 -2.32 1.48 7.33 -2.98 0 0.67 3.7 -3.75 -7.52 -3.45 -0.44 3.42 -0.51 -5.4 -2.27 4.2 7.37 -1.41 4.07 8.34 -1.96 0.13 1.92 5.11 -5.89 2.93 3.64 3.91 -1.98 0.28 -13.21
Osteoclast Signaling%WikiPathways_20191210%WP12%Homo sapiens -2.14 -0.2 1.02 -1.94 -2.11 -3.26 5.28 2.02 -0.21 0.25 4.97 0.7 4.58 0.31 1.34 -1.21 -2.57 -2.59 2.56 1.87 -5.76 -1.98 0.2 2.32 2.51 -0.56 -1.46 2.56 1.05 2.68 1.1 1.36 -3.91 -1.32 -0.01 0.9 -2.67 -2.23 -3.44
Microglia Pathogen Phagocytosis Pathway%WikiPathways_20191210%WP3937%Homo sapiens -6.47 -0.56 -1.28 8.05 -4.5 1.33 -1.68 3.58 -3.3 0.77 6.19 -4.17 -6.62 -0.77 3.38 -1.92 -5.5 2.14 -2.09 -0.79 6.42 -2.89 -2.45 -1.99 5.91 -1.89 4.05 8.42 -2.96 -5.17 2.15 1.64 -1.93 1.18 5.35 1.55 -2.48 4.97 -5.64
Peptide GPCRs%WikiPathways_20191210%WP24%Homo sapiens -2.53 1.6 1.66 -8.32 -5.83 -7.25 13.09 5.38 -0.56 1.78 10.71 4.14 11.89 -1.26 2.4 -2.97 -5.36 -5.19 5.61 2.22 -12.51 -4.94 1.54 7.26 4.06 -0.26 -3.11 6.25 3.53 7.75 2.99 2.1 -8.63 -4.86 -1.97 -0.01 -6.48 -8.13 -5.79
Nucleotide-binding Oligomerization Domain (NOD) pathway%WikiPathways_20191210%WP1433%Homo sapiens -4.9 -1.09 0.9 6.4 -4.21 -2.88 3.16 2.76 -3.26 1.95 5.79 -1.16 2.28 -0.73 1.36 -2.19 -4.04 -1.86 0.52 0.95 1.02 -1.61 -1.14 1.01 1.04 -2.57 0.87 3.14 -0.86 0.95 2.22 2.47 -3.66 -0.05 4.09 0.77 -3.13 0.11 -4.4
Wnt Signaling in Kidney Disease%WikiPathways_20191210%WP4150%Homo sapiens 2.02 -0.33 -1.37 5.31 2.65 3.32 -7.02 -1.6 0.81 -0.83 -5.43 -1.36 -7.39 0.53 -0.99 1.27 2.61 2.09 -2.99 -1.97 7.41 2.7 -0.96 -2.87 -0.49 0.3 0.98 -1.86 -0.97 -4.65 -1.19 -1.6 3.55 1.04 -0.1 -1.3 2.05 5.03 3.59
Androgen receptor signaling pathway%WikiPathways_20191210%WP138%Homo sapiens -8.76 -4.98 -0.1 0.22 -5.77 1.84 4.66 3.08 -2.29 2.08 2.23 -1.23 4.14 1.79 0.79 -3.25 -6.87 -4.93 -1.26 2.17 -3.09 -4.6 -2.29 4.73 4.53 -0.64 2.91 3.91 0.81 4.39 3.44 3.5 -3.16 4.95 1.62 4 1.06 0.23 -9.86
LTF danger signal response pathway%WikiPathways_20191210%WP4478%Homo sapiens 0.03 -1.61 -2.11 5.4 3.12 2.26 -5.56 -1.43 -0.09 0.35 -2.84 -1.43 -3.7 1.28 0.51 0.41 -0.02 1.76 -2.48 -2.75 5.41 2.74 -1.74 -2.67 -1.19 -0.74 1.84 -1.96 -1.51 -2.82 -1.23 -1.29 2.4 2.83 1.78 0.4 1.9 3.81 0.92
Splicing factor NOVA regulated synaptic proteins%WikiPathways_20191210%WP4148%Homo sapiens -8.05 -3.96 -1.19 2.22 -5.7 -1.83 5.5 4.68 -1.43 3.02 5.25 -1.07 8.62 1.5 1.95 -2.08 -6.09 -3.89 -1.37 2.74 -2.35 -5.13 -1.63 2.99 2.84 -1.51 1.85 4.42 -1.36 5.35 3.73 3.3 -6.2 2.66 1.36 2.03 -2.58 0.63 -9.2
NAD+ biosynthetic pathways%WikiPathways_20191210%WP3645%Homo sapiens -1.52 0.4 0.28 -3.84 -1.7 -1.74 4 1.39 0.81 0.5 2.21 2.13 3.45 1.28 -1.67 0.12 -1.87 -1.04 0.52 1.19 -3.58 -2.01 -0.39 1.43 0.37 0.23 -1.05 0.77 1.64 3.46 0.97 1.06 -2.01 1.18 -1.61 0.94 -0.89 -2.95 -2.47
Biogenic Amine Synthesis%WikiPathways_20191210%WP550%Homo sapiens -3.49 -1.27 0.12 -2.23 -3.43 -2.06 4.46 3.36 0.61 1.41 2.66 2.57 5.97 0.58 1.16 -2.1 -4.24 -3.07 -0.25 0.91 -4.16 -4.64 -0.69 2.37 2.21 -0.23 0.81 2.69 1.99 4.77 0.94 2.54 -4.12 0 -0.13 1.02 -1.39 -1.71 -3.92
Hedgehog Signaling Pathway%WikiPathways_20191210%WP4249%Homo sapiens -2.59 0.27 -0.51 -3.78 -3.11 -3.76 5.7 1.55 0.5 1.41 3.74 2.2 5.05 1.23 0.51 -0.99 -2.85 -2.45 1.42 2.58 -7.45 -1.91 0.58 2.57 2.04 0.71 -0.95 1.26 1.74 4.8 1.61 3.08 -4.06 -0.53 -0.22 1.08 -1.54 -4.06 -4.88
Photodynamic therapy-induced HIF-1 survival signaling%WikiPathways_20191210%WP3614%Homo sapiens -4.17 -1.85 2.4 -3.06 -3.17 -0.81 6.55 3.35 -0.54 1.06 5.5 0.52 4.91 -1.73 -0.36 -1.24 -3.49 -3.04 0.62 2.91 -4.65 -2 -0.64 3.95 2.39 0.11 0.29 4.29 0.75 4.09 0.67 2.92 -3.56 -1.43 -0.9 -0.68 -2.6 -2.38 -4.96
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling%WikiPathways_20191210%WP3612%Homo sapiens -2.23 -1.65 -0.53 3.84 0.16 1.29 -3.63 -0.45 -1.82 1.12 -3.23 -2.9 -0.35 3.9 0.42 -1.25 -0.5 0.03 -2.1 -1.41 4.86 0.07 -0.94 -2.12 1.01 -1.42 2.75 -1.44 -1.57 1.51 -0.8 -1.13 0.86 4.46 1.08 1.42 1 3.06 -1.38
Trans-sulfuration and one carbon metabolism%WikiPathways_20191210%WP2525%Homo sapiens -3.52 -0.02 1.3 -2.11 -3.14 -1.94 3.79 0.83 -2.15 1.57 2.3 0.88 3.11 1.68 0.94 -1.89 -3.24 -1.28 1.2 2.79 -4.4 -2.35 -0.16 1.8 0.56 -1.62 -0.12 0.55 0.35 4.25 2.15 4.16 -2.37 2.16 1.61 0 -1.21 -2.01 -4.44
Cytokines and Inflammatory Response%WikiPathways_20191210%WP530%Homo sapiens -1.04 1.49 2 -5.28 -4.24 -3.32 7.49 3.13 -0.69 1.42 4.46 1.95 6.9 -0.8 1.7 -1.57 -2.54 -2.99 3.13 1.95 -6.63 -3.22 1.3 4.4 2.83 -0.33 -2 3.27 2.12 4.75 2.37 0.18 -4.78 -3.47 -1.45 -0.21 -3.26 -5.26 -3.75
Homologous recombination%WikiPathways_20191210%WP186%Homo sapiens -1.06 0.02 0.86 -1.99 -1.38 -2.58 5.56 2.22 -1.24 0.7 2.64 -0.69 3.79 0.61 0.18 -1.03 -2.74 -0.94 1.66 0.19 -3.73 -1.27 -0.26 2.39 0.3 -1.45 -0.04 2.27 0.4 2.52 1.99 1.08 -3.7 -0.33 0.31 0.54 -1.81 -1.58 -2.39
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease%WikiPathways_20191210%WP3668%Homo sapiens 0.98 -0.63 0.24 4.36 1.27 2.21 -5.19 -1.07 -0.76 -0.19 -5.69 -2.26 -3.07 0.79 -0.27 0.19 0.8 1.98 -1.87 -0.3 6.73 0.88 -0.69 -1.96 0.62 -0.36 1.83 -3.17 -3.66 -2.72 -0.61 -0.52 2.41 2.62 0.43 0.21 1.6 3.72 1.13
Ethanol effects on histone modifications%WikiPathways_20191210%WP3996%Homo sapiens 5.31 2.64 0.29 -2.72 2.81 -1.6 -1.91 -2.94 -2.24 -2.2 -2.1 0.09 -3.88 0.47 -1.16 1.9 3.82 2.9 1.42 0.15 2.52 3.26 0.61 -2.24 -1.16 -0.86 -0.48 -3.92 -0.84 -1.84 -3.14 -0.61 3.02 -0.48 0.36 -1.31 0.96 -0.47 5.54
ErbB Signaling Pathway%WikiPathways_20191210%WP673%Homo sapiens -8.45 -3.43 -0.97 -1.45 -5.91 -2.75 8.55 5.35 0.19 1.23 8.93 0.5 7.1 0.1 1.89 -3.04 -5.36 -5.12 -0.36 2.99 -4.6 -4.75 -1.2 5.04 2.86 -0.19 -0.09 7 1.53 5.3 3.71 3.46 -6.79 0.16 0.19 1.77 -3.03 -1.27 -9.08
Interleukin-11 Signaling Pathway%WikiPathways_20191210%WP2332%Homo sapiens -1.83 0.85 0.76 -4.87 -2.16 -2.32 6.24 3.03 -0.46 -1.15 5.25 1.19 4.54 -1.34 1.22 0.22 -1.05 -2.6 2.48 4.21 -7.01 -0.87 1.5 3.11 -0.32 -1.21 -1.24 1.77 1.06 3.19 -0.81 2.99 -3.81 -2.45 0.07 -0.25 -2.71 -3.35 -1.89
Fatty Acid Omega Oxidation%WikiPathways_20191210%WP206%Homo sapiens 1.84 0.12 -0.78 3.15 2.68 2.88 -4.96 -2.8 0.82 -0.09 -4.37 -0.49 -3.71 0.14 -0.74 2.09 1.85 1.84 -1.67 -2.37 5.35 1.76 -1.98 -2.25 -0.62 1.08 0.93 -2 -0.65 -3.07 -3.27 -2.34 3.25 0.21 -0.08 -0.17 2.55 3.28 2.6
Vitamin D Receptor Pathway%WikiPathways_20191210%WP2877%Homo sapiens -4.71 1.2 3.27 -9.58 -7.64 -7.77 15.46 5.28 -0.8 2.8 12.93 4.15 15.21 -0.23 2.02 -3.21 -6.92 -6.46 5.74 2.26 -13.66 -6.66 0.85 7.35 3.62 -1.12 -3.2 7.8 3.75 10.21 5.07 3.44 -9.9 -4.05 -1.77 -0.35 -6.8 -9.9 -7.69
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway%WikiPathways_20191210%WP3932%Homo sapiens -9.29 -1.08 2.89 -9.06 -10.01 -8.35 18.47 8.57 -1.31 3.66 14.35 3.63 15.58 -0.49 2.81 -5.03 -9.37 -8.64 5.33 6.47 -15.15 -7.33 1.12 8.29 6.18 -0.87 -2.47 10.36 3.92 11.55 4.53 5.7 -12.13 -4.01 -0.55 0.91 -7.18 -9.43 -12.6
IL-4 Signaling Pathway%WikiPathways_20191210%WP395%Homo sapiens 5.06 2.78 0.89 -6.66 1.89 -4.4 2.57 0.28 2.7 -0.85 3.23 2.99 4.8 -1.81 -1.25 2.95 4.76 -0.45 4.15 0.06 -5.62 0.77 2.88 -0.22 -4.49 0.71 -4.45 -1.01 2.94 2.15 -2.13 -1.12 -0.42 -5.56 -3.85 -3.41 -0.96 -4.74 4.84
Wnt Signaling Pathway (Netpath)%WikiPathways_20191210%WP363%Homo sapiens 5.56 1.01 -0.38 2.48 4.28 1.43 -8.48 -3.76 -0.32 -2.02 -5.95 -1.51 -7.28 0.16 -1.33 2.89 4.8 3.58 -1.1 -2.69 6.31 4.1 -0.99 -3.04 -2.87 0.19 1.07 -3.69 -0.6 -4.71 -2.39 -2.66 5.27 0.26 1.05 -0.38 2.62 2.88 6.21
IL-3 Signaling Pathway%WikiPathways_20191210%WP286%Homo sapiens -0.34 -1.2 -0.79 7.01 1.8 3.51 -6.31 -2.79 -1.16 -0.56 -5.96 -2.69 -6.45 0.91 0.36 -0.35 0.24 2.52 -2.77 -2.31 7.93 1.52 -1.67 -3.88 0.39 -0.5 3 -0.49 -1.89 -3.95 0.63 -0.69 3.6 3.55 2.34 0.29 1.66 5.39 0.06
Cell Differentiation - Index expanded%WikiPathways_20191210%WP2023%Homo sapiens -1.61 1.39 1.09 -2.89 -2.64 -3.87 6.37 0.85 -0.12 0.66 5.3 1.26 5.03 -0.9 1.1 -1.57 -2.15 -1.8 2.91 0.99 -6.32 -1.62 0.83 2.83 1.37 -0.06 -1.68 1.49 1.25 4.06 2.47 0.54 -3.49 -2.28 -1.2 0.05 -2.6 -3.36 -1.65
Monoamine Transport%WikiPathways_20191210%WP727%Homo sapiens -5.42 -1.71 -0.14 0.27 -4.63 -1.88 5.21 4.22 0.77 1.84 4.5 1.02 6.61 0.63 1.16 -2.44 -4.41 -3.75 -0.2 2.1 -3.09 -4.11 -0.61 2.4 2.74 0.04 -0.11 4.2 0 3.95 1.91 0.94 -5.18 0.41 -0.49 0.59 -1.92 -0.03 -5.36
T-Cell antigen Receptor (TCR)  Signaling Pathway%WikiPathways_20191210%WP69%Homo sapiens -4.99 -0.11 1.48 -4.41 -6.14 -4.14 8.95 4.32 -0.99 1.03 9.46 1.6 9.63 -0.57 1.62 -2.38 -5.83 -3.58 2.52 4.59 -7.64 -5.27 0.56 4.74 2.25 -1.16 -1.08 5.02 2.11 6.57 1.52 2.81 -7.41 -1.34 -0.6 1.31 -4.67 -3.84 -5.94
One carbon metabolism and related pathways%WikiPathways_20191210%WP3940%Homo sapiens 4.39 1.59 -0.3 1.35 4.69 1.37 -5.51 -3.63 0.43 -0.34 -4.23 -1 -6.32 0.41 -1.89 2.88 4.4 3.58 -0.91 -2.89 5.21 3.87 0.09 -2.73 -1.65 1.25 -0.94 -2.48 -0.4 -3.97 -0.82 -2.93 3.55 -0.05 -2.45 -0.55 1.85 0.55 4.53
Small Ligand GPCRs%WikiPathways_20191210%WP247%Homo sapiens -2.51 0.82 1.47 -3.76 -2.84 -3.58 5.81 2.02 -0.5 1.86 4.61 1.04 5.69 -0.46 0.93 -1.38 -1.97 -2.99 2.74 1.86 -5.78 -1.95 0.78 3.23 1.89 0.07 -0.03 2.53 1.19 3.83 0.95 1.5 -4.87 -2.08 -0.35 -0.34 -3.69 -3.7 -2.03
VEGFA-VEGFR2 Signaling%WikiPathways_20191210%WP3888%Homo sapiens -19.19 -8.46 2.11 0.01 -12.98 -0.47 14.19 10.36 -2.06 5.85 10.97 -0.78 15.57 1.82 3.03 -6.68 -15.01 -9.79 -0.42 7.34 -10.38 -10.38 -2.29 10.55 9.48 -1.39 3.94 10.48 1.78 10.19 6.99 7.3 -11.62 2.76 0.43 4.49 -3.79 -2.34 -21.61
Ganglio Sphingolipid Metabolism%WikiPathways_20191210%WP1423%Homo sapiens 0.73 0.43 1.41 -3.28 -1.53 -1.43 3.97 1.83 -1.09 0.14 2.1 0.45 3.77 -0.69 0.71 -0.59 -1.66 -1.83 2.11 1.24 -5.01 -0.52 1.56 1.68 2.34 -0.37 -0.7 1.96 1 3.79 0.99 0.65 -3.38 -2.44 -1.27 0.14 -1.85 -3.06 -2.31
LncRNA involvement in canonical Wnt signaling and colorectal cancer%WikiPathways_20191210%WP4258%Homo sapiens -4.71 0.63 2.1 -5.51 -5.12 -1.68 10.38 3.56 -0.39 1.99 6.6 2.35 10.06 -0.72 0.67 -2.68 -4.8 -2.83 2.88 3.03 -9.55 -4.32 1.4 4.58 3.64 -0.71 -1.9 3.64 1.69 7 2.86 1.99 -6.07 -0.85 -1.38 0.41 -4.04 -6.51 -7.69
Pancreatic adenocarcinoma pathway%WikiPathways_20191210%WP4263%Homo sapiens -5.35 -1.77 -0.03 -6.34 -4.27 -3.89 9.07 1.58 0.59 0.37 6.57 1.15 7.59 1 0.93 -1.17 -3.66 -4.99 0.64 3.88 -6.35 -2.52 -0.05 3.55 1.36 -0.89 -1.08 2.69 1.63 8.17 1.8 4.71 -5.28 2.34 0.61 1.5 -2.22 -4.59 -7.27
Cells and Molecules involved in local acute inflammatory response %WikiPathways_20191210%WP4493%Homo sapiens -0.86 0.41 1.25 -2.85 -2.93 -3.15 4.53 2.49 -0.07 -0.4 5.09 1.05 5.37 -1.01 0.56 0.7 -1.68 -1.31 1.86 1.46 -3.87 -1.96 1 2.52 1.09 -0.03 -1.75 2.45 0.96 2.84 0.97 2.5 -4.15 -3.15 -0.25 -0.65 -2.46 -3.88 -2.69
Ciliary landscape%WikiPathways_20191210%WP4352%Homo sapiens -13.97 -7.36 1.61 -3.14 -9.13 -0.56 11.86 5.51 -4.27 2.1 9.53 -1.49 7.94 2.87 2.09 -4.52 -8.97 -8.95 -0.26 6.4 -7.01 -7.48 -1.72 7.74 3.88 -0.92 4.01 7.62 0.68 8.35 2.92 7.26 -7.22 3.99 3.89 6.29 -1.99 -2.54 -15.05
Extracellular vesicles in the crosstalk of cardiac cells%WikiPathways_20191210%WP4300%Homo sapiens -1.7 -1.64 -0.02 3 1.09 1.47 -4.1 -0.95 -1.64 1.61 -3.42 -2.49 -1.73 2.8 2.27 -0.24 -0.78 0.24 -2.68 -0.43 3.79 1.02 -0.34 -2.14 -1.75 -1.46 3.06 -2.83 -1.22 0.26 -0.92 0.51 1.46 3.08 2.63 2.62 2.74 2.21 -3.35
PI3K-Akt Signaling Pathway%WikiPathways_20191210%WP4172%Homo sapiens -9.2 -0.27 3.03 -10.96 -11.19 -9.38 21.29 10.14 -1.36 4.38 17.28 4.91 18.09 -1.51 2.91 -5.78 -10.17 -9.07 6 5.11 -17.26 -8.53 1.39 10.02 7.29 -0.62 -2.83 12.6 5.04 12.93 5.29 3.88 -13.87 -5.94 -1.89 0.88 -9.02 -10.56 -13.05
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells%WikiPathways_20191210%WP4301%Homo sapiens -4.97 -2.2 -0.7 -1.92 -2.31 -0.69 3.28 3.28 0.02 0.35 2.92 0.15 3.28 0.31 1.25 -2.28 -2.14 -2.07 -0.15 1.65 -1.51 -2.5 0.16 1.12 0.78 -0.4 0.47 2.44 0.56 2.53 0.19 1.35 -2.15 0.89 0.58 1.34 0.1 0.47 -3.49
Non-small cell lung cancer%WikiPathways_20191210%WP4255%Homo sapiens 5.45 1.7 0.29 5.2 4.08 2.54 -8.27 -3.59 -0.43 -0.4 -7.13 -1.03 -7.91 -0.86 -0.84 1.23 4.46 4.44 -0.29 -3.16 7.02 3.67 -0.11 -3.02 -1.67 0.65 1.35 -3.81 -1.61 -6.96 -2.05 -5.19 5.21 -0.92 0.25 -1.34 1.64 4.63 6.8
Breast cancer pathway%WikiPathways_20191210%WP4262%Homo sapiens -4.23 0.26 1.93 -10.03 -6.01 -7.23 12.82 4.39 0.31 1.03 9.52 3.24 12.36 -1.34 0.83 -1.3 -4.67 -5.22 4.56 3.71 -13.15 -3.58 1.06 5.99 2.63 0.16 -2.54 5.47 3.67 10.14 2.86 3.96 -7.73 -1.6 -1.12 0.42 -5.11 -9.1 -7.35
Metabolic reprogramming in colon cancer%WikiPathways_20191210%WP4290%Homo sapiens -6.12 -3.73 0.37 1.05 -4.81 -2.91 6.75 4.81 -4.16 2.61 6.54 -2.44 4.07 -1.12 0.63 -1.98 -3.93 -4.08 1.11 4.56 -3.99 -3.55 -1.48 3.37 2.14 -2.42 1.4 6.37 -1.26 3.46 2.61 3.25 -3.45 0.04 1.59 1.68 -1.04 1.07 -7.01
Methionine metabolism leading to Sulphur Amino Acids and related disorders%WikiPathways_20191210%WP4292%Homo sapiens -3.05 -2.24 1.1 -0.52 -2.64 0.48 1.57 0.48 -0.02 0.75 3.68 -0.11 0.73 1.27 0.3 -1.66 -1.84 -2.35 -0.1 2.38 -2.2 -2.53 0.56 1.84 -0.21 -1.17 0.38 1.62 -0.02 1.33 1.24 3.73 -2.06 2.14 1.73 0.74 -0.86 -0.84 -3.62
Fibrin Complement Receptor 3 Signaling Pathway%WikiPathways_20191210%WP4136%Homo sapiens -1.45 -1.47 -2.9 8.07 1.98 3.8 -5.64 -1.21 0.09 -0.14 -3.53 -2.67 -5.96 0.66 1.68 -0.03 -0.04 2.33 -3.37 -2.47 6.85 1.8 -2.02 -2.65 -0.4 -0.34 3 -0.78 -2.35 -4.59 -0.57 -2.4 2.24 3.86 2.42 0.98 2.01 5.41 -0.23
Resistin as a regulator of inflammation%WikiPathways_20191210%WP4481%Homo sapiens -5.06 -1.38 1.4 -1.11 -4.5 -1.64 6.71 2.65 -0.73 0.68 5.12 0.65 6.2 1.54 1.22 -2.27 -4.67 -2.75 -0.06 1.93 -3.94 -3.9 -0.33 3.04 3.4 -0.61 1.06 3.83 0.68 3.2 2.15 2.46 -5.52 0.83 -0.15 0.92 -2.14 -2.55 -6.36
Thermogenesis%WikiPathways_20191210%WP4321%Homo sapiens -8.84 -2.97 0.52 -2.56 -6.04 -4.61 9.49 4.47 -0.53 2.55 9.11 0.31 8.68 -0.17 2.83 -3.15 -5.58 -5.29 0.18 3.47 -7.58 -3.86 -0.43 4.18 2.4 -0.13 0 6.64 1.18 6.02 3.07 3.65 -7.18 0.27 1.78 2.17 -3.14 -2.42 -8.49
Metabolic pathway of LDL, HDL and TG, including diseases%WikiPathways_20191210%WP4522%Homo sapiens -1.93 0.08 0.9 -1.58 -3.37 -0.91 3.87 1.57 -0.81 0.84 3.23 0.27 4 -0.34 0.37 0.62 -1.6 -0.44 2.91 0.68 -4.03 -2.19 0.8 1.48 1.38 -0.25 -0.81 3.2 0.82 1.96 1.44 1.74 -4.49 -0.43 -0.25 -0.09 -3.14 -3.03 -2.48
The human immune response to tuberculosis%WikiPathways_20191210%WP4197%Homo sapiens 3.33 -0.16 -1.16 -6.24 0.19 -1.18 1.75 -1.64 2.06 0.57 -3.7 2.62 1.22 -0.62 -2.63 3.26 2.18 -4.06 1.2 -1.47 -2.69 1.87 1.59 1.69 -2.69 1.67 -1.23 -6.55 2.41 2.01 0.14 0.04 2.41 0.43 -1.89 -0.43 1.87 -0.65 4.47
The alternative pathway of fetal androgen synthesis%WikiPathways_20191210%WP4524%Homo sapiens 0.67 -0.71 -0.38 2.67 1.86 2.23 -3.12 -2.02 -0.19 -0.23 -6.36 -0.96 -2.96 0.93 -1.28 1 1.25 1.75 -1.71 -0.89 3.37 1.59 -1.27 -1.98 -0.96 1.08 1.43 -1.85 -0.42 -2.26 -0.61 -0.95 3.18 1.92 -0.08 -0.12 1.83 3.39 1.16
MET in type 1 papillary renal cell carcinoma%WikiPathways_20191210%WP4205%Homo sapiens 6.95 3.12 0.89 1.75 4.29 3.44 -5.77 -4.44 -1.36 -1.21 -6.38 -0.02 -6.1 -1.42 -1.87 1.89 3.8 3.72 0.02 -2.47 3.29 3.63 0.94 -3.88 -1.11 0.01 -0.39 -3.47 -0.88 -4.29 -1.36 -2.93 5.74 -0.95 -0.73 -2.1 1.35 0.59 7.69
Hereditary leiomyomatosis and renal cell carcinoma pathway%WikiPathways_20191210%WP4206%Homo sapiens -4.18 -2.47 0.89 0.02 -2.93 -0.37 3.71 1.83 -2.13 1.91 4.39 -0.12 3.65 -0.4 0.05 -2.12 -2.83 -2.47 -0.22 2.81 -2.84 -2.56 0.75 2.42 2.34 0.11 0.27 3.71 0.43 2.7 1.68 1.74 -2.77 -0.03 0.39 -0.08 -1.65 -0.69 -4.92
Tryptophan catabolism leading to NAD+ production%WikiPathways_20191210%WP4210%Homo sapiens -1.61 -0.26 0.52 -1.72 -2.27 -1.81 3.1 0.94 0.32 0.73 2.81 0.21 4.07 0.3 0.39 -0.73 -1.17 -0.87 1.38 3.11 -3.37 -1.64 -0.48 1.35 0.53 -0.2 -0.82 2.11 1.77 2.72 1.16 1.24 -2.87 -1.19 -0.75 0.4 -1.83 -3.18 -2.37
Transcriptional cascade regulating adipogenesis%WikiPathways_20191210%WP4211%Homo sapiens 0.91 -0.42 -1.61 2.45 2.04 0.56 -4.21 -1.03 0.27 -0.11 -2.64 -0.68 -3.73 0.55 -0.44 1.39 1.54 0.95 -2.08 -0.83 3.64 2.09 -0.35 -3.07 -1.14 -0.47 1.02 -2.38 -0.78 -2.05 -0.3 -1.2 2.2 1.77 1.29 0.42 1.59 2.7 2.15
Oxysterols derived from cholesterol%WikiPathways_20191210%WP4545%Homo sapiens -2.73 0.24 0.59 -2.79 -2.91 -1.78 5.77 3.99 -0.42 1.37 3.65 0.95 5.55 -0.67 0.74 -1.52 -3.12 -1.73 1.39 1.09 -4.54 -3.39 0.02 2.82 2.26 0.14 0.17 3.82 2.18 2.89 1.68 0.4 -3.81 -2.26 -1.24 -0.1 -2.38 -3.48 -2.86
MTHFR deficiency%WikiPathways_20191210%WP4288%Homo sapiens -3.35 -0.28 -0.09 -1.02 -4.54 -1.87 2.91 2.81 0.14 1.18 2.59 0.65 6 0.2 0.5 -2.46 -3.66 -1.02 0.91 0.4 -3.37 -3.87 -0.63 2.33 3.17 -0.6 0.99 3.3 1.04 3.83 2.54 1.27 -3.3 0.46 0.01 -0.39 -1.85 -1.86 -3.07
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome%WikiPathways_20191210%WP4320%Homo sapiens -3.02 -2.85 -0.35 6.07 -2.07 4 -2.42 3.03 1.21 3.43 -2 -2.01 -0.34 -0.85 -0.22 -0.52 -1.02 -0.36 -1.97 -1.64 2.46 -2.82 -1.59 1.28 1.61 0.18 1.91 1.76 -0.73 -3.26 3.92 -2.18 -0.52 -0.6 -0.55 0.58 0.89 3.41 -1.85
Chromosomal and microsatellite instability in colorectal cancer %WikiPathways_20191210%WP4216%Homo sapiens 6.59 1.37 -1.04 4.62 5.01 2.15 -9.27 -3.55 0.86 -1.49 -6.04 0.17 -7.57 -0.21 -1 2.24 5.17 4.31 -0.92 -3.08 7.03 3.96 -0.19 -3.83 -2.04 1.12 -1.27 -3.74 -1.21 -7.16 -2.76 -4.56 6.04 -1.26 -0.42 -1.8 3 3.22 7.53
Rett syndrome causing genes%WikiPathways_20191210%WP4312%Homo sapiens -6.48 -2.24 -0.27 1.23 -4.39 -0.25 5.12 2.6 -0.33 0.93 3.6 -0.33 6.24 0.97 0.12 -2.61 -5.35 -2.45 -0.23 2 -2.78 -3.66 -1.05 3.81 3.38 -0.51 1.92 3.11 -0.33 3.32 3.2 2.27 -4.31 1.88 0.44 2.07 -1.38 -0.97 -8.3
Genotoxicity pathway%WikiPathways_20191210%WP4286%Homo sapiens 4.58 1.14 0.29 3.22 3.31 2.05 -6.29 -2.67 -0.53 -1.4 -3.99 -1.3 -6.37 -0.06 -0.34 2.62 4.75 2.98 0.05 -1.12 5.42 3.25 0.84 -3.61 -3.61 -0.69 0.41 -5.56 -1.75 -5.19 -3.44 -1.37 3.74 0.75 1.1 -0.47 2.42 1.66 5.16
NRF2-ARE regulation%WikiPathways_20191210%WP4357%Homo sapiens -2.73 -2.13 0.32 3.99 -0.97 1.44 -3.56 1.66 -1.35 2.46 -3.69 -3.13 0.43 2.96 0 -1.32 -2.48 -0.74 -2.68 -1.29 2.55 -1.63 -0.72 -0.41 1.49 -0.92 3.59 -0.24 -0.21 1.59 0.47 -1.27 1.39 2.78 0.98 1.91 2.02 2.55 -3.12
Lipid Metabolism Pathway%WikiPathways_20191210%WP3965%Homo sapiens -5.6 -1.71 0.47 0.49 -3.86 -2.04 4.28 3.17 -1.21 2.75 4.34 -0.62 6 0.99 1.29 -2.27 -4.49 -3.31 -0.4 2.47 -4.44 -3.05 -0.77 2.54 2.21 -0.51 0.74 3.86 1.01 5.12 1.9 1.91 -5.17 0.45 0.95 1.76 -2.05 -0.76 -6.43
Phosphodiesterases in neuronal function%WikiPathways_20191210%WP4222%Homo sapiens 3.19 -0.6 -1.91 4.35 4.95 4.17 -6.8 -3.94 0.79 -1.65 -6.1 -1.29 -8.29 0.65 -2.72 2.77 3.44 3.11 -2.73 -2.56 6.31 4.1 -0.69 -3.47 -2.81 -0.24 1.22 -3.56 -1.25 -4.93 -3.41 -1.92 6.21 2.06 0.92 -0.14 4.38 3.96 4.41
Ras Signaling%WikiPathways_20191210%WP4223%Homo sapiens -8.3 -3.12 0.33 -4.67 -7.78 -4.13 12.69 6.24 0.55 2.2 9.52 1.86 10.58 1.57 1.63 -4 -8.27 -6.71 1.68 4.03 -9.78 -6.51 -0.95 6.86 6.15 -0.3 0.02 6.68 1.34 8.2 3.82 6.28 -10.1 1.5 -0.55 1.41 -4.48 -4.55 -10.92
Pyrimidine metabolism and related diseases%WikiPathways_20191210%WP4225%Homo sapiens -1.81 0.62 1.25 -3.29 -2.13 -1.99 3.63 2.12 0.15 -0.05 4.33 1.86 3.56 -0.9 0.89 -1.79 -2.48 -1.46 1.5 0.01 -3.9 -1.78 -0.57 2.41 1.89 0.83 -0.83 3 2.25 2.81 1.73 0.91 -3.3 -1.75 -0.46 -0.18 -2.55 -1.84 -2.72
Purine metabolism%WikiPathways_20191210%WP4224%Homo sapiens 1.44 1.19 0.72 6.74 1.43 3.94 -3.26 -0.4 1.27 0.74 -3.37 -1.15 -1.34 -0.25 1.18 -0.24 0.15 2.21 -1.55 -2.55 3.16 0.49 1.15 -3.26 -0.52 0.21 -0.08 -0.53 -2.31 -3.43 1.37 -1.45 0.48 0.46 -0.73 -3.08 -0.55 1.54 0.18
Ferroptosis%WikiPathways_20191210%WP4313%Homo sapiens -7.89 -4.81 0.61 2.25 -4.43 0.64 2.79 2.2 -0.61 1.95 4.29 -1.57 0.39 0.96 4.03 -3.53 -5.18 -3.43 -1.48 3.06 1.11 -3.51 -1.91 1.75 2.53 -0.58 3.56 3.39 -1.4 0.68 1.5 2.98 -2.59 3.04 3.54 2.44 -0.8 1.26 -7.2
Epithelial to mesenchymal transition in colorectal cancer%WikiPathways_20191210%WP4239%Homo sapiens -5.69 0.14 1.82 -8.23 -6.4 -5.48 12.07 5.63 -1.07 2.66 11.88 2.86 13.13 -1.45 2.57 -3 -5.95 -6.01 4.85 3.43 -13.07 -5.25 0.77 5.64 3.83 -0.68 -2.31 5.28 2.64 8.42 2.87 4.33 -8.1 -1.88 -0.53 1.25 -5.4 -8.14 -7.42
Type 2 papillary renal cell carcinoma%WikiPathways_20191210%WP4241%Homo sapiens 4.41 2.83 -1.31 0.51 2.52 -0.02 -4.64 -1.82 1.49 -0.76 -3.1 -0.75 -2.07 0.86 0.44 1.11 4.44 2.15 -0.76 -2.86 3.95 2.16 -0.07 -4.81 -2.03 0.28 -0.72 -2.7 -0.69 -0.59 -2.52 -2.62 2.68 -0.56 -0.26 -1.38 0.59 0.65 5.93
Regulation of sister chromatid separation at the metaphase-anaphase transition%WikiPathways_20191210%WP4240%Homo sapiens -0.54 2.48 -0.41 -1.51 -1.86 -3.57 3.65 0.65 -1.09 0.01 3.43 0.39 5.49 0.15 1.17 -0.64 -1.04 -1.27 2.77 2.23 -3.29 -0.47 1.25 0.91 -0.58 -0.71 -1.61 0.77 0.22 3.08 0.08 0.81 -3.06 -1.13 0.25 -0.42 -2.03 -2.7 -1.83
Vitamin D in inflammatory diseases%WikiPathways_20191210%WP4482%Homo sapiens -5.93 -1.78 0.82 3.95 -1.68 0.31 0.71 0.38 -1.24 1.36 -0.93 -1.82 3.65 2.16 1.26 -2.11 -4.55 -1.27 -1.7 1.15 0.07 0.01 -1.47 1.26 1.6 -1.88 1.99 0.44 -2.26 2.19 1.62 1.99 -1.48 4.43 1.07 3 -0.08 0.61 -5.86
Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS%WikiPathways_20191210%WP4304%Homo sapiens -0.11 -3.18 -2.98 -2.93 0.93 -0.92 4.07 0.65 3.83 -1.61 4.87 1.61 0.1 -0.42 -1.69 1.13 2.06 -1.61 -2.28 -2.06 -1.78 1.68 -5.37 1.9 2.86 3.21 -1.85 5.39 1.63 0.09 1.84 1.3 -1.34 0.28 -3.43 -0.11 -2.6 -2.84 -0.34
Viral Acute Myocarditis%WikiPathways_20191210%WP4298%Homo sapiens -3.67 -0.05 2.09 -6.72 -5.26 -4.89 8.55 4.65 -0.38 1.27 6.21 1.59 9.85 -0.5 0.9 -1.48 -4.74 -4.19 2.77 2.81 -8.64 -4.39 0.73 5.11 3.4 -0.57 -2.05 4.77 2.16 6.88 3.2 2.76 -6.29 -0.56 -1.05 0.5 -3.86 -4.8 -6.11
Disorders of Folate Metabolism and Transport%WikiPathways_20191210%WP4259%Homo sapiens -0.18 -0.99 0.13 5.08 0.46 4.7 -0.48 -0.65 1.46 0.14 -0.55 -0.48 -1.62 -1.45 -0.73 0.69 -0.04 0.94 -1.17 -0.98 2.49 0.47 0.67 -1.78 0.63 0.66 0.55 0.58 -1.19 -4.09 0.88 -2.53 -0.77 -0.03 -0.15 -0.53 -1.3 1.28 -0.14
Omega-9 FA synthesis%WikiPathways_20191210%WP4724%Homo sapiens -3.53 -0.96 -0.85 -0.21 -2.56 -1.16 2.09 1.76 1.43 0.5 3.22 0.52 1.66 0.14 0.32 -2.75 -2.64 -0.26 -0.94 -0.3 -2.48 -2.74 -0.15 2.05 3.02 1.18 0.55 4.53 0.2 0.96 2.81 -0.52 -1.59 1.36 -0.31 -1.07 -0.64 -0.55 -2.08
Mitochondrial complex I assembly model OXPHOS system%WikiPathways_20191210%WP4324%Homo sapiens -5.42 -5.19 0.8 -1.87 -3.13 -3.6 3.18 -1.12 -7.36 -5.4 8.4 -5.16 -3.38 -1.03 2.36 -1.74 0.35 -5.55 0.3 5.84 1.68 0.58 -1.07 3 -3.07 -0.98 4.28 6.29 -1.44 -1.54 -0.48 8.18 0.55 1.45 6.61 9.13 1.43 -0.41 -5.49
Sphingolipid Metabolism (integrated pathway)%WikiPathways_20191210%WP4726%Homo sapiens -5.14 -3.49 -2.09 -0.72 -1.56 -0.39 3.09 2.33 1.17 1.36 1.97 -0.36 2.96 1.78 1.79 -1.65 -2.3 -2.51 -3.24 0.24 -0.37 -1.44 -3.62 0.99 1.5 0.11 1.33 2.48 -0.07 2.43 1.46 0.09 -1.31 3.47 0.09 2.71 -0.24 1.13 -3.98
Overview of interferons-mediated signaling pathway%WikiPathways_20191210%WP4558%Homo sapiens -2.57 0.97 1.48 -5.09 -4.01 -4.54 9.02 3.23 -1.28 1.5 6.77 2.92 6.2 -1.04 0.84 -1.92 -3.19 -3.75 4.09 2.03 -6.46 -3.42 1.1 3.93 3.13 0.1 -1.88 4.47 2.38 5.51 2.62 0.96 -6.35 -3.25 -1.12 -0.25 -4.74 -4.6 -3.75
Interactions between immune cells and microRNAs in tumor microenvironment%WikiPathways_20191210%WP4559%Homo sapiens 0.9 -1.08 -1.47 5.06 2.71 4.2 -5.03 -1.59 -0.22 -0.86 -4.32 -1.91 -5.47 1.4 -0.91 0.38 1.72 2.11 -3.04 -1.8 6.3 1.54 -1.73 -2.64 -1.92 -0.17 1.62 -2.56 -1.75 -3.22 -1.13 -0.78 3.83 1.53 0.99 1.32 3.06 3.96 0.98
22q11.2 Deletion Syndrome%WikiPathways_20191210%WP4657%Homo sapiens -3.98 0.56 0.47 -4.71 -5.48 -6.03 10.46 3.95 0.88 2.19 7.15 2.99 8.61 -0.47 1.92 -2.59 -5.12 -3.72 2.92 3.19 -8.65 -3.92 -0.02 3.77 3.01 0.21 -2.24 4.25 2.07 6.48 1.92 3.17 -6.92 -1.57 0.71 0.01 -3.77 -5.45 -6.26
Neural Crest Cell Migration in Cancer%WikiPathways_20191210%WP4565%Homo sapiens -5.5 -1.25 -0.51 -1.29 -4.01 -2.52 5.45 2.87 -0.6 1.43 4.11 -0.14 4.29 1.51 1.14 -0.63 -3.14 -2.85 -0.3 1.68 -2.22 -3.39 -2.06 1.83 2.57 -0.15 1.04 2.93 0.26 3.77 1.71 3.82 -3.98 2.58 1.18 1.22 -1.84 -0.73 -8.31
Omega-3/Omega-6 FA synthesis%WikiPathways_20191210%WP4723%Homo sapiens -0.61 -0.39 -0.99 3.57 -0.88 0.18 0.14 1.83 0.72 0.7 1.16 -0.9 -1.22 -1.93 0.13 -1.19 -0.72 1.46 -0.61 -2.45 1.97 -1.78 -0.65 0.65 1.58 1.25 2.1 3.39 -0.47 -3.61 2.75 -3.46 -0.41 -1.23 0.03 -1.03 -1.17 2.18 -0.1
Cysteine and methionine catabolism%WikiPathways_20191210%WP4504%Homo sapiens -4.11 -3 0.19 1.74 -2.59 0.87 1.64 2.06 -0.59 1.93 1.83 -0.94 0.2 0.58 1.21 -1.72 -2.63 -2.98 -1.37 1.58 -0.72 -2.63 -1.31 1.8 0.67 -1.04 2.13 1.85 -0.96 1.16 2.59 1.48 -0.84 1.45 1.82 1.6 0.14 1.01 -4.08
Cell migration and invasion through p75NTR%WikiPathways_20191210%WP4561%Homo sapiens 5.23 1.5 0.19 0.61 3.84 -0.38 -4.15 -1.71 -0.36 -1.64 -2.96 -0.21 -3.79 -2.19 -0.29 1.01 3.24 3.44 0.13 -1.44 2.75 2.62 1.97 -2.06 -2.43 -0.61 -1.03 -2.16 -0.77 -3.25 -0.96 -3.51 3.29 -1.67 -0.48 -0.51 1.98 -0.02 6.76
Control of immune tolerance by vasoactive intestinal peptide%WikiPathways_20191210%WP4484%Homo sapiens -1.72 0.55 0.65 -3.68 -2.59 -3.16 5.91 2.46 -0.85 1.01 4.78 1.24 4.56 -0.68 0.76 -1.03 -2.31 -2.04 2.11 1.59 -4.35 -2.19 1.02 3.52 1.58 -0.32 -1.17 3.34 2.08 3.09 2.01 0.26 -3.78 -2.58 -0.62 -0.31 -2.95 -3.42 -2.77
Relationship between inflammation, COX-2 and EGFR%WikiPathways_20191210%WP4483%Homo sapiens -3.77 -1.11 0.94 -0.8 -4.05 -1.39 6.21 3.27 -0.67 1.02 4.78 0.48 5.46 -0.48 1.82 -3.4 -3.91 -2.44 1.02 2.62 -4.71 -3.06 -0.09 3.22 2.96 -0.29 0.42 4.16 1.51 3.05 2.04 1.42 -5.06 -1.04 -0.89 0.44 -2.06 -2.82 -4.8
IL-10 Anti-inflammatory Signaling Pathway %WikiPathways_20191210%WP4495%Homo sapiens -2.81 -1.76 -0.68 3.57 -0.07 -0.38 -1.74 0.7 -1.3 1.59 1.24 -1.66 -1.2 1.28 1.6 -1.93 -1.97 -0.57 -2.05 -0.06 3.66 -0.35 -0.83 -1.19 0.32 -1.09 3.46 2.46 -1.43 -0.54 -0.98 0.2 -0.91 2.13 2.61 2.26 -0.38 2.06 -3.25
Selective expression of chemokine receptors during T-cell polarization%WikiPathways_20191210%WP4494%Homo sapiens -2.66 0.14 0.88 -4.84 -3.51 -3.51 7.57 3.4 0.11 1.6 6.94 1.76 6.91 -0.65 1.19 -2.02 -3.61 -2.72 2.7 1.8 -6.1 -3.4 0.33 4.85 2.54 -0.12 -1.17 4.07 3.3 4.81 2.1 -0.41 -5.17 -3.01 -1.51 0.16 -3.82 -4.82 -4.1
Neural Crest Cell Migration during Development%WikiPathways_20191210%WP4564%Homo sapiens -5.42 -1.13 -0.12 -1.13 -4.03 -2.4 4.54 2.98 -0.94 1.41 3.39 -0.33 4.39 1.49 0.95 -0.74 -3.11 -2.88 0.13 1.73 -2.07 -3.45 -1.43 1.92 2.59 -0.39 1.36 2.32 0.38 3.68 1.54 3.93 -3.57 2.58 1.27 1.42 -1.68 -0.62 -8.56
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma%WikiPathways_20191210%WP4553%Homo sapiens -3.92 -1.26 0.53 0.81 -2.91 1.04 2.31 2.97 -0.42 1.61 1.14 -0.27 3.63 -0.85 0.74 -2.51 -2.96 -1.71 -0.22 0.48 -2.35 -2.19 0.18 1.9 2.72 -0.62 1.22 2.72 0.43 0.69 2.16 -0.74 -2.07 -0.91 0.01 0.98 -0.48 1.72 -3.6
Hepatitis B infection%WikiPathways_20191210%WP4666%Homo sapiens -7.23 -1.37 1.44 -6.01 -7.39 -5.67 12.02 5.29 -1.63 2.58 10.59 2.01 11.19 -0.14 1.9 -2.62 -6.91 -6.24 2.77 4.83 -9.35 -5.73 -0.03 5.61 4.49 -0.96 -0.71 7.25 2.47 8.22 3.47 5.19 -9.71 -1.32 0.62 1.27 -5.69 -5.39 -9.11
Bile Acids synthesis and enterohepatic circulation %WikiPathways_20191210%WP4389%Homo sapiens -1.66 0.76 0.63 -2.31 -3.5 -1.55 5.34 2.47 -1.04 1.2 4.26 0.76 3.77 0.11 0.73 -0.96 -2.1 -2.11 1.85 1.3 -3.49 -2.54 0.89 2.19 0.61 -0.88 -0.85 3.09 0.8 3.03 0.71 0.87 -3.04 -2.06 0.02 -0.07 -2.56 -1.66 -2.99
Signal transduction through IL1R%WikiPathways_20191210%WP4496%Homo sapiens -2.52 0.86 2.16 -2.64 -4.27 -2.67 5.54 3.08 -0.86 0.93 4.27 1.36 5.8 -1.15 1.2 -1.59 -3.95 -3.16 1.32 2.34 -3.59 -3.66 0.18 2.63 3.05 -0.28 -0.07 3.17 1.16 3.56 2.37 0.85 -3.88 -1.98 -0.95 0.44 -2.38 -2.14 -4.51
Fragile X Syndrome %WikiPathways_20191210%WP4549%Homo sapiens -10.9 -4.57 -0.62 1.01 -6.47 -3.27 8.28 6.25 -1.99 2.95 7.79 -1.99 7.87 2.91 3.37 -3.08 -7.21 -5.52 -2.11 5.02 -3.68 -5.48 -2.19 3.38 3.89 -2.11 1.46 6.13 -0.66 6.34 3.92 3.78 -7.21 4.5 1.94 2.57 -3.15 0.39 -11.56
Translation inhibitors in chronically activated PDGFRA cells%WikiPathways_20191210%WP4566%Homo sapiens 7.7 3.56 0.14 -0.54 4.39 0.07 -5.6 -2.58 0.21 -0.59 -5.98 1.02 -4.28 -0.52 -2.6 2.51 4.23 4.22 1.25 -3.75 2.05 3.03 0.11 -1.94 -2.12 1.17 -1.06 -4.79 -0.02 -3.78 -1.33 -3.96 4.73 -1.75 -1.87 -1.73 1.73 0.66 8.03
Nonalcoholic fatty liver disease%WikiPathways_20191210%WP4396%Homo sapiens -10.76 -6.9 2.16 -0.4 -7.15 -3.66 7.24 1.58 -9.68 -3.79 11.52 -6.59 -0.11 0.7 3.55 -3.95 -4.28 -7.67 -0.64 7.91 0.61 -1.89 -2.33 4.18 -0.64 -2.7 5.8 8.39 -2.35 2.48 0.03 11.32 -2.58 4.21 8.72 11.44 -0.66 -1.2 -11.91
Platelet-mediated interactions with vascular and circulating cells%WikiPathways_20191210%WP4462%Homo sapiens -1.1 -1.02 -0.58 6.8 0.76 1.36 -3.03 -0.03 -3.11 0.75 -1.32 -1.99 -4.06 0.55 1.5 -0.78 -0.59 0.88 -1.43 -1.37 5.26 1.46 -0.55 -2.6 -0.01 -1.75 1.93 0.24 -1.31 -2.52 0.07 -0.83 0.71 0.38 2.07 1.24 0.85 4.38 -1.19
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement%WikiPathways_20191210%WP4560%Homo sapiens -3.67 -1.53 0.33 -1.99 -2.3 -0.6 4.7 2.39 0.72 0.08 2.85 1.27 4.96 -0.56 -0.28 -1.07 -2.38 -2.14 0.27 1.26 -4.91 -2.13 -0.12 2.96 0.8 0.78 0.32 3.31 1.64 2.4 1.25 0.94 -2.47 -1.34 -1.86 1.03 -1.68 -0.41 -2.82
Melanoma%WikiPathways_20191210%WP4685%Homo sapiens -4.04 -0.43 0.86 -6.2 -3.04 -3.81 9.35 3.5 0.68 0 6.79 1.93 6.02 -0.06 0.32 -0.44 -3.24 -4.14 1.89 3.85 -8.11 -2.22 0.7 2.85 2.86 0.53 -3.15 3.95 1.55 6.75 0.78 4.43 -5.77 -0.33 -0.43 -0.05 -2.69 -6.32 -5.1
Glycosylation and related congenital defects%WikiPathways_20191210%WP4521%Homo sapiens 3.78 2.78 -1.97 0.97 2.77 1.24 -3.27 -2.75 0.87 -1.82 -2.71 -0.16 -1.99 0.23 0.59 1.1 2.71 4.5 -0.6 -1.72 3.46 2.87 -0.25 -2.5 -2.31 -0.18 -1.5 -3.61 -1.7 -1.24 -1.92 -1.69 2.72 0.85 -0.33 -1.89 0.6 0.48 3.59
Classical pathway of steroidogenesis, including diseases%WikiPathways_20191210%WP4523%Homo sapiens -0.78 0.36 0.96 -3.75 -1.16 -3.58 4.23 1.52 0.56 0.9 5.99 1.12 4.04 -0.62 1.04 -1.63 -1.78 -2.28 1.86 2.07 -5.32 -1.05 0.7 2.26 1.08 -0.83 -1.67 1.42 0.84 3.26 1.61 0.71 -3.64 -1.57 -0.32 0.06 -2.67 -3.36 -0.59
Computational Model of Aerobic Glycolysis%WikiPathways_20191210%WP4629%Homo sapiens -5.51 -3.82 0.97 2.65 -3.13 -0.77 5.26 4.56 -1.8 2.39 5.02 -1.59 2.59 -2.01 0.18 -1.37 -2.65 -3.24 0.25 3.42 -1.76 -2.9 -0.95 3.38 1.24 -1.15 0.86 5.04 -0.41 0.33 2.27 1.05 -2.83 -1.16 -0.67 1.34 -0.47 0.69 -5.29
Hippo-Yap signaling pathway%WikiPathways_20191210%WP4537%Homo sapiens -2.96 -1.04 -0.44 -1.57 -1.84 -1.53 4.08 -1.22 -0.2 0.45 2.43 0.82 2.1 1.43 0.64 -1.5 -2.56 -1.57 -0.58 0.83 -3.14 -0.5 -1.07 1.49 0.44 -0.45 0.12 1.06 -0.01 5.75 1.7 4.64 -2.65 4.02 1.3 0.15 -2.17 -2.21 -4.23
Synaptic signaling pathways associated with autism spectrum disorder%WikiPathways_20191210%WP4539%Homo sapiens 6.37 1.92 -0.65 0.41 4.67 3.03 -6.26 -4.22 0.94 -1.84 -6.65 0.02 -5.95 0.01 -2.09 2.75 4.34 3.73 -0.61 -2.79 4.92 4.2 0.32 -2.64 -3.3 0.77 -0.2 -5.75 -1.03 -3.85 -3.73 -2.56 6.41 -0.01 -1.02 -1.27 2.75 1.86 7.02
Hippo-Merlin Signaling Dysregulation%WikiPathways_20191210%WP4541%Homo sapiens -7.06 -2.31 -0.11 -2.36 -6.65 -1.91 10.59 3.56 1.53 2.75 7.38 1.93 8.48 0.55 1.48 -3.58 -7.21 -5.31 1.49 2.45 -7.6 -5.53 -1.03 5.8 5.74 0.21 -0.33 5.24 1.07 5.95 4.23 3.43 -7.25 1.64 -0.57 1.12 -4.43 -3.41 -9.99
Regulatory circuits of the STAT3 signaling pathway%WikiPathways_20191210%WP4538%Homo sapiens -5.17 -1.89 1.11 -2.65 -4.83 -3.63 8.2 5.17 -1.5 2.12 6.75 1.26 9.06 -0.98 1.92 -3.09 -4.69 -3.33 1.83 1.34 -6.3 -4.05 0.25 4.52 2.6 -1.35 0.25 6.64 2.02 4.73 2.44 2.01 -5.88 -2.78 -0.49 0.82 -3.34 -3.94 -5.16
Transcription co-factors SKI and SKIL protein partners%WikiPathways_20191210%WP4533%Homo sapiens -4.21 -1.62 0.44 -0.73 -3.44 -0.29 3.29 2.2 -0.88 2.31 2.3 0.31 2.05 0.69 0.43 -1.79 -2.73 -2.27 -0.4 2.64 -3.49 -1.99 -0.3 1.05 1.34 -1.08 1.42 1.44 -0.5 3.61 1.5 2.09 -2.38 1.97 0.84 0.37 -0.43 0.78 -4.54
Genes related to primary cilium development (based on CRISPR)%WikiPathways_20191210%WP4536%Homo sapiens -5.8 -1.5 3.15 -2.77 -6.8 0 6.91 5.77 -0.87 1.64 6.52 1.42 8.47 -0.19 0.95 -2.3 -5.14 -3.74 1.52 2.91 -5.63 -5.19 0.49 3.79 2.33 -0.18 0.1 4.51 1.84 3.72 2.82 1.39 -4.59 -1.42 -0.82 0.02 -4.03 -2.65 -6.64
Intraflagellar transport proteins binding to dynein%WikiPathways_20191210%WP4532%Homo sapiens -5.17 -2.96 0.67 0.51 -2.17 -0.48 2.36 1.09 -1.55 1.05 3.59 -1.67 1.25 1.41 1.81 -2.09 -2.58 -3.2 -0.33 2.89 -0.44 -2.88 0.22 0.92 -0.66 -0.75 1.74 2 -0.29 2.27 0.11 3.72 -3.09 2.34 2.58 3.45 -0.05 0.36 -6
Envelope proteins and their potential roles in EDMD physiopathology%WikiPathways_20191210%WP4535%Homo sapiens -5.87 -3.45 -1.47 0.82 -4.23 -1.44 3.41 4.92 -0.05 1.08 4.47 -0.65 6.29 -1.31 1.25 -2.39 -3.52 -3.33 -0.28 1.61 -2.04 -3.46 -0.49 3.14 2.21 0.03 1.98 4.24 0.7 2.52 1.77 0.1 -3.81 -0.35 0.06 1.11 -0.87 2.58 -5.27
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms%WikiPathways_20191210%WP4534%Homo sapiens -4.6 -1.37 0.34 -2.45 -4.2 -3.2 6.75 1.44 0.04 2.07 4.17 1.29 5.95 0.46 1.1 -2.44 -4.38 -2.91 0.37 1.29 -5.1 -2.77 -1.15 3.32 3.26 -0.37 -0.03 2.19 0.28 6.23 3.4 2.64 -4.02 1.38 0.49 1.16 -2.21 -1.66 -6.74
Pathways Regulating Hippo Signaling%WikiPathways_20191210%WP4540%Homo sapiens -7.44 -2.97 0.15 -2.81 -5.69 -0.75 10.95 3.77 0.33 2.96 7.52 1.18 8.75 0.95 1.28 -4.06 -7.02 -5.77 0.59 2.62 -7.9 -4.91 -0.24 5.56 5.17 0.04 0.11 5.73 1.32 6.6 4.68 3.09 -7.81 0.95 -0.43 0.76 -4.74 -3.5 -9.01
Small cell lung cancer%WikiPathways_20191210%WP4658%Homo sapiens -3.23 0.81 1.3 -7.79 -4.11 -4.45 9.37 3.1 1.16 0.46 7.65 2.17 9.02 -0.22 0.13 -1.7 -4.12 -3.96 2.09 1.63 -9.26 -3.43 0.27 5.09 2.68 -0.25 -1.58 5.49 2.23 6.89 1.54 4.1 -5.41 -1.13 -1.06 0.17 -3.02 -7.25 -5.38
Joubert Syndrome%WikiPathways_20191210%WP4656%Homo sapiens 4.75 1.84 -1.92 1.86 5.25 0.97 -7.11 -4.17 0.15 -1.25 -7.03 0.16 -6.5 -0.22 -1.68 3.26 4.29 3.71 -0.74 -1.12 4.75 3.88 0.74 -3.3 -3.65 -1.11 0.35 -6.41 -1.48 -3.2 -3.88 0.1 5.86 1.57 0.95 -0.44 3.16 1.93 5.69
Cytosolic DNA-sensing pathway%WikiPathways_20191210%WP4655%Homo sapiens 3.51 -0.89 -1.79 5.87 4.99 5.47 -8.69 -3.2 2.07 -1.43 -8.25 -2.88 -6.84 0.69 -1.11 1.62 3.53 3.14 -3.61 -3.69 7.66 3.34 -0.27 -4.31 -3.92 0.62 1.4 -5.81 -1.64 -6.22 -1.86 -2.66 6.99 1.95 0.5 -0.29 5.43 5.67 4.94
Cancer immunotherapy by CTLA4 blockade%WikiPathways_20191210%WP4582%Homo sapiens -4.41 -0.78 0.08 1.11 -2.65 -0.7 1.77 1.96 -1.6 0.08 4.61 -2.57 0.66 0.03 0.57 -0.14 -3.15 -0.91 -0.39 0.82 0.26 -2.32 -0.03 0.5 2.56 -1.33 0.54 4.16 -0.44 1.4 0.96 3.38 -2.53 1.92 1.89 0.85 -1.3 0.11 -4.99
Biomarkers for pyrimidine metabolism disorders%WikiPathways_20191210%WP4584%Homo sapiens -1.82 0.47 1.4 -1.42 -2.51 -1.04 3.59 1.8 0.13 -0.04 2.84 1.5 3.23 -0.41 1.04 -2.13 -3.51 -1.67 1.58 0.03 -3.24 -1.83 -0.11 2.17 1.53 0.85 -0.79 2.88 1.18 2.8 1.94 0.64 -3.16 -0.65 -0.07 -0.04 -2.27 -2.19 -2.68
Biomarkers for urea cycle disorders%WikiPathways_20191210%WP4583%Homo sapiens -3.4 -0.34 0.16 -1.52 -2.23 -0.96 3.41 1.94 -1.24 2.49 4.62 -0.55 3.34 -0.32 0.74 -0.8 -2.01 -1.79 1.24 0.88 -3.16 -2.74 0.2 1.84 0.78 -0.9 0.93 2.23 0.62 2.28 0.78 0.2 -1.88 -1.41 -0.39 1.74 -1.08 -0.35 -3.36
Cancer immunotherapy by PD-1 blockade%WikiPathways_20191210%WP4585%Homo sapiens 1.12 -0.84 -0.92 3.39 2.57 3.24 -5.1 -2.08 1.07 -1.2 -5.64 -0.77 -6.51 -0.01 -1.08 1.28 2.49 1.65 -2.49 -1.64 6.18 2.09 -0.37 -3 -1.54 0.85 1.16 -3.33 -1.3 -3.29 -0.91 -0.91 4.28 1.74 0.66 0.57 2.72 3.74 2.12
Pathways of nucleic acid metabolism and innate immune sensing%WikiPathways_20191210%WP4705%Homo sapiens -3.37 0.28 -0.28 0.41 -3.19 -2.11 3.34 1.95 -1.3 0.87 4.14 -1.1 1.49 -0.34 0.93 -1.73 -2.87 2.23 0.55 1.86 -1.22 -2.93 0.1 0.03 2.15 -0.27 0.52 3.75 -0.37 1 1.3 0.36 -1.69 -1.09 1.08 0.96 -1.03 -1.79 -2.63
Major receptors targeted by epinephrine and norepinephrine%WikiPathways_20191210%WP4589%Homo sapiens -0.13 0.89 1.21 -2.38 0.61 0.77 0.18 -1.28 2.25 0.91 -4.53 3.18 2.23 1.74 -0.86 -0.73 -1.8 0.44 0.65 -0.02 -1.58 -0.57 1.17 -0.44 -0.36 1.26 0.7 -5.78 1.59 2.42 -0.34 -0.38 0.56 0.37 -1.71 0.11 1.2 -3.23 1.71
Urea cycle and associated pathways%WikiPathways_20191210%WP4595%Homo sapiens -5.24 -2.57 -0.49 -2.5 -3.32 -0.67 4.64 2.83 -2.59 2.29 4.72 -2.26 2.66 0.4 1.68 -1.56 -2.99 -3.49 -0.35 1.72 -2.76 -3.26 -1.56 2.16 1.83 -1.19 2.85 4.37 0.16 3.14 0.78 2.41 -1.73 1.29 1.36 2.9 -0.33 0.65 -5.95
Eicosanoid metabolism via Cyclo Oxygenases (COX)%WikiPathways_20191210%WP4719%Homo sapiens -1.53 -0.16 1.43 -3.86 -2.62 -1.77 4.03 2.37 -1.77 1.77 3.54 1.6 7.45 -0.15 1.46 -1.56 -2.1 -3.64 2.14 2.62 -5.48 -1.82 1.35 1.88 0.82 0.07 0.49 1.3 1.81 4.74 0.28 0.67 -3.52 -2.17 -0.57 -0.3 -2.19 -4.64 -1.99
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways)%WikiPathways_20191210%WP4718%Homo sapiens 7.39 4.32 0.4 0.44 5.6 3.82 -2.11 -3.59 3.6 -2.51 -3.97 3.61 -3.85 -2.9 -3.67 3.09 4.44 2.9 -0.05 -2.09 2.17 4.36 0.48 -3.81 -2.98 2.22 -2.21 -3.9 1.83 -4.28 -3.05 -3.7 1.03 -4.79 -4.09 -1.14 0.15 -0.72 7.55
Genes involved in male infertility%WikiPathways_20191210%WP4673%Homo sapiens -5.16 0 3.08 -6.44 -7.31 -5.15 13.52 5.07 -2.04 2.59 9.78 2.62 10.51 -1.21 1.23 -3.48 -5.97 -5.61 3.82 3.32 -11.27 -5.43 1.68 7.58 3.35 -0.69 -1.47 7.39 2.88 6.96 5.47 3.72 -8.66 -4.24 -1.12 0.98 -5.7 -6.68 -7.89
Head and Neck Squamous Cell Carcinoma%WikiPathways_20191210%WP4674%Homo sapiens 6.86 1.64 -0.22 1.91 4.85 2.32 -7.24 -4.9 0.74 -0.73 -7.91 -1.34 -6.69 0.8 -1.81 3.37 4.78 4.72 -0.99 -2.91 4.61 3.82 -1.66 -4.18 -2.91 0.62 0.55 -4.7 -1.41 -3.78 -2.24 -3.37 6.39 1.47 -0.78 -1.38 2.45 2.51 6.78
Eicosanoid metabolism via Lipo Oxygenases (LOX)%WikiPathways_20191210%WP4721%Homo sapiens -1.28 -0.06 1.45 -3.21 -3.02 -3.43 6.33 2.45 -1.47 1.97 5.8 2.63 4.51 -0.82 1.37 -1.65 -2.23 -4.11 2.22 2.1 -6.58 -2.48 1.1 3.15 1.69 0.36 -0.28 4.37 2.13 4.47 2.21 0.46 -4.12 -3.09 -0.91 0.18 -3.38 -5.71 -3.12
Sphingolipid Metabolism (general overview)%WikiPathways_20191210%WP4725%Homo sapiens -5.14 -3.49 -2.09 -0.72 -1.56 -0.39 3.09 2.33 1.17 1.36 1.97 -0.36 2.96 1.78 1.79 -1.65 -2.3 -2.51 -3.24 0.24 -0.37 -1.44 -3.62 0.99 1.5 0.11 1.33 2.48 -0.07 2.43 1.46 0.09 -1.31 3.47 0.09 2.71 -0.24 1.13 -3.98
Nephrotic syndrome%WikiPathways_20191210%WP4758%Homo sapiens 2.81 -0.04 -2.18 4.8 3.47 2.4 -6.46 -2.7 1.43 -0.89 -5.94 -1.77 -5.48 -0.28 -0.66 1.26 3.25 3.13 -2.07 -2.28 6.66 3.44 -1.71 -2.36 -3.89 0.35 1.25 -3.78 -1.6 -3.28 -1.89 -2.27 4.61 0.5 0.9 -0.24 3.43 3.94 4.16
Gastrin Signaling Pathway%WikiPathways_20191210%WP4659%Homo sapiens -8.26 -2.61 0.51 -2.07 -6.05 -2.4 9.37 5.08 -0.71 1.21 9.25 0.91 9.82 0.78 2.06 -3.28 -7.21 -4.97 0.42 3.91 -7.85 -4.19 -0.88 5.07 4.71 -0.4 -0.09 5.77 0.45 5.73 2.89 3.63 -7.07 1.57 0.22 1.58 -3.81 -3.78 -9.35
